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 INTRODUCTION 
Well being of humans are not designed in heaven but by us and the atmosphere 
around us. Dramatic life style modifications have introduced lots of harmful effects in 
the form of diseases to the society. Health of an individual not only depends on his 
physical state but also on his Mental state. Healthy state of a person is not only good to 
himself but also for the people around him and the community. So, in the present era, it 
is very important for every individual to keep their health on right track. To make the 
body and the mind in perfect shape, people are in a quest for a natural remedy which 
will be rendered by our traditional system. 
One such Traditional system is Siddha system of medicine which is one of the 
oldest Traditional system in the world. It is a system which not only deals with the 
physical health but also induces changes in the soul of an individual. Our Siddha system 
stabilises the mind and improves the well being of a person. The medicines used in 
Siddha system are prepared from Herbals, Minerals and Animals which will not cause 
any side effects on proper usage. It is a science which deals with the Nature. Natural 
materials are always admired by people from the past. In this materialised world, people 
have started to look back at their Traditional science in which the natural atmosphere 
dwells. Nowadays not only the body of the human being gets affected by disease but 
also the Mind due to various activities being followed nowadays. So it is very obvious 
that the society is looking for a system which provides holistic approach for curing 
diseases and it will be provided by our Siddha system. 
Siddha system of medicine was introduced by Siddhars who practised and 
professed Spiritual practice to attain Salvation. Siddhars are persons who practised 
Meditations, Pranayamas and other Yogic practices so that they could reach a stage of 
insight which would provide them supernatural power to cure the sufferings. They 
discovered many natural medicines which are widely used for treating many diseases. 
Siddhar Yugi Munivar has classified Vatha diseases into 80 types in Yugi 
Vaithiya Chinthamani 800. Cegana Vatham is one among them.The symptoms are pain 
around the neck, giddiness, pain in the limbs, burning sensation of the eyes, pain all over 
the body like a sting of a scorpion. This condition can be correlated with Cervical 
Spondylosis in Modern science. 
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Cervical spondylosis is a disease which causes pain, swelling, restriction of 
movements in the cervical region and produces lots of hindrance in day to day activities 
of an individual. Nowadays pain in the neck has become a matter of major concern. It is 
mainly due to life style modifications. Pain in the neck is experienced by many people 
due to increase in usage of computers not only by software professionals but also by 
people of other professions. Apart from them hard workers who have to lift heavy 
weights also undergo the same problem. Nowadays most of the people are following a 
sedentary way of life. So the chances of developing Cervical Spondylosis is also highly 
increased. 
  The hectic schedule followed by the people nowadays has reduced the time 
which was utilised for doing yoga, physical exercises, relaxation etc. Degenerative 
changes in the body which used to happen only after the fifth decade in life has started 
to produce degenerative changes in the third decade itself. Many youngsters nowadays 
are affected by Cervical spondylosis due to degenerative changes in the spine.  
It can be seen in people as early as 25 years of age. As the age increases so does 
the incident rate. 60% of the population older than 45 years of age and 8% older than 65 
years of age account for the case of cervical spondylosis reported. In males, the 
prevalence was 13% in the third decade, increasing to nearly 100% by age 70 years. In 
females, the prevalence ranges from 5% in the fourth decade to 96% in women older 
than 70 years. 
People are looking for a treatment without any adverse effects which may be 
caused by Analgesics and Anti–inflammatory drugs used in Modern science. 
Furthermore, Surgery is also one of the treatment options for Cervical spondylosis in 
Allopathic system. It may prove to be costly. So the community is looking for a 
treatment which is cost effective, free from side effects and the one which provides good 
relief from the disease. Increased prevalence of the disease and the dreadful effects 
caused by the disease reckons a suitable treatment for the disease.  
Maha Analuruva Chooranam (Internal) and Pungan ennai (External) have been 
taken as the trial drugs. These drugs are also mentioned in Siddha Sastric texts. The 
Internal drug Maha Analuruva Chooranam is a Herbal preparation. Most of the raw 
drugs in Pungan ennai which is used for external application have Anti –Vatha property.   
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 Other than the internal and external medications used in Siddha system, an 
unique art in the name of Varmam has been gifted to the community by Siddhars. 
Stimulation of certain energy (Varmam) points in the body cures diseases pertaining to 
the muscles, tendons, ligaments, bones and internal organs. In this study, apart from 
Internal and External medicines, the effect of Varmam therapy also be assessed. 
The Pre clinical and clinical study on “Maha analuruva chooranam” (Internal) 
and “Pungan ennai” (External) for the treatment of “Cegana vatham (Cervical 
spondylosis)” has been framed to find out the efficacy of the internal and external 
medicines along with Varmam. 
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AIM AND OBJECTIVES 
Primary objective: 
To evaluate the safety and therapeutic efficacy of “Maha Analuruva 
Chooranam” (Internal medicine) and “Pungan Ennai” (External medicine) in reducing 
the pain in Cegana vatham. 
Secondary objectives: 
 To evaluate the effect of varmam along with trial medicines.  
 To study the Siddha parameters before and after treatment.  
 To access the disease related to Age, Sex, Socio – economic status, Habits, 
Family history etc. 
 To find out any adverse effects during the trial. 
 To evaluate the safety of the trial drug by doing Toxicological studies in animal 
models.  
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LITERATURE REVIEW 
Anti – Inflammatory and Analgesic activity 
K.Lakshmi Sindhoor et al. evaluated the anti inflammatory activity of petroleum ether 
and ethanolic extracts of Brassica juncea against carrageenan induced paw edema. 
Acute toxicity study was performed up to 2gm/kg p.o and animals did not show any 
mortality and behavioral changes. Both the extracts inhibited carrageen induced paw 
edema in a dose dependent manner and among the two extracts ethanolic extract shows 
better anti-inflammatory activity when compared to petroleum ether extract
1 
Sekar Mahendran et al. evaluated the Synthesis and evaluation of analgesic and anti-
inflammatory activities of most active free radical scavenging derivatives of embelin-A 
structure-activity relationship. Para-substituted embelin derivatives along with embelin 
were studied for analgesic and anti-inflammatory activities at 10 and 20 mg/kg doses by 
standard methods. Potent analgesic activity higher than the standard pentazocine was 
observed. Embelin and both of its derivatives almost completely abolished the acetic 
acid induced writhing. p-Sulfonylamine phenylamino derivative showed better anti-
inflammatory activity than embelin.
2 
M.S Al-Ghamdi
 
et al. evaluated the anti-inflammatory, analgesic and antipyretic 
activity of Nigella sativa. The aqueous extract of Nigella sativa (N. sativa) was 
investigated for anti-inflammatory, analgesic and antipyretic activities in animal models. 
The extract has an anti-inflammatory effect demonstrated by its inhibitory effects on 
Carrageenan induced paw edema. It also produced significant increase in the hot plate 
reaction time in mice indicating analgesic effect. However, N. sativa crude suspension 
had no effect on yeast induced pyrexia. This study therefore, supports its use in folk 
medicine both as analgesic and anti-inflammatory agent and calls for further 
investigations to elucidate its mechanism of action.
3 
PEI LUO et al. evaluated the Anti-inflammatory and analgesic effect of plumbagin 
through inhibition of nuclear factor-kappa B activation. He reported that Plumbagin 
exhibits anti-carcinogenic, anti-inflammatory and analgesic activity. The results showed 
that Plumbagin  significantly and dose-dependently suppressed the paw edema of rats 
induced by carrageenan and various pro-inflammatory mediators, including histamine, 
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serotonin, bradykinin and prostaglandin E2.  Studies showed that Plumbagin effectively 
decreased the production of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α. It also 
inhibited the expression of pro-inflammatory mediators iNOS and COX-2 while did not 
inhibit the expression of COX-1. Further studies demonstrated that PL suppressed IκBα 
phosphorylation and degradation and thus inhibited the phosphorylation of p65 subunit 
of NF-κB. This study suggests that PL has a potential to be developed into an anti-
inflammatory agent for treating inflammatory diseases.
4 
Kumar et al. demonstrated that piperine inhibits adhesion of neutrophils to endothelial 
monolayer. The inhibition of neutrophils to endothelial monolayer by piperine is due to 
its ability to block the tumor necrosis factor-α (TNF-α) induced expression of cell 
adhesion molecules i.e. ICAM-1 (intercellular adhesion molecule-1), VCAM-1 
(vascular cell adhesion molecule-1) and E-selectin as analyzed by cell-ELISA and 
confirmed by flow cytometry. Further, we demonstrate that inhibition of ICAM-1 by 
piperine is reversible. As nuclear factor-κB (NF-κB) is known to control the 
transcriptional regulation of cell adhesion molecules hence, we measured the effect of 
piperine on NF-κB in the cytoplasm and in the nucleus of endothelial cells. We 
observed that pretreatment of endothelial cells with piperine blocks the nuclear 
translocation and activation of NF-κB via blocking the phosphorylation and degradation 
of its inhibitory protein, IκBa. Piperine blocks the phosphorylation and degradation of 
IκBa by attenuating TNF-α induced IκB kinase activity. These results suggest a possible 
mechanism of anti-inflammatory activity of piperine. Therefore, piperine or its 
structural analogues could be used for the development of new anti-inflammatory 
molecules.
5 
Mohan et al. demonstrated the effect of a polyherbal formulation-PHF [each 3 g 
powder containing Terminalia chebula R.(0.24 g), Nelumbo nucifera G. (0.24 g), 
Hemidesmus indicus R. (0.24 g), Zingiber officinale R. (0.24 g), , Quercus infectoria O. 
(0.12 g), Hibiscus rosa-sinensis L. (0.24 g), Rosa damascene M.(0.24g), Eclipta alba 
H.(0.24 g), Glycyrrhiza glabra L. (0.24 g)]. Analgesic activity of PHF containing 
Terminalia chebula was studied in mice using acetic acid induced writhing, tail 
immersion and hot plate methods. Anti-inflammatory activity of PHF was studied in rats 
using carrageenan induced hind paw edema and formalin induced rat paw edema 
methods. PHF significantly (P < 0.05) reduced the number of writhings, increased 
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latency to flick tail in tail immersion method and elevated the mean basal reaction time 
in hot plate method. PHF significantly (P < 0.05) inhibited carrageenan induced hind 
paw edema and formalin induced rat paw edema. The PHF was tested at dose of 30, 
100, 300 and 500 mg/kg. Thus, it is concluded that PHF posses analgesic and anti-
inflammatory properties which are probably mediated via inhibition of prostaglandin 
synthesis as well as central inhibitory mechanism and may have a potential benefit for 
the management of pain and inflammatory disorders.
6 
Haw-Yaw Young et al. demonstrated the analgesic and anti-inflammatory effects of 
[6]-gingerol, which is the pungent constituent of ginger. Intraperitoneal administration 
of [6]-gingerol (25 mg/kg–50 mg/kg) produced an inhibition of acetic acid-induced 
writhing response and formalin-induced licking time in the late phase. [6]-Gingerol (50 
mg/kg–100 mg/kg) also produced an inhibition of paw edema induced by carrageenin. 
These results suggested that [6]-gingerol possessed analgesic and anti-inflammatory 
activities.
7 
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PREVIOUS STUDIES ON THE EFFICACY OF SPECIFIC DRUGS IN 
CEGANAVATHAM: 
 In April 2012, Chandraprakasa Maththirai and Azhinjil Thailam were studied in 
treating Ceganavatham. 
 In April 2011, Sundara Agnikumara Rasam and arkathy thailam were studied in 
treating Ceganavatham. 
 In April 2011, Theer Anthaskan Maththirai and Arkathi thailam were studied in 
treating Ceganavatham . 
 In March 2010, Mahaveera mezhugu and Vathasamhari thailam were studied in 
treating Ceganavatham . 
 In March 2010, Vithurasa mezhugu and Vatha ennai were studied in treating 
kumbavatham which is a clinical entity mimicking Ceganavatham. 
 In September 2007, Saganavatha chooranam and Vatha noi thailam were studied 
in treating Ceganavatham. 
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SIDDHA ASPECTS 
The main cause for the disease Ceganavatham is due to the derangement in 
Vatham.  
VATHAM 
Definition: 
 In Siddha system, Vatham or Vayu performs motor and sensory functions at 
cellular level in the body. It is responsible for the movements of the body. So Vatha 
humour is responsible for the anabolic activity in the human body. 
Synonyms – Vayu, Vali, Arasan, Air. 
Vatham: 
 Vatha = Vali + Aagayam 
 The combination of Vali bootham and Aagaya bootham forms vatham 
Mode of Action: 
 Actually it is invisible.  It can be professed through its movements in our body. 
Locations:  
 Below the navel. 
  „ehnkd;w thjj;Jf; fpUg;gplNk Nfsha; 
    ehgpf;Ff; fPnod;W etpy yhFk;.”                 - A+fpKdp 
As per Yugi muni, “Vatham” lives in, 
1. Abaanan 
2. Edakalai 
3. Kamakodi 
4. Undhiyin Keezh moolam 
5. Hip region 
6. Bones 
7. Muscles 
8. Nerves 
9. Joints 
10.  Skin 
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11.  Hair follicles and 
12.  Stools. 
It also lives in the Gastro Intestinal Tract, Bones, Ear, Thigh, Hip and Skin. 
 Properties of Vatham
8 
1. Giving briskness 
2. Expiration and Inspiration 
3. Functioning of the mind, thoughts and body 
4. Regulation of the “Fourteen Physiological Reflexes” (Vegam) 
5. Functioning of the “Seven Udal Kattukal” uniformly 
6. Protection and strengthening of the Five sensory organs. (Iymporigal) 
Charecteristics of Vatham: 
1. Body ache 
2. Pricking pain 
3. Tearing pain 
4. Nerve weakness 
5. Mental distress 
6. Movements 
7. Pain in the joints 
8. Traumatic pain 
9. Dislocation of joints 
10.  Weakness of organs 
11. Paralysis of limbs 
12.  Polydypsia 
13.  Severe pain in calf and thigh muscles 
14.  Bony pricking pain 
15.  Anuria and constipation 
16.  Unable to do flexion and extension of the limbs 
17.  All tastes like astringent 
18.  Excess salivation. 
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Natural Qualities of Vatham: 
  1. Kadinam  -  Roughness 
  2. Varatchi  -  Dryness 
  3. Elesu   -   Lighter 
  4. Kulirchi  - Coldness 
  5. Asaithal  -  Unstableness 
  6. Anuthuvam      -  Subtleness 
Opposite Qualities of Vatham: 
  1. Mirudhu  - Softness 
  2. Pasumai  - Unctuous  
  3. Baluvu  - Heaviness 
  4. Akkini  - Hot 
  5. Sthiram  - Stableness 
  6. Katti                -      Solidity. 
Relation of Vatham with Taste: 
  ‘GspJtH tpQ;Rq;fwp ahw;G+hpf; Fk;thjk; 
   xspAtH ifg;Ngwpy; gpj;JrPWk; - fpspnkhopNa 
   fhHg;gpdpg;G tpQ;rpw;fgk; tpQ;RQ; rl;bujr; 
   Nrug; GzH NehaZfhNj” 
 The tastes, which increase „Vatham‟ are Sour and Astringent. 
 ‘thj Nkypl;lhy; kJuk; Gspag;G 
 NrjKwr; nra;AQ; rpiwiak; -Xjf;Nfs; 
 fhue; JtH frg;G fhl;LQ; Ritnay;yhk; 
 rhug; ghpfhuQ; rhw;W” 
                     - fz;Zrhkpak; 
The tastes, which neutralizes Vatham are Sweet, Sour and Salt. 
Relation of Uyir Thathukal with Five Elements: 
 Vatham - Air  +  Sky. 
 Pitham  - Fire 
 Kabam  - Water + Earth. 
  “Air” and “Sky” constitutes vatham. Any alterations in the normal functions of 
Air and Sky causes derangement in Vatham.  
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Regarding taste, “Air” contains bitter, pungent and astringent taste and “Sky” 
has Bitter as its taste. So if these are consumed in excessive amounts results in the 
vitiation of vatham and eventually vatha disease. The six tastes and their constituent 
elements are as follows. 
 1. Sweet =         Earth + Water 
 2. Sour  =         Earth + Fire 
 3. Salt  =         Water + Fire 
 4. Bitter =         Air + Sky 
 5. Pungent =         Air + Fire 
 6. Astringent   =        Earth + Air 
 
DESCRIPTION OF VATHAM: 
As per Siddha texts, the general principles of Vatham are divided into ten 
subsidiary forms that differs from one another by their Anatomical and by their 
Physiological actions . They are, 
1. PRAANAN :   (Centre of Heart) 
 It corresponds to the Cardiac plexus and refers to the chest. It maintains the 
action of the heart, the functioning of the mental faculties of perception and 
concentrations and also responsible for the actions of arteries, veins and nerves. It 
regulates respiration and digestion. It is otherwise called as “Uyirkkaal”. 
2. ABAANAN: (Centre of Moolaadharam) 
 It corresponds to the pelvic plexus and controls excretion. It is mainly focussed 
in the lower part of the gut and also occupies the sites in the bladder and genitals. It has 
the tendency to move downwards. It moves in the whole Genito Urinary Tract and 
regulates defaecation, micturition, menstruation, parturition and ejaculation. It is 
otherwise termed as “Kezhnokkum kaal”. 
3. VIYAANAN: (Centre of Fore head) 
 It corresponds to the naso cilary plexus present at the root of the nose and base 
of the skull and controls the will. It helps in the circulation of energy throughout the 
nervous system and the movements of various parts of the body. It also transports 
nutrients and blood throughout the entire body. It is also known as “Paravukaal.” 
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4. UDHAANAN: (Centre of Throat) 
 This corresponds to the pharyngeal plexus in the throat region and controls 
speech and breathing. It is also responsible for the physiological reflex actions like 
vomiting, hiccup, cough, etc., It has the tendency to travel upwards. It is otherwise 
named as “Melnokkum kaal.” 
5. SAMAANAN: (Navel Centre) 
It corresponds to the navel region and controls digestion. It supplies the energy 
derived from digested food substances to all parts of the body. It balances other „Vayus” 
it is also called “Nadukkaal.” 
6. NAAGAN: 
 It is responsible for the intelligence of an individual, winking, singing and the 
action of  pilo erection. 
7. KOORMAN: 
 It is responsible for yawning, closing of mouth, winking, shedding of tears, 
vision and opening of the eyes. 
8. KIRUKARAN: 
 It is responsible for salivation and nasal secretion. It helps in digestion and 
meditation. It produces cough and sneeze. 
9. DHEVATHATHAN: 
 It is responsible for laziness, lassitude, quarreling, arguing, and also for 
excessive anger. It helps in the movements of the eyeball along various directions and is 
present in genital and anal region. 
10. DHANANJEYAN: 
 It is present in nose and responsible for swelling of the body and tinnitus. It 
leaves from the body by blowing up the cranium on the third day after death of an 
individual.
9
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BEHAVIOURAL CHARACTERISTICS OF VATHA DHEGI:
10 
1. Performs activity              -  Very rapidly 
2. Motivated enthusiastic and excitable-  Very easily 
 3. Consistency of faeces   -  Hard, Dry, Stools 
 4. Sexual desire  -           Less 
 5. Amount of sleep  -  Usually 5-6 hours 
 6. Quality of sleep  -   Light, easily interrupted 
 7. Type of dreams  -   Fear, Flying, Running, Jumping, climbing  
  trees and mountains 
 8. Response to challenge  -   Uncertain, worried and indecisive 
 9. Speech   -    Fast, omitting words and digressing 
 10. Gait   -             Fast, with a light step. 
PHYSICAL CHARACTERISTICS OF VATHA DHEGI
11 
1. Structure        -   Thinbody and elongated plain looking 
2. Complexion             -  Dark, brownish or Black 
3.  Body weight  -  Light and below normal 
4.  Skin   -  Dry 
5. Body temperature             -          Low, cold extremities 
6. Stamina   -  Short 
7. Charateristics of eyes  -  Dry, frequent blinking 
8. Teeth   -  Very small or protruding crooked 
9. Nails   -           Short, rough, brittle, dark and lustreness. 
10. Lips              -   Dark, dry, and cracked 
11. Colour and texture of hair - Thin, Coarse, dry and wiry, darker in colour  
12. Joints   -  Loose or rigid and cracking sound  
13. Body odour            -           Little or no smell or perspiration 
AETIOLOGY OF VATHA DISEASES: 
 The aetiological factors for all types of vatha diseases including 
“Ceganavatham” have been described generally in “Yoogimunivar Vaithya Sindhamani 
perunool-800” and Agasthiyar Kanma Kaandam-300”. 
18 
 
THE FEATURES OF EXAGGERATION OF VATHAM:
12 
1. Body weakness and darkness 
2. Desire to eat hot foods 
3. Shivering 
4. Abdominal distension 
5. Constipation 
6. Reduced  immunity 
7. Giddiness 
8. Insomnia 
9. Laziness 
THE FEATURES OF DIMINUTION OF VATHAM
12 
1. Body ache 
2. Hoarseness of voice 
3. Loss of memory 
4. Semi consciousness 
5. Difficulty in performing work 
6. Paleness and coolness of the body 
7. Heaviness of the body 
8. Cough, sleep and abdominal distension 
1. Kanmendhiriyam: 
1. Kai    - Work done by the hands 
2. Kaal  - For walking 
3. Vaai  - For speaking 
4. Eruvai  - For defaecation 
5. Karuvai  - For reproduction 
In Ceganavatham, Kai is affected since pain and numbness is present in both 
upper limbs  
2. Gnaanendhiriyam: 
 The five Gnaanendhiriyam are 
1. Mei   - Feels all types of sensations 
2. Vaai  - For taste 
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3. Kan   - For vision 
4. Mookku   - For smell 
5. Sevi   - For hearing 
3. Uyir Thaathukkal: 
1. Vatham: 
 In Ceganavatham the following Vayus are affected. 
a) Viyanan: 
Neck pain, restricted movements of the neck, radiating pain in the shoulders and 
upper limbs, tingling sensation, numbness and giddiness. 
b) Abanan: 
Constipation 
c) Samanan: 
Indigestion, imbalance in the functions of other vayus. 
d) Udhanan: 
Cough may be present 
e) Naagan: 
Sluggishness, mental depression 
f) Devathathan: 
Sleeplessness 
PITHAM: 
 Pitham is located in Urinary bladder, Heart, Head, Umbilicus, Pinkalai, 
Abdomen, Stomach, Sweat, Blood, Eye and skin. It is classified into five types as, 
1. Anar pitham  :  It digests all the ingested food substances 
2. Ranjaga pitham  :  It gives colour to the blood 
3. Saadhaga pitham            :  It is used to complete the work properly   
4. Alosaga pitham            :          It gives vision to the eye 
5. Piraasaga pitham            :          It gives colour to the skin. 
Saadhaga pitham is more commonly affected in Cegana vatham. 
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KABAM: 
 Kabam is located in Semen, Fat, Bone marrow, Nose, Chest, Nerves, Bones, 
Brain, Large intestine, Stomach and Pancreas. It is divided into five types. They are 
1. Avalambagam   :  It controls other four types of kabham 
2. Kiledhagam              :  It moistens the food 
3. Podhagam              :  It helps to know the taste 
4. Tharpagam              :          It gives cooling effect to the eyes. 
5. Sandhigam             :  It gives lubricating effect to the joints 
In Cegana Vatham Tharpagam and Sandhigam are affected. 
Udal Thaathukkal: 
1. Saaram   -  It strengthens the body and mind 
2. Senneer   -  It gives power, knowledge and boldness to a person      
3. Oon  -  It gives structure and shape to the body and  it is  
                 responsible for the movements of the body 
4. Kozhuppu            -   Lubricates the joints and facilitates their   
                 functions 
5. Enbu   -  Protects all the internal organs and gives   
                structure to the body 
6. Moolai   -  It is present in the bones and gives strength 
7. Sukkilam             -           Useful in reproduction  
 (or) Suronidham 
Thinaigal: 
Nilam is classified into five types. They are, 
1. Kurinji   :  Mountain and its surroundings. Kabanoigal  
and liver diseases are common 
2. Mullai   :  Forest and its surroundings, pitha noigal, vatha
    noigal, liver diseases are common 
3. Marutham      :           Field and its surroundings.It is the perfect place to
    maintain good health. 
4. Neidhal   :          Sea and its surrounding, Vatha diseases and  
Hepatomegaly  are common. 
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5. Paalai   :     Desert and its surroundings, Vatha, Pitha and 
        kaba noigal are common. 
 Study of the five lands is very much needed, as some diseases are common in 
particular lands. 
PARUVA KAALANGAL: 
 As per Siddha Literature a year is divided into six seasons, each consisting of 
two months. 
Sl.NO. Season Months Kuttram 
1. Kaarkaalam 
Aavani & Purattasi 
August 16 – October 15 
Vatham ↑↑ 
Pitham ↑ 
2. Koodhir kaalam 
Ayppasi and kaarthigai 
October 16 – December 15 
Vatham (-) 
Pitham ↑ 
3. Munpani kaalam 
Margali and Thai 
December 16 – February 15 
Pitham (-) 
4. Pinpani kaalam 
Maasi and Panguni 
February 16 – April 15 
Kabam ↑ 
5. Elavenir kaalam 
Chithirai and Vaigasi 
April 16 – June 15 
Kabam ↑ ↑ 
 
6. 
Mudhuvenir 
kaalam 
Aani and Aadi 
June 16 – August 15 
Vatham ↑ 
Kabam (-) 
↑  - Thannilai valarchi   ( - ) - Thannilai adaidhal 
↑↑  - Vetrunilai valarchi 
 The final diagnosis is confirmed by summarizing all the clinical findings 
observed by the above methods. 
DEFINITION OF CEGANA VATHAM: 
Ceganavatham presents with the symptoms like pain in the neck radiating upto 
the groins, pain in the upper limbs and lower limbs which is of stinging nature, feeling 
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of heaviness in the body, mental depression, giddiness, burning sensation of the eyes 
and oliguria. It has been classified under eighty types of vatha diseases. 
                 - Yugi Vaidhya Chinthamani 800 
AETIOLOGY: 
The common aetiological factors for all types of vatha diseases including 
ceganavatham have been described generally in Yugi Vaidhya Chinthamani-800 and 
Agasthiyar Gunavagadam. 
In Yugi Vaidhya Chinthamani, the following causes have been given, 
 “¾¡¦ÉýÈ ¸ºô§À¡Î ÐÅ÷ôÒ¨ÈôÒ 
º¡¾¸Á¡ö Á¢ïÍ¸¢Öõ º¨Áò¾ Åñ½õ 
¬¦ÉýÈ Å¡È¢ÉÐ ¦À¡º¢ò¾Ä¡Öõ 
¬¸¡Âò§¾ÈÄÐ ÌÊò¾Ä¡Öõ 
À¡¦ÉýÈ À¸ÖÈì¸ Á¢Ã¡ Å¢Æ¢ôÒ 
ÀðÊÉ¢§Â Á¢¸×Ú¾ø À¡Ã¦Áö¾ø 
§¾¦ÉýÈ ¦Á¡Æ¢Â¡÷ §Áüº¢ó¨¾Â¡¾ø 
º£ì¸¢ÃÁ¡ö Å¡¾Á¢Ð ¦ºÉ¢ìÌó¾¡§É” 
“À¸Ã§Å Å¡¾ÁÐ §¸¡À¢ò¾ô§À¡ 
ÀñÀ¡¸ ¦Àñ§À¡¸ ÁÐ¾¡ý 
¿¸Ã§Å ¦ÅÌàÃÅÆ¢ ¿¼ì¸¢ø 
¿Ç¢Ã¡É ¸¡üÚ§Á ÀÉ¢§ÁüÀð¼¡ø 
Á¢¸Ã§Å ¸¡ö¸û ¸É¢¸¢ÆíÌ ¾ý¨É 
Á¢¸ÅÕò¾¢ Á£È£§Â ¾Â¢÷¾¡ý ¦¸¡ñ¼¡ø 
Ó¸Ã§Á ÓÐ¦¸Öõ¨À ÓÚì¸¢ ¦¿¡óÐ  
ÓÆí¸¡Öõ ¸¨½ì¸¡Öõ ¸ÎôÒ ¯ñ¼¡§Á” 
 Excessive consumption of bitter, astringent and pungent food items  
 Consumption of food cooked on the previous day 
 Drinking polluted water 
 Changing sleep rhythm  
 Excessive starvation 
 Lifting heavy weight 
 Excessive lust 
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 Sexual indulgence 
 Walking long distance 
 Living in chill environment 
 Excessive consumption of tubers, fruits, curd, etc 
Pathology: 
 When the lifestyle, occupation, food habits of a person is normal there is no way 
for the development of disease. When any one of them is altered it causes derangement 
of micro elements in the body (Panchaboothangal). Improper food habits directly affects 
the elemental composition while other acts also cause derangement of these elements 
indirectly. 
When elemental composition is altered naturally, Uyir thathukkal of the three 
humours which are made up of these elements also get deranged. This simultaneously 
leads to derangement of seven udal thathukkal and produces symptoms. 
The aetiological factors for Ceganavatham are due to diets which produce 
excessive Vayu and other factors which causes vitiation of Vayu, Aahayam. Here Vali 
and Aahayam constitute Vatham, earth and water corresponds to Kabam and fire 
corresponds to Pitham. So Vatham, Pitham and Kabam are deranged. Simutaneously 
Udal thathukkal get deranged. These give rise to clinical features of Ceganavatham. 
In the Uyir thaathu Vatham, derangement of Viyanan causes pain in the cervical 
and dorsal spine, pain along the upper limbs, pain like scorpion sting and heaviness of 
the body. Derangement of Abanan leads to constipation. 
Derangement of Uthanan leads to cough with expectoration. Derangement of 
Samaanan leads to indigestion and imbalance of functions of other vayus. Derangement 
of Naagan leads to sluggishness and mental depression and of Koorman leads to 
diminished vision and Devathathan affects the normal sleep rhythm. 
 In Ceganavatham, Saathaga pitham is also affected with vatham. It produces the 
features like mental depression and difficulty in performing regular duties because of 
the pain in the neck and upper limbs. 
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 In Kabam, Tharpagam and Santhigam are affected. Derangement of Thrapagam 
produces burning sensation in the eyes and the derangement of  Santhigam produces 
pain and stiffness in the neck (cervical joints) rendering difficulty in movements. 
 Simultaneously along with Uyir thathus there is derangement of Saaram, Senner, 
Oon, Kozhuppu and Enbu thathus. The whole events constitute the clinical condition 
Ceganavatham. 
Uyir Thathukkal affected in Ceganavatham: 
The three Uyir thathukkal Vatham, Pitham and Kabam are affected in Ceganavatham. 
Vatham affected in Ceganavatham: 
Commonly affected vatham among the Dhasavayukkal (Ten vathams ) are 
Viyanan, Samanan, Abanan, Naagan and Koorman. 
 Derangement of Viyanan (vaayu+earth) leads to pain in the cervical and 
dorsal spine, pain along the upper limbs, pain felt like scorpion sting and 
heaviness of the body. 
 Derangement of Abanan leads to oliguria. 
 Derangement  of Samanan leads to imbalance of function of other vaayus 
 Derangement of Nagan leads to mental depression 
 Derangement of Koorman leads to burning sensation in eyes, diminished 
vision. 
Pitham affected in Ceganavatham: 
Commonly affected pitham is Saathaga pitham 
 Derangement of Saathagapitham produces features like mental depression 
and difficulty in performing regular activities.  
Kabam affected in Ceganavatham: 
Commonly affected kabam among the five kabam are tharpagam, santhigam and 
avalambagam. 
 Derangement of Avalambagam leads to imbalance of functions of other 
vaayus too. 
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 Derangement of  Tharpagam produces burning sensation in eyes 
 Derangement of Santhigam produces pain  and stiffness in joints 
Udal thathukkal affected in Ceganavatham: 
Panchaboothangal forming the basic constituents of Seven Udal thathukkal  
(Saaram, Senneer, Oon, Kozhuppu, Enbu, Moolai and Sukkilam) get deranged. 
Commonly affected Udal thathukkal in Ceganvatham are Saaram, Oon and Enbu. 
Gnanenthiriyam affected in Cenganavatham: 
Panchaboothangal forming the basic constituents of these Gnanenthiriyam 
become deranged. Commonly affected Gnanenthiriyam are Mei (skin) and Kan (eye). 
Kanmenthiriyam affected in Cenganavatham: 
               Panchaboothangal forming the basic constituents of these kanmenthiriyam 
become deranged. Commonly affected Kanmenthiriyams are Kai (upper limbs) and 
Eruvai (excretory organs). 
CLINICAL FEATURES: 
The signs and symptoms of Ceganavatham are described in Yugi Vaidhya 
Chinthamani and Pararasasekaram as: 
 Pain in the neck 
 Radiating pain in the shoulders and upper limbs 
 Heaviness of the body 
 Mental depression 
 Giddiness 
 Burning sensation of the eyes 
 Constipation 
 Pain felt like sting of a scorpion 
 Numbness and tingling sensation of the upper limbs 
 They have been mentioned in the following verses: 
“§¸Ù§Á ¸Øò¾¢ý ¸£Æ¨ÃìÌý §ÁÖõ 
¦¸ÊÂ¡É ¸ÃÁ¢ÃñÎ Á¢¸§Å ¦¿¡óÐ 
Å¡Ù§Á º¡¢Ã¦ÁÄ¡í ¸Éò¾¢ÕìÌõ 
Å¡Ä¢À÷ìÌ ÁÉí¸ñÏ ÁÂì¸Á¡Ìõ 
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²Ù§Á Â¢ÃñÎ¸ñÏ ¦Á¡¢îºÖñ¼¡ 
§ÁüÈÁ¡ö ºÄó¾¡Û Á¢Ú¸¢ì ¸¡Ïó  
§¾Ù§Á ¦¸¡ðÊÉÐ §À¡üì ¸ÎìÌõ 
º¸ÉÅ¡ ¾ò¾¢É¢¼ ¾£÷ì¸ó¾¡§É” 
             - ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢ 
 
“¸ñ¼§¾¡÷ º¢¸ýÉ Å¡¾í ¸Øò¾¢ý ¸£Æ¨ÃìÌ §ÁÖõ 
Á¢ñ¼Äí ¸ÃÁ¢ÃñÎ Á¢¸ ¦¿¡óÐ ¸Éò¾¢ÕìÌõ 
ÁñÊ§Â ¾¢Á¢÷òÐì ÌòÐõ ÅÄ¢ Á¢ÌòÐ×ñ¼¡Ìõ 
Åñ¼Á÷ ÌÆÄ¢É¡§Ç Á¾¢Â¢É¡ÖýÛÅ¡§Â” 
       - ÀÃÃ¡º§º¸Ãõ 
NOI KANIPPU (DIAGNOSIS) 
Diagnosis of Ceganavatham in Siddha is based on Envagai thervu (eight types of 
examination) and the state of  
 Uyirthathukkal 
 Udalthathukkal 
 Gnanenthiriyam 
 Kanmenthiriyam 
Envagai thervu (eight types of examination): 
“¿¡Ê vÀ¡¢ºõ ¿¡ ¿¢Èõ ¦Á¡Æ¢ Å¢Æ¢ 
ÁÄõ ãò¾¢Ãõ þ¨Å ÁÕòÐÅÃ¡Ô¾õ” 
                    “¦ÁöìÌÈ¢ ¿¢Èò¦¾¡É¢ Å¢Æ¢¿¡Å¢ÕÁÄõ ¨¸ìÌÈ¢” 
        - §¿¡ö ¿¡¼ø, À¡¸õ 1 
The eight types of examination are, 
1. Naadi (pulse reading) 
2. Sparism (tactile sensation) 
3. Naa (tongue) 
4. Niram (colour) 
5. Mozhi (speech or voice) 
6. Vizhi (eye) 
7. Malam (stools) 
8. Moothiram (urine) 
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The findings of Envagaithervu in Ceganavatham are:  
1. Naadi 
Naadi means a vital force responsible for birth (- Agathiyar) 
This vital force is divided into three humours, Vatham, Pitham and Kabam. It 
can be assessed in 10 sites. The commonest site is wrist (over radial artery). 
2.Sparisam 
By Sparisam the temperature of the body, smoothness, or roughness, dryness, 
hardness, patches, abnormal growth, sweating, swelling, tenderness and nourishment 
can be felt. 
3. Naa 
Colour, coating, dryness, movement, deviation, sensory changes, ulcer, 
conditions of the tooth, and gums are noted. 
4. Niram            
Colour of the skin, mucous membranes, hair and nail are examined. 
5. Mozhi 
Disturbance in speech, hoarseness of voice, etc are assessed. 
6. Vizhi 
Testing for acuity of vision, colour, redness, pallor, whiteness, burning 
sensation, excessive lacrimation. 
7. Malam  
The waste and excretory products of body are called as malam. The faeces 
should be semi- solid without hardness and looseness. 
Nature, quantity, colour, odour, froth, presence of blood and mucous are noted. 
8. Moothiram: 
The urine is examined by two methods 
1. Neerkkuri  
2.  Neikkuri 
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Features in Ceganavatham 
1. Naadi: 
Vathapitham, Pithavatham 
“¦À¡ÕÇ¡É Å¡¾ò¾¢ø À¢ò¾ï§º÷óÐ 
¨¸¸¡ø ¾È¢ôÒ ¿¡¸ºìÌÁýÉõ”            - §¿¡ö¿¡¼ø  
“À¢ò¾ò¾¢ø Å¡¾Á¡¸¢ø À¢¼¡¢Ôõ ¸¡Öõ ¨¸Ôõ Ìò¾Ð §À¡§Ä Â¡Ìí ÌÚ¸¢ 
¦ÁöÀÐÚõ À¢ý§É” 
2. Sparisam: 
General body temperature – slight warmth 
Tenderness present in neck and upper extremities 
3. Naa 
The tongue is coated. 
4.Niram     
General colour – mixed colour (Thonthaniram due to mixed thodam) 
5.Mozhi 
No change or disturbance of voice are found. 
6. Vizhi 
Burning sensation of the eyes is present. In aged patients acuity of vision is 
diminished. 
7.Malam  
Some Patients have constipation. 
 8. Moothiram: 
Some patients have oliguria. 
NEERKKURI: 
              Urine is collected in early morning after taking a well balanced diet previous 
day, which do not alter the three thodams. It should be examined within 3 ¾ Naazhigai 
(90 minutes). 
                        “Åó¾ ¿£÷ì ¸È¢ ±¨¼ Á½õ Ñ¨Ã ±ïº¦Äý 
¨Èó¾¢Â ÄÇ¨Å Â¨ÈÌÐ Ó¨È§Â” 
       - §¾Ãý ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢ áø. 
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In Neerkkuri examination the following features are observed: 
 Niram (colour) 
 Manam (smell)  
 Nurai (froth) 
 Yedai (specific gravity)  
 Enjal (quantity)  
Apart from these the frequency of urination, presence of abnormal constituents 
such as sugar, proteins, sediments, etc. are also noted.
NEIKKURI: 
The collected urine is kept in a glass bowl and is placed under direct sunlight. A 
drop of gingelly oil is dropped on the surface and nature of neikkuri is noted. If the drop 
of oil lengthens like a snake it indicates vatham, if it appears like a ring it indicates 
Pitham, if it appears like a pearl it indicates kabam. 
     “«Ã¦ÅÉ ¿£ñÊý «·§¾ Å¡¾õ” 
     “¬Æ¢§À¡ø ÀÃÅ¢ý «·§¾ À¢ò¾õ” 
     “Óò¦¾¡òÐ ¿¢ü¸¢ý ¦Á¡Æ¢Å¦¾ý ¸À§Á” 
      - §¿¡ö ¿¡¼ø À¡¸õ-1 
When the drop of oil shows shapes of two Kuttram, it indicates thontha neer. 
NOI KANIPPU VIVADHAM (DIFFERENTIAL DIAGNOSIS): 
Some other types of Vatha diseases mimic Ceganavatham. Careful, clear history 
taking and examination will reveal the diagnosis. They are: 
1. Kumba vatham 
2. Kurisa kirisavatham. 
3. Kazhuththu vatham 
4. Paei vatham  
The clinical features of above diseases are mentioned in literatures as below: 
1. Kumba Vatham: 
“¿Å¢Ä§Å §¾¡ûÁ£Ðí ¸Ã¸ò¾¢ý Á£Ðõ 
¿Ä¢óÐ ¦Áò¾ Å¡¸¢§Â ¿º×ñ¼¡Ìõ 
¸Å¢Ä§Å ¸ýÉ¦Á¡Î ¿ÂÉó ¾¡Ûõ 
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¸ØòÐ§Á Å¢ÚÅ¢ÚôÒ ¦Á¡¢×í ¸¡Ïõ 
ÐÅ¢Ä§Å ÐÊôÀ¡Ìï º¢ÃÍ ¾ýÉ¢ü   
ÍÆüº¢§Â ¿¡À¢ì¸£ú ÅÄ¢Ô Óñ¼¡õ 
«Å¢Ä§Å ÂÊ¿¡ì¸¢ ÄÆýÚ ¸¡Ïõ 
«ÄÕ§Á ÅÕ ÌõÀÅ¡¾ó ¾¡§É”. 
 
 Burning sensation in shoulder and upper limbs  
 Burning sensation in the cheek and the eyes 
 Twitching over the scalp 
 Spasmodic pain in the lower abdomen 
 Glossitis 
2. Kurisa kirisa vatham: 
         “º¢ÈôÀ¡É À¡õÒÅ¢¼õ §À¡Ä ²È¢î 
             ¦ºÈ¢Å¡¸ Å¢Èí¸¢Â§¾¡÷ ¦ºö¨¸ §À¡Öó 
          ÐÈôÀ¡É Ý¨ÃÂ¡ Â¨ÃÂ¢ü Èð¨¼î 
             ÍÆÄ§Å ÍÕì¸¢¾¡ý ÀüÈ¢ Âí¸õ 
          À¢ÈôÀ¡É À£È¢Â§¾¡÷ Ì¼¨Äô §À¡Ä 
             À¢¾¢÷¸¢ýÈ Åý§À¡Öõ À¢ÃÁ¢ ¦ÂýÉ 
          Á¢ÈôÀ¡É §¾¡Ç¢øÓû ¦À¡¾¢ó¾¡ü §À¡Ä 
             ÓÂýÈ¢Îí ¸¡ñÌÃ¢º ¸¢Ã¢º ã÷ì¸ó ¾¡§É.” 
 Pain in the groins  
 Pricking pain in the shoulders 
3. Kazhuththu Vatham (Kooni Kiraga Vatham): 
          “¸Øò¨¾ ¾¢ÕôÀ¡§¾ À¢ÊòÐ 
          ¸¾¢¡¢ðÎ ¯¨Çó¾¡ü §À¡§Ä ¸¡Ïõ 
          ¦ºÆ¢ò§¾ ¿ÃõÒ ¾ÊòÐ ¿¢üÌõ 
          º£Ã¡¸ «¨ºì¸ ¦Å¡ð¼¡Ð  
          ¸Øò§¾ À¢ÊòÐ þÃ¡ôÀ¸Öõ  
          þ¼§Ã ¦ºöÔõ ¸ØòÐ Å¡¾õ 
          ÅØòÐõ Ì½í¸û ¾Ã½¢ ¾ýÉ¢ø 
          Å¨ºÂ¡ö «È¢Å£÷ ÀñÊ¾§Ã” 
                                  - Å¡¾§¿¡ö ÁÕòÐÅõ  
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 Stiffness and restriction of movements of the neck 
 Burning pain in neck  
 Thickening of nerves in neck  
 Symptoms continuing day and night 
4. Paei Vatham: 
“¦ÀüÈ¢Â¡õ ¦ÀÕ¨ÁÂ¡õ ¸¡Öõ ¨¸Ôõ 
¦ÀÕÅÂ¢Ú ¦¿ï§º¡Î Å¢ÃÖ ãìÌ 
²üÈ¢Â¡ ¦ÁÈ¢¸ØòÐ ¦ÁíÌõ ÀüÈ¢ 
²ì¸Á¡ö ¦¿¡óÐ¼×õ ¦ÀíÌõ Å£í¸¢ 
¯üÈ¢Â¡ ã½§Å ¿¢Á¢÷ò¦¾ÎòÐ 
¯Ú¾¢Â¡öô À¢Êì¸× ¦Á¡½ÁÄ¡Ìõ 
ºì¾¢Â¡ö Å¡ö ¸ºóÐ ÁÂì¸Á¡Ìõ 
¾¡¢ò¾¢¼ ¦Å¡ñ ½¡Ð §ÀöÅ¡¾ó ¾¡§É” 
 Pain and swelling in the abdomen, upper and lower limbs 
 Weakness of hand muscles, difficulty in holding things in the hand. 
 Vomiting  
 Giddiness 
 Swelling all over the body 
MANAGEMENT: 
In Siddha system the management is mainly based upon the Mukkuttram 
principle. Treatment is not only for perfect cure but also for the prevention of diseases 
and rejuvenation of Udal kattukkal. The physician‟s duty is to diagnose the disease, 
trace the etiology and choose proper line of treatment.  
           Thiruvalluvar has stated this as, 
“§¿¡ö ¿¡Ê §¿¡ö Ó¾ø¿¡Ê «Ð ¾½¢ìÌõ 
Å¡ö ¿¡Ê Å¡öôÀî ¦ºÂø” 
“¯üÈ¡ÉÇ×õ À¢½¢ÂÇ×õ ¸¡ÄÓõ 
¸üÈ¡ý ¸Õ¾¢î ¦ºÂø”                            - ¾¢ÕìÌÈû 
So it is essential to know the disease, its etiology, the nature of the patient, 
severity of the illness, duration of disease, seasons and the time of occurrence etc. 
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The management of the disease in Siddha is as follows, 
1. Neekkam(treatment) 
2. Niraivu(restoration) 
3. Kaappu(prevention) 
After occurrence of the disease, first it should be treated, restoration should be 
done and recurrence or further complications should be prevented.  
1. NEEKKAM: 
Nekkam is based on,  
 Balancing deranged thodams  to normal state of equilibrium. 
 Treating with internal medicine and external medicine. 
 Deranged Vatham has to be brought to its normal state by giving purgation. It is 
mentioned in the following verses, 
“Å¢§ÃºÉò¾¡ø Å¡¾õ ¾¡Øõ” 
            -º¢ò¾ ÁÕòÐÅ¡í¸ ÍÕì¸õ 
Purgation: 
Agasthiyar kuzhambu – 200 mg given with palm jaggery, in early morning (for 
the first day only) 
Internal drug: 
Maha Analuruva Chooranam – 1.5 gms bd, with Honey for 48 days. 
External drug:  
Pungan ennai (QS) 
Diet Restrictions: 
 Mustard, sesame oil, pumpkin, garlic, asafoetida, bengal gram, horse gram, 
sesbania, bitter guard, coconut, mango and jack fruit should be avoided by patients with 
Vatha diseases. Sour and astringent diet should be avoided as it will increase Vatham. 
“¸ÎÌ ¿üÈ¢Äò ¦¾ñ¦½ö ÜúÀ¡ñ¼í¸û ¸¼¨Ä 
ÅÎÅ¾¡¸¢Â ¦¾íÌÁ¡ ÅÕì¨¸ ¿ü¸¡Âõ 
ÁÊÅ¢Ä¡¾ ¦ÅûÙûÇ¢ ¦¸¡û Ò¨¸Â¢¨Ä ÁÐ¦Àñ 
þ¼Ú À¡¸§Ä¡ ¼¸ò¾¢ ¿£ì¸¢¼Ä¢îº¡ Àò¾¢Âõ” 
     - º¢ò¾ ÁÕòÐÅ¡í¸ ÍÕì¸õ 
 
33 
 
                       “ÒÇ¢ÐÅ÷ Å¢ïÍ ¸È¢Â¡ø â¡¢ìÌõ Å¡¾õ” 
    - §¿¡ö¿¡¼ø §¿¡öÓ¾ø ¿¡¼ø ¾¢ÃðÎ 
2. NIRAIVU: 
The patient is convinced to accept the eventuality of the disease and 
modification of life style. 
“´ýÈ¢Â Å¡¾À¢ò¾ ¸ÀÁ¢¨Å ÔÂÃ¡ Åñ½õ 
¿ýÚÚ ¸È¢¸¦ÇøÄ¡õ ¿¡Ù§Á º¨ÁôÀ¡Ã¡öó§¾¡÷ 
¾¢ýÈ¢Î Á¢ÇÌ Áïºû º£Ã¸ ÓÂ÷ó¾ ¸¡Âõ 
¦ÅýÈ¢ ¦¸¡û Íì§¸¡§¼Äõ ¦Åó¾Âõ ¯ûÇ¢ §º÷ò§¾” 
- §¿¡Â¢øÄ¡ ¦¿È¢ 
  To maintain normal level of three humours, pepper, turmeric, cumin seeds, 
asafoetida, dry ginger, cardamom, fenugreek and garlic should be added generously in 
diet. 
3. KAAPPU: 
Siddha system prominently projects prevention of diseases. This is attained by 
the following methods, 
1. Maintaining equilibrium of three humors by adopting vaanthi, kazhichal, 
nasiyam, nei muzhukku techniques. 
2. Avoiding stress and strain. 
3. Maintaining good mental health by doing meditation. 
 
 
 
 
 
 
34 
 
VARMAM 
          Apart from internal and external medications, Siddha system has some special 
therapies like Varmam, Yogam and Kayakarpam which are distinctive to this system. 
Varmam refers to vital points in the body that act as energy transformers. They form 
centres for boosting the vital pranan flow through the intricate nadi system of the body. 
Nature, by its design, has protected these vital centres by placing them deep inside the 
body or by covering them with tissues inaccessible to normal attempts of breach. 
Varmam is a holistic therapy on its own and tackles the body, mind and spirit. 
Varmam forms a link between the body, prana and the mind. Varmams have been 
classified based on the type of pressure needed to apply  (a) Paduvarmam (Varmam due 
to injury), (b) Thodu Varmam (by touch); Thattu Varmam (by blows); (c) Thaduvu 
Varmam (by massage); (d) Nakku Varmam (by licking); and (e) Nokku (by staring). 
The widely used and recognised ones are the 12 Padu Varmams and 96 Thodu 
Varmams; there is less consistency with the other categories simply because of the way 
of application or the deeper knowledge needed to apply them. In these categories, the 
Nokku Varmam is the most awe-generating and is rarely seen practiced, as those 
masters who were able to do this are almost extinct. 
   Vital points are located over arteries, veins, nerves, joints, bony prominence, 
ligaments, etc. The changes occurring in the body on being hit at some specific points 
on the body directly or indirectly with particular force is Varmam
13
.  
By manipulating the following Varmam points, the symptoms of Ceganavatham 
can be reduced 
 Muduchi  
 Kakkattai kaalam 
 Manibanthagam  
 Kai viral madakku varmam  
 Kavuli 
Muduchi Varmam:  
It is located in nape at the bony prominence of cervical region. 
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Kakkattai kaalam: 
It is located at the shoulder, two finger breadth lateral to the junction of neck and 
head.
14 
Manibanthagam:  
It is situated in dorsal aspect of wrist.
15 
Kai viral madakku Varmam: 
It is located in medial aspect of arm just below the shoulder. 
Kavuli Kaalam: 
It is located above the web space of fingers. For Ceganavatham pressure is 
applied in kavuli between thumb and index finger. 
VARMAM THERAPY: 
 Varmam points indicated for Ceganavatham: 
 Muduchi Varmam (Varma odivu murivu sara soothiram - 1200) 
 Kakkattai Kaalam ( Varma Beerangi – 100) 
 Manibanthaga Varmam ( Varma Beerangi – 100) 
 Kai viral madakku Varmam (Varma vilakkam) 
 Kavuli Kaalam (Varma soothiram – 101) 
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MODERN ASPECTS 
Functional Anatomy of the Cervical Spine 
The cervical spine consists of upper seven vertebrae of the spine below the skull. 
The lower five vertebrae are similar, while the upper two, i.e., atlas (C1) and axis (C2) 
are different in their anatomical structure.  
Each vertebra has two main parts: 
1. The body, and 
2. The vertebral arch. 
The bodies are separated from each other by intervertebral disc and are held 
together by anterior and posterior longitudinal ligaments. 
 
 
 
 
 
 
 
 
 
The pedicles project dorsolaterally giving triangular shape to the vertebral canal. 
The pedicles are notched both above and below. The transverse process of cervical 
vertebra is a composite structure. Essentially it has two roots. The true transverse 
process (posterior root) originates at the junction of the pedicle with lamina and projects 
ventrolaterally behind foramina transversarium to end in posterior tubercle. The anterior 
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root projects laterally from the side of the vertebral body (homologous to thoracic rib). 
Ventral to foramen transversarium and ends in anterior tubercle.  
Intervertebral disc 
All intervertebral discs put together constitue 25 percent of the height of the 
vertebral column excluding sacrum. The ratio of the disc to vertebral body in the 
cervical spine is 1:3. The disc between C6/7 is the thickest. The cervical disk is thicker in 
front than at the back with the result that in erect posture, the anterior height of the discs 
(summated) is 8mm more than posterior heights (lordosis of the cervical spine). As 
elsewhere the disk is avascular. The nucleus pulposus has a volume of 0.2ml and a 
diameter of 0.7cm. It has important property of absorbing and retaining water against 
pressure. It can change its shape and can distribute equally. 
 Intervertebral foramina 
In the cervical region, the foramina is like a short tunnel bounded ventromedially 
by the disc and unco vertebral joints and dorsolaterally by the apophyseal joints or 
superior articular facet. The notched pedicles are superiorly and inferiorly placed. They 
open obliquely forwards, downwards and laterally and become progressively smaller 
from above downwards.  
Apophyseal Joints 
 They are paired transverse true synovial joints between superior and inferior 
articular processes of adjacent vertebrae. The uppermost is at C2/3 level. The joints are 
surrounded by fibrous capsule and lined by synovial membrane and permits movement. 
They are not meant for weight bearing. They stabilize the motion segment and more 
important prevents forward displacement of one vertebra over another. 
The Vertebral Artery 
 The vertebral artery arises from the first part of the subclavian artery and ascends 
in the transverse foramina of the cervical vertebrae usually from C6 to C1. It is 
accompanied by vertebral plexus of veins and by sympathetic fibers which arise in the 
inferior cervical ganglion in the neck. The artery enters the cranial cavity through 
foramen magnum.
 16
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Movements and Instability of the Cervical Spine 
 
The cervical spine is a classical engineering device of a structure which has 
adapted to its function. It supplies a strong,  stable, flexible and buffered support to the 
head. It protects the upper part of the spinal cord. It increases in width from above 
downwards. There is forward convexity and has a mild scoliosis with thoracic spine to 
the left in 80percent of the cases. The motion segment as described by Junghans 
includes apophyseal joints and the uncovertebral joints. The movement at a given 
motion segment is not much, but the cumulative effect is significant. 
Possible Movement 
 Flexion, extension, lateral flexion and rotation are the possible movements. 
Lateral flexion and rotation is always combined. Nodding movement occurs mainly at 
the atlantooccipital joint. The atlantoaxial joint is mainly concerned with the rotation of 
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the head. The pivot for flexion extension is uncovertebral joint. The range of extension 
is greater than flexion. The posterior neck muscles are the most powerful limiting force 
for the flexion. In extension, the anterior longitudinal ligament is the limiting force. 
Taking I1 vertabra as pivot, the cervical spinal canal changes direction from full flexion 
to full extension through 90 degrees. Greatest movement occurs at C5/6 level. The size of 
intervertebral foramina increases in flexion and diminishes by as much as one-third in 
extension of the neck. Such a diminution in the size of the foramina is a feature in 
individuals with extension of neck compensatory to dorsal kyphosis. 
Atlanto occipital Joint 
 Stability is provided by the cup-shaped articular facets, the anterior and posterior 
atlantooccipital membranes, the tectorial membrane, the cruciate ligament and the 
ligamentum nuchae. If these are disrupted the joint is unstable. 
Atlanto axial Joint 
 AA joint is the most complex joint and, therefore, the most difficult to analyze. 
Stability is chiefly provided by the transverse ligament. The tectorial membrane is also a 
strong ligament. 
Instability of the Cervical Spine 
 The ability of the spine under physiological loads to limit patterns of 
displacement so as not to damage or irritate the spinal cord or the nerve roots and in 
addition, to prevent incapacitating deformity or pain due to structural changes defines 
the stability of the spine. The spine is in a state of unstable equilibrium. It achieves 
stability with the help of wires such as discs, ligaments and muscles attached to them. 
Stability of the functional spinal unit is achieved by four stabilizing effects. They are 
 Passive stabilization 
 Dynamic stabilization 
 Active stabilization 
 Hydrodynamic stability17 
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Cervical vertebrae 
 
The seven cervical are relatively small and enclose a wide vertebral canal with 
adequate space for the cervical part of the spinal cord. Each transverse process is 
perforated by a foramen transversium transmitting the vertebral vessels. The spinous 
processes all give attachment to a strong midline elastic ligament, the ligamentum 
nuchae. 
The first cervical vertebra, the atlas has anterior and posterior arches, relatively 
large transverse processes and two lateral masses. The atlas has no body and its spinous 
process is represented by a tubercle. On the superior surface of each lateral mass is a 
concave facet which articulates with the convex occipital condyle of the skull. The 
atlanto-occipital joints permit flexion and extension (nodding movements). 
The second cervical vertebrae, the axis possesses some of the features of a 
typical cervical vertebra but it has a unique vertical projection, the dens (odontoid 
process). This projects superiorly from the upper surface of its body and represents the 
body of the atlas. The dens articulates by a synovial joint with a facet on the posterior 
surface of the anterior arch of the atlas, where it is retained by the alar, apical and 
transverse ligaments. The planes of the lateral atlantoaxial joints and the pivot joint of 
the dens allow rotation of the head as in looking from side to side. 
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The seventh cervical vertebra possesses a long, non-bifid spine, which provides 
the inferior attachment for the ligamentum nuchae. The spinous process is easily 
palpable and hence the vertebra is called the vertebra prominens. The foramina 
transversia of this vertebra are traversed by the vertebral veins but not by the arteries. 
Arthiritis involving joints of the cervical spine is often associated with the 
formation of bony outgrowths which may compress the nerve roots that contribute to the 
brachial plexus. Injuries to the cervical column, particularly involving fracture or 
dislocation of vertebrae, may result in spinal cord injury leading to quadriplegia or 
death. The atlantoaxial joint is particularly liable to disruption in hyperextension 
injuries.
18 
CERVICAL SPONDOLYSIS 
          
This vague term is applied to a cluster of abnormalities arising from chronic 
intervertebral disc degeneration. Changes are most common in the lower two segments 
of the cervical spine (C5/6 and C6/7), the area which is prone to intervertebral disc 
prolapse. The discs degenerate, flatten and become less elastic. The facet joints and the 
unconvertebral joints are slightly displaced and become arthiritic, giving rise to pain and 
stiffness in the neck. Bony spurs, ridges or bars appear at the anterior and posterior 
margins of the vertebral bodies; those that develop posteriorly may encroach upon the 
spinal canal or the invertebral foramina, causing pressure on the dura (which is pain 
sensitive) and the neutral structures. 
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Clinical features 
The patient, usually aged over 40, complains of neck pain and stiffness. The 
symptoms come on gradually and are often worse on the first getting up. The pain may 
radiate widely: to the occiput, the back of the shoulders and down one or both arms; it is 
sometimes accompanied by parasthesia, weakness and clumsiness in the arm and hand. 
Typically there are exacerbations of more acute discomfort, and long periods of relative 
quiescence. 
The appearance is normal, but the muscles at the back of the neck and across the 
scapulae are tender. Neck movements are limited and painful. 
Sometimes the clinical picture is dominated by features arising from narrowing 
of the intervertebral foramania and compression of the nerve roots (radiculopathy): these 
include pain referred to the interscapular area and upper limb, numbness and/or 
paraesthesiae in the upper limb or the side of the face, muscle weakness and depressed 
reflexes in the arm or hand. In advanced cases there may be narrowing of the spinal 
canal and changes due to pressure on the cord. 
Imaging x-rays show narrowing of one or more intervertebral spaces, with spur 
formation (or lipping) at the anterior and posterior margins of the disc. These bony 
ridges (often referred to as „osteophytes‟) may encroach upon the intervertebral 
foramania. MRI is more reliable for showing whether the nerve roots are compressed.
19 
Clinical features of Cervical Spondylosis 
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Symptoms 
Pain in cervical spine disease is either local, referred or radicular. Local and 
referred pain result from damage to vertebral or articular nerve endings by neoplastic or 
degenerative processes, or more rarely from stimulation of meningeal receptors by dural 
distortion. The spinal cord itself is insensitive. Pain is commonly referred upwards to 
the occiput, downwards to the inetrcapsular region, or laterally to the shoulders and 
upper arms. It is usually characterised as an “ache” and is not usually felt below the 
elbows. 
True radicular pain can usually be distinguished from referred pain by its nature. 
It is more sharp than referred pain, and its distribution follows a dermatomal pattern. It 
may be accompanied by varying degrees od sensory or motor loss in the same 
districtbution. It can be reproduced or exacerbated by passive or active movement of the 
neck in such a way as to cause nerve root compromise. 
Neurological dysfunction may be sensory or sensory plus motor. The presence of 
an isolated motor neuropathy is less characteristic of root or cord compression, as the 
fine sensory fibers are usually the first to be affected, and an anterior hron cell disorder 
should be considered. 
Radicular sensory/motor symptoms are rarely painless. They result from 
compression of a root within the foramen or rarely from infiltration by tumor. 
Parasthesia is followed by numbness and clumsiness as proprioception becomes 
affected, and finally by motor involvement in the same radicular distribution. 
Cord compression may cause myelopathy, which may, in acute cases (eg: 
trauma, metastatic collapse) be initially flaccid but which rapidly becomes spastic. 
Symptomatically, the spasticity in chronic cases gives rise to „jumpy legs‟, usually at 
night, and leads to stiffness and clumsiness. Lhermitte‟s sign, where flexion causes an 
electric shock-like feeling to shoot into the arms and legs, may be seen in spondylosis. 
Weakness may only be apparent fairly late. A sensory level will develop, which rses as 
the myelopathy increases. Bladder involvement usually occurs late in cervical 
myelopahy. Acute cord compression in spinal injury is well known to cause priapism. In 
extreme cases of degenerative disease, anterior osteophytes can cause dysphagia. 
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Examination 
As clinicians one is most interested in symptoms. They fall into five main groups: 
1. Radiculopathy 
2. Myelopathy 
3. Neck pain 
4. Head ache 
5. Vertebrobasilar ischemia20 
Pathogenesis and Pathology of Cervical Spondylosis
 
 Cervical Spondylosis and its manifestations like pain in the neck, branchial 
neuralgia or spondylotic myelopathy is of more recent recognition.   
           The term spondolysis does not convey the meaning of pathology but is 
noncommittal and is universally accepted. It covers the pathology in the spine and the 
neurological syndrome associated with it. Cervical spondylosis is essentially a 
degenerative disorder starting in the intervertebral disc and progressing with 
advancement in age to involve more than one disk. The disorder is common in this 
country is elsewhere. Payne and Spillane,
 
found that 50 percent of people over the age 
of 50 and 75percent of those over the age of 65, have typical radiographic changes of 
cervical spondylosis. This cannot necessarily be related to actual symptoms or disability 
of the patients. Forty percent of their patients had some restriction of neck movements 
and 60percent had some neurological abnormality. 
 Conversely the upper disc levels of C3-4 and C4-5 showed a comparatively greated 
mobility and vertebral olisthesis particularly retrolisthesis in extension. These age-
related changes of the cervical spine might influence AP canal diameters in aged 
individuals. That degenerative changes in the cervical spine produce cervical 
spondylotic myelopathy (CSM) or cervical spondylotic radiculopathy (CSR) after the 
middle age has now been well recognized. As age advances, several changes occur in 
the cervical spine, and there are a large number of reports describing these changes.
 
Payne and Spillane have given a detailed anatomic-opathological study based on the 
work done on 70 specimens of cervical spine. 
 The pathomechanism of degenerative changes with age play an important role in 
the development of myelopathy. As age advances these people do develop other 
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problems like diabetes and high blood pressure, and this has an important bearing on the 
development of myelopathy as well as its treatment. 
 Occupational stress is significant contributing factor to the symptomatology of 
spondylosis making it extremely common in dock workers who carry 100kg weights on 
their shoulders. It is also common in mine workers, wrestlers, gymnasts, etc. 
Spondylosis obviously is more common in males. Degenerative changes do occur at the 
site of the old injury, and indeed their evolution can be followed radiologically from the 
time of the injury. 
 When joints become defective in pain sensibility as in diabetes and 
syringomyelia, unnoticed and repetitive trauma to the joints can give rise to spondylotic 
changes.  
Pathology 
 Whatever may be the cause of spondylosis the motion segment is affected. 
Involvement of following structures has to be considered: 
i) The intervertebral disc, 
ii) Uncovertebral joints,  
iii) Apophyseal joints, 
iv) The foramina (intervertebral), and 
v) The transverse foramina. 
Cervical Spondylotic changes in the Aged 
 Most recently in 1988, Hayashi et al from Japan have come out with the concept 
that CSM in aged patients could have different etiopathology. Generally cervical 
spondylosis is more common at C5-6 and C6-7 levels. As age advances, the range of 
motion at these levels decreases. The upper levels of C3-4 and C4-5 have more mobility 
and vertebral olisthesis in extension (retrolisthesis), while narrowing of the 
intervertebral disk and osteophytes predominates at the lower disk levels of C5-6 and C6-
7.  These age-related changes of the cervical spine influence the AP diameter of the canal 
in the aged. AP diameter is a good indicator of myelopathy. In the aged, dynamic AP 
canal diameter in addition to static diameter plays an important role. Posterior 
osteophytes at C5-6 and C6-7 have and retrolisthesis at C3-4 or C4-5 were the major cause of 
dynamic canal stenosis. This canal stenosis along with the associated disk protrusion, 
posterior osteophytes, and the infolding of the ligamentum flavum are responsible for 
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the myelopathic changes. Penning reported the pincer mechanism whereby the spinal 
cord was pinched between the posteroinferior margin of the superior vertebral body and 
the anterosuperior margin of the laminae of the inferior vertebra. Under the influence of 
these aging changes in the cervical spine, disc protrusion, posterior osteophytes at C5-6 
or C6-7, and retrolisthesis at C3-4 or C4-5 were important as the primary etiological factor 
of myelopathy in the aged patients. 
Factors Responsible for Myelopathy in Cervical Spondylosis 
1. Uncovertebral osteophytes cause anterior compression of the cord 
2. Bony ridges on the posterior vertebral bodies cause central compression on the 
cord 
3. Zygapophyseal osteophytes causing posterior compression 
4. Incurling of the ligamentum flavum causing posterior compression on the cord 
5. Developmentally narrow cervical canal 
6. Dynamic effect of narrowing of the cervical canal narrowing 
7.  Calcification of the posterior longitudinal ligament 
8. Teethering of the roots to the osteophytes 
9. Arachnoiditis 
10. Interference with the vascular supply of the cord 
11. Pincer mechanism - The spinal cord is pinched between the posteroinferior 
margin of the vertebral body and the anterosuperior margin of the laminae of the 
inferior vertebra[Penning in 1963]
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Imaging of the Cervical Spine 
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Radiography with appropriate views give a lot of information about the 
underlying pathology. The common views are the AP, lateral obliques, open mouth, 
swimmers view for the C7 region and the dynamic radiograph. The curvature of the 
cervical spine is a gentle lordotic curve. The disc space accounts for about one-third of 
the body height. The AP diameter of the body should be roughly equal to the canal AP 
diameter. The anterior and the posterior osteophytes are looked for. The effective canal 
diameter due to these osteophytes is studied. Any calcification in the disc space or 
behind the bodies is looked for.  
Myelogram 
 Intraspinal tumors and ruptured intervertebral cannot be demonstrated on routine 
radiographs therefore, various contrast studies have been developed to aid in their 
detection. Universally used and most helpful of these contrast procedures is 
myelography. The contrast medium Lipiodol was used initially but is no longer given 
because of its instability and significant meningeal irritation. Thorotrast was used for a 
short time, but has been discontinued because of its delayed retention and persistent 
radioactivity. Isotope myelography or myeloscintigraphy has been described but is 
considered impractical. A technique of radioisotope scanning of the spinal canal can 
outline dural, epidural, and vertebral space-occupying lesions.. 
Computed Tomography 
 Computed tomography is now commonly used to diagnose herniated discs, 
spinal canal stenosis and other lesions of the lumbar spine. When this technique is 
employed, imaging should be done on late-generation scanner with high-contrast 
resolution. Various scanning techniques may be employed. In general, the slices should 
be thin (4 to 5 mm) with some overlap (0 to 2 mm). Some centers use continuous 
nonangled slices, whereas, others use discontinuous slices and change the gantry angle 
correspond to the plane of the disk being studied. Reformation of images is used at some 
centers, others believe that this technique provides little real additional information. 
 When correctly performed and interpreted, computed tomography has a high 
accuracy rate. It has the advantages of being safe, comfortable and noninvasive. It can 
detect abnormalities in the lateral recess and foramen, which are less obvious on a 
myelogram. 
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3-D Reconstruction Images 
 The process requires a special software package. Thin 1.5 or 3 mm untangled 
contiguous or overlapping axial images are postprocessed to produce a 3 D contour 
image of the bony structures, which can then be rotated and viewed from any angle. 
Patient cooperation is of utmost importance, and the patient must be motionless during 
the scan. It is important to stress here that this technique does not provide any new 
information, but rather presents data in a unique way to be better understood by the 
referring physician. An experienced radiologist or clinician can obtain all the 
information from axial and reformatted images, and 3D CT is not an absolute must.  
Magnetic Resonance Imaging (MRI) 
 
MRI demonstrates the cord and the subarchnoid space and its relation with the 
extradural bony and soft tissue elements. Degenerated disc and its protrusion in the 
spinal canal, associated posterior osteophytes and the thickening of ligaments, facetal 
hypertrophy, and foraminal narrowing can be demonstrated. It also helps delineate 
between the intra- and the extradural tumors and also between the intra- and the 
extramedullary tumours. Gadolinium is the paramagnetic substance used to help 
diagnosis in difficult cases
22
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PREPARATION AND PROPERTIES OF TRIAL DRUGS 
¦¸¡Ê§ÅÄ¢ 
Botanical name : Plumbago zeylanica 
English name  : Ceylon, leadwort 
Family  : Plumbaginaceae 
Organoleptic character: 
Suvai   : Kaarppu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐìÌ½õ: 
“¸ðÊÅ¢Ã ½í¸¢Ãó¾¢ ¸¡ø¸û «¨ÃÂ¡ôÒì 
      ¸ðÊîÝ ¨ÄÅ£ì¸í ¸¡úãÄõ ÓðÊÃò¾ì 
      ¸ðÎ¿£ §ÃüÈ ¸Éò¾ ¦ÀÕÅÂ¢Úõ 
      «ðÎí ¦¸¡Ê§ÅÄ¢ Â¡õ”.  
                                            -  «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
þ¾É¡ø ¸ðÊ, Òñ, ¸Æ¨Ä, ÅÇ¢§¿¡ö, «¨ÃÂ¡ôÒìÌò¾ø, §º¡¨À, 
ãÄ§Ã¡¸õ, ¯¾¢Ãì¸ðÎ, ¿£§ÃüÈõ, ¦ÀÕÅÂ¢Ú þ¨Å §À¡õ. 
CHEMICAL CONSTITUENTS: 
Root contains an acrid crystalline principle called „plumbagin‟ in the form of 
yellow needles. It is present in all varieties of plumbago to a maximum of about 0.91%. 
Root bark – Free glucose, fructose, enzymes – Protease and Invertase.23 
ACTIONS: 
Alterative 
Stimulant 
Appetizer 
Laxative 
Uses: 
Root is useful in dyspepsia, piles, anasarca, diarrhea, rheumatiam, skin diseases 
and diseases of the spleen.
24
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Òí¸ý §Å÷ 
Botanical name : Pongamia pinnata 
English name  :           Indian Beech  
Organoleptic character: 
Suvai   : Kaippu, Thuvarppu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐìÌ½õ: 
“Å¡¾ì ¸ÎôÒ Á¸¡ã÷î¨º ¾¡ÀÍÃõ 
Å¡¾ÌýÁõ Ãò¾ò¾¡ø Åó¾¢Î§¿¡ö µÐ¸¢ýÈ 
ÀñÒ¨ÃÔõ ÅøÅ¢¼Óõ §À¡Ìõ¾¢Ãñ¼Õñ§¼ 
ÀñÒÚÒí ¸õ§Å÷ìÌô À¡÷. “ 
- «¸ò¾¢Â÷Ì½Å¡¸¼õ 
   þÐ Å¡¾Ì¨¼îºø, ã÷î¨º, ÅÈðÍÃõ, Å¡¾ÌýÁõ, ÌÕ¾¢Â¢É¡ø 
À¢Èì¸¢ýÈ §¿¡ö¸û, Òñ, Ò¨Ã§Â¡¼ø, À¡õÒ ¿ïÍ þ¨Å¸¨Ç ¿£ìÌõ. 
CHEMICAL CONSTITUENTS: 
 Furanoflavones, karanjin, pongamin, kanjone, pongaglabrone, pongamol
25
  
ACTIONS: 
Astringent 
Alterative 
Antiseptic 
Stimulant 
Pharmacological activities: 
Anti bacterial, antipyretic, anthelmintic, sedative.
26
  
Uses: 
               Root extract  mixed  with coconut oil can be used for healing wounds.    
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¬Â¢ø Àð¨¼ 
Botanical name : Chukrasia tabularis 
¦À¡ÐìÌ½õ: 
“¬Â¢ÖÃ¢¨Â ÂÊ¿£Õ ½¢ò¾¢Â¦Áö 
Â¡Â¢ ÖÃ¢¨Â¦ÂÉ¢ Ä¡Å¢Á¢¨º Â¡Â¢ø 
ÅÃ¢¨ºÂ¡ì ¸üÌ¿¢¸÷ ÅøÄ¢ÂðÎñ ¦ÁöìÌ 
ÅÃ¢¨ºÂ¡ì ¸ò¨¾ÔÚ ¨Å.” 
- §¾¨ÃÂ÷ ÂÁ¸õ 
    Å¡¾¡¾¢ Óò§¾¡¼í¸¨ÇÔõ À¨ÆÂ ÍÃò¨¾Ôõ §À¡ìÌõ. 
 CHEMICAL CONSTITUENTS: 
 Haloptelin – A & B, friedelin, epifriedelinol, B - sitosterol, tannins,                         
2 - aminonapthaquinone.     Database, Vol – II, P – 172 
ACTIONS: 
Febrifuge 
Counter –irritant 
Pharmacological activities: 
Anti – inflammatory, astringent, digestive. (Database, Vol – II, P – 171, 172) 
Uses: 
They are used in inflammations, rheumatism. (Database, Vol – II, P – 171 – 172) 
Å¡öÅ¢Çí¸õ 
Botanical name  :  Embelia ribes 
Synonyms   : Embelia robusta, Embelia indica 
English name   : Embelia 
Family   : Myrsinacae 
Organoleptic character: 
Suvai    : Kaippu 
Thanmai   : Veppam 
Pirivu    : Kaarppu 
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¦À¡ÐìÌ½õ: 
         “À¡ñÎÌð¼õ ÌýÁõ ÀÕóàÄ §¿¡öÅ¡¾ó 
          ¾£ñÎ ¾¢Ã¢Å¢¼ï º¢ÃóÐñ¼õ âñ¼ÁÊ 
          §¿¡öÅ¢Çí¸ì ¸¡ð¼¡¾ Ññ¸¢ÕÁ¢ Â¡ºÉôÒñ 
          Å¡öÅ¢Çí¸ì ¸¡ð¼ Å¢ÕÁ¡÷”.         - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
þ¾É¡ø À¡ñÎ, ÌýÁõ, Å¡Ô, À¡õÒ ¿ïÍ¸û, ÑñÒØì¸Ùõ ±ÕÅ¡ö 
ÒñÏõ §À¡õ. 
CHEMICAL CONSTITUENTS: 
Embelin, Quercitol, Christembine, Tannins, Volatile oil
27 
ACTIONS: 
          Carminative 
          Anthelmintic 
          Stimulant 
          Alterative 
Pharmacological activities: 
       Anti - inflammatory, diuretic, Anti carcinogenic, Immunostimulant, Antibiotic 
       Database Vol – V, P – 480 
Uses: 
Seeds are powdered and used to expel tape worms. Young leaves of the plant 
combined with ginger are used for gargling in sore throat and apthous ulcers. 
¾¢ôÀ¢Ä¢ 
Botanical name : Piper longum 
Synonym  : Charica roxburgii 
Family  : Piperacae 
Organoleptic character: 
Suvai   : Kaarppu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
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¦À¡ÐìÌ½õ: 
“¬ºÉ§¿¡ö ¦¾¡ñ¨¼§¿¡ö ¬ÅÃ½ À¢ò¾Ó¾ø 
¿¡º¢Å¢Æ¢ ¸¡¾¢¨Å§¿¡ö ¿¡ðÒØ§¿¡ö Å£º¢ÎÅ¢ 
Âí¸Ä¡ïº Éïº¢¨¾Ôõ «õÀ¡ö «Æ¢Å¢óÐõ 
¦À¡í¸Ä¡ïº ¿í¨¸Â÷§¸¡ð§À¡ø”.         -  §¾Ãý ¦ÅñÀ¡ 
þ¾É¡ø, ¬ºÉ§¿¡ö, ¦¾¡ñ¨¼§¿¡ö, À¢ò¾õ, ãìÌ-¸¡Ð, ¸ñ§¿¡ö¸û,  
ÒØ§¿¡ö¸û ¬¸¢Â¨Å ¿£íÌõ. 
CHEMICAL CONSTITUENTS: 
  Piperine(4 – 5%), volatile oil, piperlonguminine, piplartine, sesamin, 
terpenoids, resin, piperundecalidine.
28 
ACTIONS: 
Stimulant 
Carminative 
Alterative 
Pharmacological activities: 
 It works as an analgesic when applied locally.
29
  
 Anti Inflammatory, anti spasmodic, anti bacterial, immunostimulatory
30 
Uses: 
Powdered long pepper administered with honey will relieve cough,cold, asthma, 
hoarseness of voice and hiccough. 
¸Îì¸¡ö 
Botanical name : Terminalia chebula 
Synonyms  : Terminalia reticulata 
English name  : Inknut, Terminalia myrobalan 
Organoleptic character: 
Suvai   : Thuvarppu, inippu, pulippu, kaarppu, kaippu 
Thanmai  : Veppam 
Pirivu   : Inippu 
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¦À¡ÐìÌ½õ: 
“¾¡¨¼ ¸Øò¾¢ì¸¢ ¾¡Ö ÌÈ¢Â¢Å¢¼ô 
       À£¨¼ º¢Ä¢À¾Óü §À¾¢Ó¼õ ¬¨¼¦Âð¼¡ò 
       àÄÁ¢Ê ÒñÅ¡¾ §º¡½¢¸¡ Á¡¨ÄÂ¢Ãñ 
       ¼¡ÄÁ¢Ê §À¡õÅÃ¢ì¸¡ Â¡ø”. 
¸Îì¸¡Â¢É¡ø, ¸ýÉõ, ¸ØòÐ, ¿¡, ¬ñÌÈ¢, þùÅ¢¼í¸Ç¢ý §¿¡ö¸û, 
¸¡ÄÊôÒüÚ§¿¡ö, «¾¢àÄõ, þÊôÒñ, Å¡¾§º¡½¢¾Å¡¾õ, ¸¡Á¡¨Ä, ¾¡ÅÃ, 
ºí¸ÁÅ¢¼í¸û þ¨Å §À¡õ. 
CHEMICAL CONSTITUENTS: 
Tannin45%, anthraquinones, chebulinic acid, chebulagic acid, chebulic acid, 
ellagic acid, gallic acid.   (Indian Herbal Pharmacopoeia, P – 443) 
ACTIONS: 
Laxative 
Astringent 
Alterative 
Pharmacological activities: 
Anti oxidant, It is used in Rheumatism.
31
      
Uses: 
Cold infusion of it is used as a gargle in stomatitis. 
Cures Trithodham.      
¸ÎÌ 
Botanical name : Brassica juncea 
English name  : Mustard 
Organoleptic character: 
Suvai   : Kaarppu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
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¦À¡ÐìÌ½õ: 
“­Ê¸¡º ¿¡º¢îÝ Ã£¨Ç¸Àõ À¢ò¾í 
¸ÊÅ¡¾ º£¾í ¸Îô§À¡ Î¼Ä¢ü 
ÀÎ§¸¡ðÎ §¿¡¦ÂýÛõ Àí¸¢¨Å¸ ¨ÇôÒñ 
¸Î§¸¡ðÎ §ÁýÁÕóÐ ¸¡ñ” 
“Áó¾ÁÂì¸õ Å¡¾õ Å¡ö¿£÷î ÍÆüÈÄÚ 
ÓóÐ Í¸ôÀ¢Ãº Åí¸Ùñ¼¡ Á¢óÐÑ¾ý 
Á¡§É ¸¢Ã¡½¢ÌýÁ Á¡ÚÓò §¾¡¼Óõ§À¡õ 
¾¡§É ¸Î¸¢üÌò ¾¡ý.”               - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
þÐ ¾¨ÄÂ¢Êô¨Àò ¾ÃìÜÊÂ þÕÁø, ãìÌ¿£÷ ÅÊ¾ø, §¸¡¨Æ, 
¦ÅÈ¢, Ì¨¼îºø, ÅÂ¢üÚÅÄ¢ ÓôÀ¢½¢,¸£øÅ¡Ô, þ¨Å¸¨Ç ¿£ìÌõ. 
CHEMICAL CONSTITUENTS: 
 Glucosides - Sinalbin, Sinargin 
ACTIONS: 
Emetic 
Stimulant 
Rubefacient 
Vesicant 
Digestive 
Diuretic 
Uses: 
              Powdered mustard mixed with hot water  can be given for Hiccough. 
              It is mixed with honey and can be given for Bronchial Asthma. 
              Externally it can be  applied in the chest for Hiccough.  
ÍìÌ 
Botanical name  : Zingiber officinale 
English name   : Dried ginger 
Family   : Zingiberaceae 
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Organoleptic character: 
Suvai    : Kaarppu 
Thanmai   : Veppam 
Pirivu    : Kaarppu 
¦À¡ÐìÌ½õ: 
“Ý¨ÄÁó¾õ ¦¿ï¦ºÃ¢ôÒ §¾¡¼§Áô Àõ ÁÆ¨Ä 
ãÄõ þ¨ÃôÀ¢ÕÁø ãìÌ¿£÷ Å¡Ä¸À 
§¾¡¼Á¾¢º¡Ãó ¦¾¡¼÷Å¡¾ ÌýÁ¿£÷ò 
§¾¡¼õ ¬Áõ §À¡ìÌï ÍìÌ”.           - «¸ò¾¢Â÷Ì½Å¡¸¼õ 
Íì¸¢É¡ø ¦ºÃ¢Â¡¨Á, Á¡÷¦ÀÃ¢îºø, ÒÇ¢§ÂôÀõ, ¦ÅôÀ þÕÁø, 
¿£§ÃüÈõ, ÌýÁõ, ÅÂ¢üÚôÀ¢ºõ, ¸¡ÐÌò¾ø, À¡ñÎ, ÅÂ¢üÚìÌò¾ø §À¡õ. 
CHEMICAL CONSTITUENTS: 
Indian ginger contains an aromatic volatile oil having a characteristic odour.  It 
contains camphene, phellandrene, zingiberine, cineol and borneol, gingerol a yellow 
pungent body, an oleoresin-gingerin the active principle, other resins and starch.  
B – sesquiphellandrene, gingerdiols, gingerdiacetates are also present. 
        Indian Herbal Pharmacopoeia P - 443 
ACTIONS: 
Aromatic 
Carminative 
Stimulant 
Stomachic 
Digestive 
Pharmacological activities: 
 Inhibition of Prostoglandin synthesis by the constituents of Ginger is thought to 
play a role in the Anti – inflammatory activity. 
     Indian Herbal Pharmacopoeia P - 487  
Uses: 
Dry ginger is much used as a carminative adjuvant along with black pepper and 
long pepper under the name of trikaduku. 
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Ginger is valuable in dyspepsia, flatulence, vomiting,colic spasms and other 
painful affections of stomach. 
¸Õïº£Ã¸õ 
Botanical name : Nigella sativa Linn 
English name  : Black cumin 
Family  : Ranunculaceae 
Organoleptic character: 
Suvai   : Kaippu, 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐÌ½õ: 
“¸Õïº£ Ã¸ò¾¡ý ¸ÃôÀ¦É¡Î ÒñÏõ 
ÅÕïº¢Ã¡öô À£¿¢ºÓ Á¡üÚõ «Õó¾¢É¡ø 
¸¡öîºø ¾¨ÄÅÄ¢Ôí ¸ñÅÄ¢Ôõ §À¡ÓÄ¸¢ø 
Å¡öîº ÁÕó¦¾É§Å ¨Å.” 
                                           -  «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Áñ¨¼ì ¸ÃôÀ¡ý, Òñ, ¯ðÝÎ, ¾¨Ä §¿¡ö, ¸ñ§½¡ö þ¨Å¸Ùõ 
º¢ÃíÌ ÅÂ¢üÚô ¦À¡ÕÁø, ÌýÁõ, Á¡÷Ò ÅÄ¢, þÕÁø, Å¡ó¾¢, µì¸¡Çõ, 
Å£ì¸õ, ¸¡Á¡¨Ä ¬¸¢Â¨Å¸Ùõ ¸Õïº£Ã¸ò¾¡ø ¿£íÌõ.           
ACTIONS: 
Carminative 
            Stomachic 
            Anthelmintic 
             Diuretic 
Pharmacological activities: 
Diuretic, anti microbial, analgesic, anti inflammatory, anti oxidant, anti 
spasmodic, immunomodulatory. 
    Database Vol – VI, P - 422 
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Chemical Constituents: 
Seeds also contain rich in unsaturated fatty acids like linoleic acid (50-60%) 
Oleic acid 20%,saturated fatty acids like palmitic acid, stearic acid present in about 
<30%. Carvone, d – limonene,cymene, nigellone, melanthin, melanthigenin, nigellidine 
– indazole, campesterol, citronellyl acetate. 
    Database Vol – VI, P - 422 
Uses: 
Powdered form of Black cumin with Vinegar can be taken for deworming 
process. 
§ÅõÒ 
Botanical name  : Azadirachta indica 
English name     : Neem tree 
Family               : Meliaceae 
Organoleptic character: 
Suvai   : Kaippu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐìÌ½õ: 
“¸¢ÕÁ¢Ìð¼ Á¡ó¾í ¦¸ÎÅ¢¼ïÍ Ãí¸û 
¦À¡ÕÁ¢ÂÁ ÝÃ¢¨¸Â¢ý Òñ¸û ´ÕÁ¢ì¸ 
¿¢õÀò ¾¢¨ÄÂ¢Õì¸ ¿£ÎÄ¸¢ø ¿£í¸¡Áø 
¸õÀò ¾¢¨ÄÂ¢Õì¸ì ¸¡ñ” 
                                             -«¸ò¾¢Â÷ Ì½Å¡¸¼õ 
      ÅÂ¢üÚôÒØ, ¦ÀÕ§¿¡ö, Á¡ó¾õ, ¿îÍÍÃõ, «õ¨ÁôÒñ, ¦º¡È¢, º¢ÃíÌ 
¬¸¢Â þ¨Å¸¨Çô §À¡ìÌõ. 
Chemical constituents: 
 Azadirachtin, Azadirachtol, Azadiradione, Nimolinone, Nimbochalcin, 
Nimbocetin, Nimbidic acid, Salannin, Salannol                       
     Database Vol – I, P - 291 
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ACTIONS: 
Stimulant 
Discutient 
Anthelmintic 
Spasmogenic 
Anti inflammatory 
Anti ulcerative 
Analgesic 
Antibacterial                                                                  Database Vol – I, P - 292 
 
¬Á½ìÌ ±ñ¦½ö 
Botanical name : Ricinus communis 
English name  : Castor oil plant 
Organoleptic character: 
Suvai   : Kaippu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐìÌ½õ: 
“¬Á½ìÌ ¦¿öÂ¡ø ¿ÄÓñ¼¡õ Â¡Å÷ìÌõ 
âÁ½ìÌ §ÁÉ¢ ÒÃ¢ÌÆ§Ä Å¡öÁ½ì¸ì 
¦¸¡ûÇ¢ø ÅÂ¢ÚÅ¢Îí §¸¡ÃÓûÇ Å¡ÔÅÚõ 
¯ûÇ¢øÅÕ ÌýÁõ §Á¡Ð”              -«¸ò¾¢Â÷Ì½Å¡¸¼õ 
þÐ ÅÂ¢ü¨Èì ¸Æ¢ìÌõ. §¸¡Ã ÅÄ¢ §¿¡ö, ÌýÁõ, Ì¼§ÄüÈõ, ¯¼ø 
¸ñ ¦ºÅ¢ ãìÌ Å¡ö þ¨Å¸Ç¢Öñ¼¡¸¢ýÈ ±Ã¢îºø þÅü¨È §À¡ìÌõ. 
¯¼¨Äô ¦À¡ýÉ¢ÈÁ¡ìÌõ. 
 
CHEMICAL CONSTITUENTS: 
 Lipids – fixed oil (45 -55), a mixture of triglyceride, triricinolein – which on 
hydrolysis yields ricinoleic acid which is responsible for its cathartic effect.
32
  
60 
 
ACTIONS: 
Laxative 
Emollient 
Anti inflammatory 
Spasmolytic 
Uses: 
 They are useful in Inflammations and rheumatic affections. 
       (Database volume – 4,P – 123) 
Òý¨É 
Botanical name  : Calophyllum inophyllum 
English name     : Alexandrian Laurel 
Family               :  Guttiferae 
Organoleptic character: 
Suvai   : Kaippu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐìÌ½õ: 
“Òý¨ÉÂ¢Ä¢ñ ¼¡¦¿öÂ¡ü ¦À¡íÌºýÉ¢ À¡¾Ó¾ý 
ÁýÉ¢Â¢¨Äì Ìí¦¸¡ÊÂ Å¡ö×Óý À¢ýÉ¢º¢×õ 
¦À¡øÄ¡ ÅÄ¢Â¢ÉÓõ Òñ¸¢ÕÁ¢ Ôó¦¾¡¨ÄÔõ 
«øÄ¡÷ ÌÆ§Ä «È“                      - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
þ¾É¡ø ÓôÀ¢½¢ ¦ÀÕÅÇ¢§¿¡ö¸û, ÓýÉ¢º¢× À¢ýÉ¢º¢×, ³Å¨¸ ÅÄ¢, 
Òñ ÒØì¸û ¬¸¢Â þ¨Å¸¨Çô §À¡ìÌõ 
ACTIONS: 
Astringent 
Anthelmintic 
Emetic 
Purgative 
Irritant 
Rubefacient 
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Uses: 
 It is used as an external application for Rheumatism
33
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¿ø¦Äñ¦½ö 
Botanical name : Sessamum indicum 
English name  : Gingelly oil plant 
Organoleptic character: 
Suvai   : Inippu 
Thanmai  : Veppam 
Pirivu   : Inippu 
¦À¡ÐìÌ½õ: 
“Òò¾¢¿ÂÉìÌÇ¢÷îº¢ âÃ¢ôÒ ¦ÁöôÒÇ¸ï 
ºòÐÅí ¸ó¾¢ ¾É¢Â¢Ç¨Á ¦Áò¾×ñ¼¡í 
¸ñ§É¡ö ¦ºÅ¢§¿¡ö ¸À¡ÄÅÆø ¸¡º§¿¡ö 
Òñ§½¡ö§À¡ ¦Áñ¦½öÂ¡ü §À¡üÚ.”          - «¸ò¾¢Â÷Ì½Å¡¸¼õ 
Òò¾¢ìÌò ¦¾Ç¢×, Å¢Æ¢¸ÙìÌì ÌÇ¢÷îº¢, ¯¼ø âÃ¢ôÒ, ¯¼ø Åý¨Á, 
¸ñ§½¡ö, ¸¡Ð§¿¡ö, ¾¨Äì ¦¸¡¾¢ôÒ, ¦º¡È,¢ º¢ÃíÌ, Òñ. 
ACTIONS: 
Demulcent 
Laxative 
Nutritive 
Emollient 
Uses: 
 The oil is Bitter, Astringent, useful in vitiated conditions of vatha
34
  
¦ÅûÙûÇ¢ 
Botanical name  : Allium sativum 
English name     : Garlic 
Family               : Liliaceae 
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Organoleptic character: 
Suvai   : Kaarappu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐìÌ½õ: 
     “ºýÉ¢¦Â¡Î Å¡¾ó ¾¨Ä§¿¡× ¾¡ûÅÄ¢ 
     ÁýÉ¢ÅÕ ¿£÷ì§¸¡¨Å Åýº£¾õ «ýÉ§Á 
     ¯ûÙûÇ¢ ¸ñÀ¡ö ¯¨ÇãÄ §Ã¡¸Óõ §À¡õ 
     ¦ÅûÙûÇ¢ ¾ýÉ¡ø ¦ÅÕñÎ”           -«¸ò¾¢Â÷ Ì½Å¡¸¼õ 
      º¢È¢Â ¸ðÊ¸û, ¦ºÅ¢Î, ¿¡ðÀð¼ þÕÁø, þ¨ÃôÒ, ÅÂ¢üÚôÒØ 
þ¨Å¸ðÌõ ÓôÀ¢½¢, ÅÇ¢§¿¡ö¸û, ³Âò¾¨ÄÅÄ¢, Å¡ö§¿¡ö, ¿£§ÃüÈõ, 
º£¾ì¸Æ¢îºø, ãÄõ  
Chemical constituents: 
 Scordine, diallyl trisulphide, allyl methyl trisulphide, glucofrictan, alliin, allicin, 
enzyme – alliinase, alltin, allisatin, allixin, allyl alcohol      (Database Vol – VI, P – 158) 
ACTIONS: 
           Carminative 
Stomachic 
Tonic 
Alterative 
Stimulant 
Expectorant 
Diuretic 
Anti inflammatory 
Anti arthritic 
Anti oxidant 
Antibacterial                                                                Database Vol – VI, P - 158 
Uses: 
  It is used in Rheumatism, Arthralgia, disorders of Spleen and Liver (Database 
Vol – VI, P – 157) 
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ÅºõÒ 
Botanical name  : Acorus calamus 
English name     : Sweet flag   
Family               : Areceae 
Organoleptic character: 
Suvai   : Kaarappu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐìÌ½õ: 
“À¡õÀ¡¾¢ ¿ïºü À¾ôôÒñ ÅÄ¢Å¢¼À¡¸í ÌýÁõ 
ÝõÀ¡ Ã¢Ãò¾À¢ò ¾õÓ¸ ¿¡üÈõÅý Ý¨ÄºýÉ¢ 
Å£õÀ¡õ¨À ¸¡ºõ ÄÀ¢Ä£¸ï º¢Ä¢À¾õ Å£È¢ÕÁø 
¾¡õÀ¡í ¸¢ÕÁ¢ Â¢¨Å§ÂÌ Á¡º¢Å ºõÀ¢¨É§Â” 
            - §¾¨ÃÂ÷ Ì½Å¡¸¼õ 
      þ¾É¡ø ±øÄ¡ ¿ïÍ¸û, Òñ Å¨¸¸û, ³Å¨¸ÅÄ¢, ÌýÁõ, 
þÃò¾À¢ò¾õ, Å¡ö¿¡üÈõ, Ý¨Ä, ÓôÀ¢½¢, þÕÁø, ®Ãø §¿¡ö¸û, 
Â¡¨Éì¸¡ø, ¿¡¼¡ôÒØ ¬¸¢Â¨Å §À¡õ 
Chemical constituents: 
 Asarone, calamenol, calamene, eugenol, methyl eugenol, pinene, camphene, 
calamol, azulene.      Database Vol – I, P - 471 
ACTIONS: 
Stimulant 
Stomachic 
Antiperiodic 
Carminative 
Nauseant 
Emetic 
Disinfectant 
Germicide 
Spasmolytic 
Hypothermic 
Anticonvulsant                   - Database Vol – I, P - 471 
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Uses: 
Plant causes sedative effect. It also reduces pain (Analgesic effect) 
 
¦ÀÕí¸¡Âõ 
Botanical name  : Ferula asafoetida 
English name     : Asafoetida 
Synonyms          : Ferula foetida         
Family               : Umbelliferae  
Organoleptic character: 
Suvai  : Kaippu, karakarappu 
Thanmai : Veppam 
Pirivu  : Kaarppu 
¦À¡ÐìÌ½õ: 
“¾ó¾§Å ¾ó¾ ãÄò¦¾ØõÀ¢½¢ 
ºÕÅ¸¡Çõ Å¢Õîº¢¸í¸£¼õÁ¡ 
Áó¾õÅ¡¾õ ¯¾¡Å÷ò¾õ «øÌø§¿¡ö 
  Á¡÷À½í¸ð¼ ÌýÁõ Á§¸¡¾Ãõ 
 ¯óÐ¦¸÷ôÀò¾¢ý Å¢ò¾¢ÃïÝ¨Äî 
 ¯¾¢Ãôâîº¢ º¢§ÄòÐÁòÐÚõÅÄ¢ 
Åó¾¦Áöì¸Îô §À¡Ê¨ÅÓüÚ§Á 
Á¡¿¡Ú¿ü ¸¡Âí¸¢¨¼ì¸¢§É”.             - §¾Ãý Ì½Å¡¸¼õ 
þ¾É¡ø Àø§¿¡ö¸û, À¡õÒ¿ïÍ¸û, Áó¾õ, ²ôÀõ, ÌýÁõ, ¦ÀÕÅÂ¢Ú, 
Ý¾¸îÝ¨Ä þ¨Å¸û §À¡õ. 
Chemical constituents: 
  Organic sulphur compound, volatile oil containing essential oil of garlic-allyl, 
allylpersulphide and two terpenes, ferulic acid, ester of asaresino-tannol, alsomali, 
acetic, formic & valerainic acids. 
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ACTIONS: 
Stimulant 
Anti spasmodic 
Anthelmintic 
Emmenagogue 
Expectorant 
Nervine tonic
35 
Uses: 
It is used as anthelmintic for round worms in children, typhoid fever, cholera, 
convulsions and flatulent diseases of children. 
Á¢ÇÌ 
Botanical name : Piper nigrum 
English name  : Black pepper 
Family  : Piperaceae 
Organoleptic character: 
Suvai   : Kaippu, kaarppu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐìÌ½õ: 
“º£¾ÍÃõ À¡ñÎ º¢§ÄòÁí ¸¢Ã¡½¢ÌýÁõ 
      Å¡¾õ «Õº¢À¢ò¾õ Á¡ãÄõ µÐºýÉ¢ 
      Â¡ºÁÀŠ Á¡Ãõ «¼ý§Á¸õ ¸¡ºÁ¢¨Å 
      ¿¡ºí ¸È¢ Á¢Ç¸¢É¡ø “.                  
                           - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
þ¾É¡ø, ÌÇ¢÷ÍÃõ, À¡ñÎ, §¸¡¨Æ, ÌýÁõ, Å¡Ô, Í¨ÅÂ¢ý¨Á, ãÄõ, 
ºýÉ¢, þÕÁø ¬¸¢Â¨Å §À¡Ìõ. 
CHEMICAL CONSTITUENTS: 
A volatile alkaloid piperine or pipirine 5-9%, piperidine or piperidin 5%, 
abalsamic volatile essential 1-2%, fat7%. 
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Mesocarp contains chavicin, a balsamic volatile oil, starch, gum. 
Piperine, Piperrttine, Piperanine, Pipericide Sarmentine, Eugenol,  
     Indian Herbal Pharmacopoeia, P – 321 
ACTIONS: 
Carminative 
Pungent 
Antiperiodic 
Analgesic 
Anti inflammatory 
Anti - oxidant             - Indian Herbal Pharmacopoeia, P – 324 
Cyclooxygenase inhibitory activity                - Database, Vol – 190 
Uses: 
It is useful in dyspepsia and flatulence in doses of 10-15 grains of the powder 
and in haemorrhoids in form of confection. It is a useful ingredient in tooth powder. 
µÁõ 
Botanical name  : Carum copticum 
Synonyms   : Tachyspermam ammi 
English name   : Bishops weed 
Family   : Solanacae 
Organoleptic character: 
Suvai    : Kaarppu 
Thanmai   : Veppam 
Pirivu    : Kaarppu 
¦À¡ÐìÌ½õ: 
    “º£¾ÍÃí ¸¡ºï ¦ºÃ¢Â¡Áó ¾õ¦À¡ÕÁø 
      §À¾¢Â¢¨Ãî ºø¸ÎôÒ §ÀÃ¡Áõ µ¾¢ÕÁø 
      Àø¦Ä¡ÎÀø ãÄõÀÍÁ¢¨Å§¿¡ ¦Âý¦ºÔ§Á¡ 
      ¦º¡ø¦Ä¡Î §À¡õ µÁ¦ÁÉî ¦º¡ø ”. 
                                            -«¸ò¾¢Â÷ Ì½Å¡¸¼õ 
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þ¾É¡ø, º£¾ÍÃõ, þÕÁø, ¦ºÃ¢Â¡Á¡ó¾õ, ¦À¡ÕÁø, ¸Æ¢îºø, þ¨ÃôÒ, 
Àø §¿¡ö, þ¨Å¸û §À¡õ. 
CHEMICAL CONSTITUENTS: 
The chemical composition of essential oil obtained from dry fruits of carum. 
Thymol (35-60), further more, a-pinene, p-cymene, limonene and a-terpinene 
have been found. 
Camphene, Carvacrol, cymene, dipentene, myrcene, phenols, terpinene, 
thymene, thymol, linoleic acid.                                  - Database, Vol – VII, P - 498 
ACTIONS: 
Carminative 
Stimulant 
Stomachic 
Anti spasmodic 
Tonic 
Antimicrobial 
Diuretic 
Antispamodic 
USES: 
A paste of the crushed fruit is applied externally for relieving colic pains 
(Database, Vol – VII, P – 497 – 498) 
¸¢Ã¡õÒ 
Botanical name  : Syzygium aroamaticum    
Family               : Myrtaceae 
Organoleptic character: 
Suvai   : Kaarappu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
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¦À¡ÐìÌ½õ: 
“À¢ò¾ ÁÂì¸õ §À¾¢¦Â¡Î Å¡ó¾¢Ôõ§À¡õ 
Íò¾Å¢Ãò ¾ì¸ÎôÒó §¾¡ýÚ§Á¡ ¦Áò¾ 
þÄÅí¸í ¦¸¡ñ¼ÅÕì §¸ü Í¸Á¡Ìõ 
ÁÄÁí§¸ ¸ðÎ¦ÁÉ Å¡úòÐ”       -«¸ò¾¢Â÷ Ì½Å¡¸¼õ 
þÐ ÁÂì¸õ, §À¾¢, Å¡ó¾¢, ÌÕ¾¢¸Æ¢îºø, ¿¡ðÀð¼ ¸Æ¢îºø, 
±ÕÅ¡ö¸ÎôôÒ, ¦ºÅ¢§¿¡ö, º¢Åó¾Áîºõ, ¸Úò¾ Áîºõ, ¸ñ½¢ø â, À¨¼¸û 
¬¸¢ÂÅü¨È ¿£ìÌõ. 
Chemical constituents: 
 Volatile oil, eugenol, acetate, caryophyllene, humulene, acetophenone, cardinal, 
hexanol, muuvolene, palustrol                        -Indian Herbal Pharmacopoeia, P - 424 
ACTIONS: 
Stimulant 
Stomachic 
Antiperiodic 
Carminative 
Nauseant 
Emetic 
Disinfectant 
Germicide 
Antioxidant 
Anti convulsant 
Radical scavenging activity 
Rejuvenating                                                 - Database, Vol – IV, P – 359 – 360 
Uses: 
Externally the oil is used as an application for rheumatic pains, headache, 
neuralgia.                                                             - Database, Vol – IV, P – 359 - 360 
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º¾Ìô¨À 
Botanical name  : Anethum graveolens 
English name     : Gardendill 
Family               : Apiaceae 
Organoleptic character: 
Suvai   : Inippu, Kaarappu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
 
¦À¡ÐìÌ½õ: 
“Å¡¾¦Á¡Î Ý¾¢¸¡ Å¡¾õ º¢ÃÍ§¿¡ö 
§Á¡Ð¦ºÅ¢ §¿¡ö¸À§¿¡ö ãÎÍÃõ µÐ¸¢ýÈ 
ãÄì ¸ÎôÒ Ó¾¢÷À£É¢ºõ §À¡Ìõ 
»¡Äî º¾Ìô¨À ¿¡Î”             -«¸ò¾¢Â÷ Ì½Å¡¸¼õ 
      þ¾É¡ø ÅÇ¢ §¿¡ö, ÌÕ¾¢§À¡ìÌ, ¾¨ÄÅÄ¢, ¸¡ÐÅÄ¢, ãìÌ¿£÷À¡ö¾ø, 
¸£úÅ¡öì¸ÎôÒ ¿£íÌõ. 
ACTIONS: 
Carminative 
Deobstruent 
Diuretic 
Stimulant 
Stomachic 
Anti inflammatory 
Antispasmodic   
Uses: 
 They are used in arthralgia and inflammation of joints.
36
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¸ÎÌ§Ã¡¸¢½¢ 
Botanical name  : Picrorhiza scrophulariiflora 
English name     : Picorrhiza 
Family               : Scrophulariaceae 
Organoleptic character: 
Suvai   : Kaippu, Kaarappu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐìÌ½õ: 
“Á¡ó¾ï ÍÃ¨ÁÂõ Å¡Ô¸Ãô À¡É¡Áï 
§º÷ó¾ÁÄì ¸ðÎ ¾¢Ã¢§¾¡¼õ §À¡ó¾¦À¡ðÎô 
ÒñÅÂ¢Ú §¿¡Â¢¨Å§À¡õ ¦À¡ü¦¸¡Ê§Â §À¾¢Ôñ¼¡õ 
¾¢ñ¸ÎÌ §Ã¡¸½¢ìÌò §¾÷.”                 - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
      Á¡ó¾õ, ÍÃõ, ³Âô ¦ÀÕìÌ, ¸ÃôÀ¡ý, º£¾ì ¸Æ¢îºø, ÅÂ¢üÚÅÄ¢, 
Òñ¸û, ÅÇ¢ §¿¡ö¸û ±ýÛõ þ¨Å¸û §À¡õ. 
Chemical Constituents: 
 Iridoid glycosides, picroside I and kutkoside (Indian Herbal Pharmacopoeia – 
Revised Edition  - 2, P – 296) 
ACTIONS & USES: 
Antiperiodic 
Cathartic 
Stomachic 
Anthelmintic 
Antioxidant  
 Indian Herbal Pharmacopoeia - Revised Edition  - 2, P – 296 
It is used as a Laxative     - Database, Vol – 7, P - 180 
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MATERIALS AND METHODS 
STUDY DESIGN  :  A Pilot study. 
STUDY PLACE : Ayothidoss Pandithar Hospital, National Institute of Siddha,  
                                      Tambaram Sanatorium, Chennai-47. 
STUDY PERIOD : 12 months 
SAMPLE SIZE : 40 patients  
              (20 - OP; 20 - IP -10 with trial medicines, 10 with Varmam  
              along with  trial medicine) 
TRIAL DRUGS: 
INTERNAL DRUG: MAHA ANALURUVA CHOORANAM:  
(Reference: Agathiyar Vaithiya Vallathi 600) 
Ingredients 
Kodiveli ver (Plumbago zeylanica)                    1 balam (35 grams) 
Pungu ver (Pongamia glabra root)            1 balam (35 grams) 
Aayil pattai (Haloptelia integrifolia stem and root bark)1 balam (35 grams) 
Vaaividangam (Emblia ribes)                               ½ balam (17.5grams) 
Thippili (Piper longum)                               ½ balam (17.5grams) 
Kadukkkaai (Terminalia chebula)                     ½ balam (17.5grams) 
Kadugu (Brassica juncea)                            ½ balam(17.5 grams) 
Chukku (Zingiber officinale)                       ½  balam(17.5grams) 
Karunjeeragam (Nigella sativa)                             ½ balam(17.5 grams) 
Dose   : Verugadi (1.5  grams) b.i.d 
Adjuvant  : Honey. 
Duration  : 48 days 
Source of raw drugs:  
The required raw drugs are purchased from authorized centers and standardized 
before preparing medicines. The raw drugs will be authenticated and then they are 
purified and the medicines are prepared in Gunapadam laboratory of National Institute 
of Siddha. 
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Purification of raw drugs: 
Thippili (Piper longum):  It is soaked in lemon juice. 
Inji (Zingiber officinale): It is soaked in lime stone water 
Vaividangam (Emblia ribes): It is dried in sunlight 
Kadukkai (Terminalia chebula): The seeds are taken off and the outer portion is used. 
Kadugu (Brassica juncea) : It is dried in sunlight for 2 days 
Karujeeragam (Nigella sativa) : It is dried in sunlight and is then roasted 
Kodiveli (Plumbago zeylanica) : Inner nerve of  the bark is removed and the bark 
alone is powdered. The above said powder is taken in a broad mouthed vessel 
containing cow‟s milk, closed with another broad mouthed vessel, subjected to heat for 
three hours. The resultant powder is again finely powdered in a Kalvam and then taken 
Pungu (Pongamia glabra) (root bark) : It is cleaned with a cloth and its outer portion 
is scratched off. 
Aayil Pattai -stem bark (Haloptelia integrifolia) : It is cleaned with a cloth and its 
outer portion is scratched off. 
Aayil Pattai - roots (Haloptelia integrifolia) : It is washed in purified river water.                               
- Reference: Sikitcha Ratna Deepam, Sarakku Suthi Muraigal 
Preparation: 
35 grams each of Kodiveli ver (Plumbago zeylanica), Pungu ver (Pongamia 
glabra root), Aayil pattai (Haloptelia integrifolia stem and root bark) are taken. They are 
dried in shade and then made into fine powder. 
17.5 gms. of Vaaividangam(Emblia ribes), Thippili(Piper longum), Kadukkkaai 
(Terminalia chebula), Kadugu(Brassica juncea), Chukku(Zingiber officinale), 
Karunjeeragam(Nigella sativa) are taken and roasted. Then they are made into a fine 
powder. This powder is then mixed with the above mentioned powder. 
Drug storage: 
The trial drug Chooranam is stored in clean dry air tight container and it is 
dispensed to the patients in packets. 
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EXTERNAL DRUG: PUNGAN ENNAI 
(Reference: Gunapadam Mooligai Vaguppu) 
Ingredients: 
1. Pungan oil  (Oil of   Pongamia glabra)           700 ml 
2. Vaeppam oil  (Oil of Azadirachta indica)            700 ml 
3. Aamanakku oil (Oil of Ricinus communis)            700 ml 
4. Punnai oil  (Oil of Calophyllum inophyllum)   700 ml 
5. Gingelly oil  (Oil of Sessamum indicum)           700 ml 
6. Velluli   (Allium sativum)               17 gms 
7. Vasambu   (Acorus calamus)         17 gms 
8. Perungkayam   (Ferula asafoedita)       17 gms 
9. Chukku   (Zingiber officinale)     17 gms 
10. Milagu   (Piper nigrum)              17 gms 
11. Thippili   (Piper longum)            17 gms 
12. Omam    (Carum capticum)         17 gms 
13. kirambu   (Syzium aromaticum)   17  gms 
14. Sadha kuppai   (Anethom graveolens)  17 gms 
15. Kadugu rogini  (Piccorhiza kurroa)       17 gms 
16. Sitthira moolam ( Plumbago zeylanica)   17 gms 
Method of Preparation: 
Pungan oil, Vaeppam oil, Aamanakku oil, Punnai oil, Gingelly oil are taken and 
mixed well in a big container. The raw drugs (listed from 6 to 16) were powdered and 
then mixed well with Kaadi (Vinegar). This mixture is added with the above oil. Then 
2800 ml of Kaadi is added with the above mixture and subjected to heat till it attains the 
consistency (Patham) of Mezugu. After that the oil is filtered and stored. This oil is used 
externally for vatha diseases. 
Indications:  
It is indicated externally for 80 types of Vatha diseases, Megam, Soolai, Isivu, 
Soothaga vali.. 
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Drug storage: 
The trial drug is stored in clean dry air tight container and it is given to the 
patients in disposable pet bottles. 
VARMAM THERAPY: 
 Varmam points indicated for Ceganavatham: 
 Muduchi Varmam (Varma odivu murivu sara soothiram - 1200) 
 Kakkattai Kaalam ( Varma Beerangi – 100) 
 Manibanthaga Varmam ( Varma Beerangi – 100) 
 Kai viral madakku Varmam (Varma vilakkam) 
 Kavuli Kaalam (Varma soothiram – 101) 
ETHICAL CLEARANCE:  
  After the trial drugs were chosen, they were scrutinized by the Institutional 
Ethical Committee for ethical clearance. 
ETHICAL ISSUES: 
1. To prevent any infection, while collecting blood samples from the patient, only 
disposable syringes, disposable gloves, with proper sterilization of laboratory 
equipments will be used. 
2. There will be no infringement on the rights of patient. 
3. The data collected from the patient will be kept confidential.  
4. The patient will be informed about the disease and other details of the treatment. 
5. After obtaining the written consent of the patient (through consent form in their 
vernacular language) they will be enrolled in the study. 
6. Treatment would be provided free of cost. 
7. In case of any adverse reactions, the patients will be referred to the OPD of 
National Institute of Siddha for further management. 
8. The patient will be allowed to withdraw from this trial if he or she is not satisfied 
with this treatment and procedures. 
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PATIENT SCREENING 
Inclusion/Exclusion 
 
INCLUSION CRITERIA EXCLUSION CRITERIA 
EXCLUDED FROM TRIAL 
METHODOLOGY 
       STUDY NUMBER 
     HISTORY TAKING 
LAB INVESTIGATION 
 TRIAL DRUG  
CLINICAL ASSESSMENT 
OUTCOME 
INFORM ABOUT STUDY 
AND TRIAL DRUG 
 
INFORMED CONSENT FORM 
 
ADVERSE REACTION 
ADVICED TO TAKE 
TREATMENT IN OPD 
ABNORMAL VALUES 
VALUES 
PHARMACOLOGICAL 
ASSESSMENT 
FURTHER MANAGEMENT OF 
ADVERSE DRUG REACTION 
WITH 
VARAMAM 
WITHOUT 
VARAMAM 
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STUDY ENROLLMENT: 
Patients reporting at the OPD of Ayothidoss Pandithar Hospital of National 
Institute of Siddha with clinical features of pain in nape radiating to upper limbs, 
stiffness were chosen for the enrollment based on the inclusion criteria. 
The patients who were enrolled were informed (Form VII) about the study, trial 
drug, possible outcomes and the objectives of the study in the language and terms 
understandable to them. The informed consent were obtained in writing from them in 
the consent form (Form V).  
Unique registration cards were given to all the patients in which the patients 
Registration number, Address, Phone number and Doctors phone number etc. will be 
given, so as to report easily if any complications arise. 
Complete clinical history, complaints, duration, examination findings and 
laboratory investigations -- were recorded in the prescribed Proforma. 
Screening Form- I was filled initially. Form –II, Form –III and Form – IV were 
used for recording the patients history, clinical examination of symptoms, signs and 
laboratory investigations respectively. Patients were advised to take the trial drug and 
appropriate dietary advice were given according to the patients perfect understanding. 
  
CONDUCT OF THE STUDY: 
 The trial drugs Maha Analuruva Chooranam (Internal) and Pungan Ennai 
(External) were given for 48 days. Purgation with Agasthiyar kuzhambu – 200 mg with 
palm jaggery was given at early morning one day before the treatment for balancing the 
deranged mukkuttram. Among the 20 subjects in IPD 10 were given varmam therapy 
additionally. The clinical assessment was made daily and recorded in the appropriate 
forms for all subjects.  For subjects visiting the OPD, the trial drugs were given and they 
were asked to have regular follow-up in the OPD once in 7 days. In every visit, the 
clinical assessment was recorded. The laboratory investigations were done before and 
after the treatment and was recorded. If any trial subject failed to collect the trial drug on 
prescribed day, but wanted to continue in the trial from next day or two he/she was 
allowed. Defaulters for one week were not allowed to continue and were withdrawn 
from the study. At the end of the treatment the subjects were advised to have follow-up 
visits in the OPD for 2 more months. 
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DATA MANAGEMENT: 
After enrolment of the subjects in the study, a separate file was maintained for 
each subject and all the forms were filed. Study number was entered on the top of the 
file for easy recognition. Whenever the subjects visited OPD during the study period, 
required entries were made in the assessment forms.  
The data entries were monitored by the Head of the Department and Department 
of Pharmacovigilance for detecting occurrence of any adverse reactions. 
All the forms were further scrutinized in presence of investigations by Sr. 
Research Officer (Statistics) for logical errors and incompleteness of data to avoid any 
bias. No modifications in the results were permitted for unbiased reports. Finally the 
outcome was assessed. 
 
DATA COLLECTION FORMS:  
Required information was collected from each patient by using following forms: 
FORM I          : Screening and selection proforma  
FORM lI  : History proforma on enrollment 
FORM llI        : Clinical assessment proforma 
FORM lV        : Laboratory investigations on enrollment and conclusion of trial 
FORM V     : Consent form 
FORM VI    : Withdrawal form 
FORM VII      : Patient information sheet 
FORM VIII    : Drug Compliance Form 
FORM IX       : Dietary advice form  
FORM X        : Adverse reaction form 
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THE   CLINICAL ASSESSMENT AND OUTCOME WERE ASSESSED BASED 
ON THE FOLLOWING: 
TESTS AND ASSESMENTS 
1. Clinical assessment  
2. Routine investigations 
3. Specific investigations  
Clinical assessment: 
Pain in nape 
Radiating pain in upper limbs 
Tenderness 
Numbness 
Stiffness of neck and restriction of movements 
Giddiness 
PAIN ASSESMENT:  
Universal Pain Assessment Scale 
                 
 A.   0    :  No Pain 
                B. 1 -3 :   Mild pain 
                C. 4-6  :   Moderate pain 
                 D. 7-10 :   Severe pain
37 
GRADATION: 
1. Grade 1 - Fit for all activities and to do the works  without support (Normal). 
2. Grade 2 - Mild pain and mild restriction of movements. 
3. Grade 3- Moderate pain with or without radiation to upper limbs and 
moderate restriction of movements. 
4. Grade 4 - Severe pain with or without radiation to upper limbs and severe 
restriction of movements. 
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ROUTINE TESTS AND INVESTIGATION: 
INVESTIGATIONS BASED ON SIDDHA SYSTEM 
Envagai Thervu: 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
7. Malam 
8. Moothiram 
 Neerkkuri: 
 Neikkuri: 
Blood: 
TC, DC, ESR, Hb, TRBC 
Blood Sugar 
Fasting 
Post prandial 
Serum Uric acid 
Serum Calcium 
Serum Phosphorus 
Renal function tests: 
Blood urea 
Serum creatinine 
Lipid profile: 
HDL, LDL, VLDL 
Total Cholesterol & TGL 
Liver Function tests: 
SGOT 
SGPT 
Alkaline Phosphatase 
Total Protein 
Albumin 
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Globulin 
Serum Bilirubin 
Total, Direct & Indirect 
Serology: 
C - reactive protein 
RA factor 
ASO titre 
Urine: 
Albumin 
Sugar 
Deposits 
SPECIFIC INVESTIGATIONS: 
X- Ray:  Cervical spine -  AP, Lateral and Oblique view 
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OBSERVATIONS AND RESULTS 
Results and observations of various categories are presented mentioned as under: 
1. Age  
2. Gender 
3. Profession 
4. Society Role 
5. Paruva Kaalam (Seasonal changes) 
6. Thinai 
7. Derangement of kanmenthriyam 
8. Derangement of Vaatham 
9. Derangement of Pitham 
10. Derangement of Kabam 
11. Udal Thathukkal 
12. Envagai Thervugal 
13. Naadi 
14. Neikkuri analysis 
15. Duration of Illness 
16. Clinical features  
17. Progress due to the treatment 
18. Enhancement due to the varmam treatment(10 Patients) 
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1. AGE: 
AGE 
PATIENTS 
NO PERCENTAGE 
21-30 4 10 
31-40 14 35 
41-50 15 37.5 
51-60 7 17.5 
Total 40 100 
 
 
Inference:    
          Among the 40 patients recruited for trial, people of age group between 41-50 
years  had more occurrence of the disease. 
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2. GENDER: 
 
GENDER 
PATIENTS 
NO PERCENTAGE 
M 21 52.5 
F 19 47.5 
Total 40 100 
 
 
 
Inference:    
          Among the 40 patients recruited for trial, Male (52.5%) had more occurrence of 
the disease. 
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3. PROFESSION:   
PROFESSION 
PATIENTS 
NO PERCENTAGE 
Clerk 4 10 
Labour 7 17.5 
Operator 3 7.5 
Mechanic 1 2.5 
Home maker 13 32.5 
Musician 1 2.5 
Driver 3 7.5 
Tailor 4 10 
Supervisor 3 7.5 
Farmer 1 2.5 
Total 40 100 
 
 
Inference:    
          Among the 40 patients recruited for trial, mostly home makers (32.5%) had more 
occurrence of disease. 
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4. SOCIETY ROLE: 
SOCIETY ROLE 
PATIENTS 
NO PERCENTAGE 
Below Middle class  32 80 
Middle class 7 17.5 
Above Middle class 1 2.5 
Total 40 100 
 
 
 
Inference:    
          Among the 40 patients recruited for trial, below middle class people had more 
occurrence of the disease. 
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5. PARUVA KAALAM 
PARUVA KAALAM 
PATIENTS 
NO PERCENTAGE 
Kaar 11 27.5 
Koothir 0 0 
Munpani 0 0 
Pinpani 0 0 
Ilavenil 0 0 
Mudhuvenil 29 72.5 
 
 
Inference:    
72.5% patients among 40 got admitted during Mudhuvenil kalam and 27.5% 
patients during kaarkalam. No patients got admitted in other seasons. 
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6. THINAI: 
THINAI 
PATIENTS 
NO PERCENTAGE 
Kurinji 0 0 
Mullai 0 0 
Marutham 4 10 
Neithal 36 90 
Paalai 0 0 
Total 40 100 
 
 
Inference:    
90% of patients among 40 admitted were from Neithal thinai and 10% from 
Marutham thinai. No patients got admitted in other thinais. 
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7. KANMENTHIRIYAM: 
KANMENTHIRIYAM 
PATIENTS PATIENTS 
RELIEVED 
FROM 
SYMPTOMS 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Kai 40 1 39 
Kaal 3 1 2 
Vai 0 0 0 
Eruvai 7 2 5 
Karuvai 3 3 0 
 Inference:    
Kai was affected in all the 40 patients, 39 got relieved from symptoms after 
treatment. Kaal was affected in 3 patients, 2 got relieved from symptoms after treatment. 
Eruvai was affected in 7 patients, 5 got relieved from symptoms after treatment. 
8. DISTURBANCES IN VAATHAM: 
VAATHAM 
PATIENTS AFFECTED PATIENTS 
RELIEVED FROM 
SYMPTOMS 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Praanan 0 0 0 
Abaanan 7 2 5 
Samaanan 40 3 37 
Udhaanan 0 0 0 
Viyaanan 40 3 37 
Inference:       
Among the 40 patients observed, Viyaanan and Samaanan were affected in 
almost all the patients, while Abaanan was affected in 7 patients before treatment. After 
treatment Viyaanan and Samaanan remained affected in 3 patients and Abaanan in 2. 
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9. PITHAM: 
PITHAM 
PATIENTS AFFECTED 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Analakam 1 1 
Ranjakam 3 3 
Saathakam 40 10 
Prasakam 0 0 
Aalosakam 0 0 
Inference:    
Saathagam was affected in 40 patients before treatment, 30 got relieved from 
symptoms after treatment. 
10. KABAM:  
KABAM 
PATIENTS AFFECTED 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Avalambagam 0 0 
Kilethagam 0 0 
Pothagam 0 0 
Tharpagam 0 0 
Santhigam 40 1 
Inference:    
Santhigam was affected in all the 40 patients. 39 patients got relieved after 
treatment. 
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11. UDAL THATHUKKAL: 
UDAL THATHUKKAL 
PATIENTS AFFECTED 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Saaram 40 7 
Senneer 5 5 
Oon 21 2 
Kozhuppu 40 2 
Enbu 40 1 
Moolai 0 0 
Sukkilam/Suronitham 2 2 
 
 
Inference:   
Kozhuppu and Enbu were affected in all the 40 subjects (100%). 38 Patients got 
relieved from Kozhupu and 39 patients got relieved from Enbu after treatment. 
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12. ENVAGAI THERVUGAL 
ENVAGAI 
THERVUGAL 
PATIENTS AFFECTED PATIENTS 
RELIEVED FROM 
SYMPTOMS 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Niram 0 0 0 
Naa 12 12 0 
Mozhi 0 0 0 
Vizhi 7 7 0 
Malam 6 4 2 
Neer 0 0 0 
Sparisam 0 0 0 
Inference: 
There was no change in Niram, Naa, Mozhi and Sparisam. Malam 
(Constipation) got reduced in 2 patients. 
13. NAADI 
NAADI 
PATIENTS 
NO PERCENTAGE 
Pithavatham 16 40 
Vathapitham 7 17.5 
Kabapitham 6 15 
Kabavatham 9 22.5 
Pithakabam 2 5 
Total 40 100 
 
Inference:   
Among 40 patients, 40% patients had Pithavatham, 17.5% had Vathapitham, 
15% had Kabapitham, 22.5% has Kabavatham and 5% had Pithakabam nadi. 
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14. NEIKKURI:  
SPREADING PATTERN 
PATIENTS 
NUMBER PERCENTAGE 
Aravena Neendathu (Vatha Neer)  
(Snake like pattern) 
1 2.5 
Aazhipol Paraviathu (Pitha neer) 
(Annular/Ringed pattern) 
20 50 
Muththothu Ninrathu (Kaba neer) 
(Pearl beaded pattern) 
19 47.5 
Total 40 100 
Inference:   
          Among 40 patients, 50% patients had Pitha neer, 47.5% had Kaba neer and 2.5% 
had Vatha neer. 
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15. DURATION OF ILLNESS: 
DURATION OF ILLNESS 
PATIENTS 
NUMBER PERCENTAGE 
Upto 6months 17 42.5 
7-12 months 4 10 
13-18 months 3 7.5 
19-24 months 2 5 
25-30 months 1 2.5 
Above 30months 13 32.5 
Total 40 100 
 
 
Inference:   
In 42.5% of patients, the duration of illness was upto 6 months, 10% patients had 
illness for about 7-12 months, 7.5% patients had illness for about 13-18months, 5% 
subjects had illness for about 19-24 months, 2.5% had illness for about 25-30months 
and 32.5% of patients had illness more than 30months. 
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16. CLINICAL FEATURES: 
CLINICAL FEATURES 
PATIENTS 
NUMBER PERCENTAGE 
Pain in neck 40 100 
Pain in shoulder 38 95 
Radiating pain in  the right upper limb 28 70 
Radiating pain in  the left upper limb 23 57.5 
Numbness 25 62.5 
Tenderness 19 47.5 
Restriction of movements(ROM) 38 95 
Burning sensation 1 2.5 
Giddiness 11 27.5 
Swelling 3 7.5 
 
 
 Inference:   
All the 40 patients had pain in their neck. 
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17. PROGRESS: 
CLINICAL FEATURES 
PATIENTS 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
% OF 
SUBJECTS 
RELIEVED 
FROM 
SYMPTOMS 
Pain in neck 40 0 100 
Pain in shoulder 38 6 84.21 
Radiating pain in  the right upper 
limb 28 3 89.29 
Radiating pain in  the left upper 
limb 23 1 95.65 
Numbness 25 5 80 
Tenderness 19 2 89.47 
Restriction of movements(ROM) 38 11 71.05 
Burning sensation 1 0 100.0 
Giddiness 11 3 72.73 
Swelling 3 1 66.67 
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18. ENHANCEMENT IN PATIENTS TREATED WITH VARMAM ALONG 
WITH TRIAL DRUGS (IN 10 SUBJECTS): 
CLINICAL FEATURES 
PATIENTS 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
% OF SUBJECTS 
RELIEVED FROM 
SYMPTOMS 
Pain in neck 10 0 100 
Pain in shoulder 10 1 90 
Upper limbs 10 0 100 
Numbness 7 0 100 
Tenderness 8 0 100 
ROM 9 1 88.89 
Burning sensation 0 0 0 
Giddiness 2 0 100 
 
 
Inference:   
From the Varmam treatment results, thus it is proved that this treatment 
decreases the illness to a marginal level. Regular observation was done for 48 days. The 
outcome was assessed based on pain scale and gradation on a specific periodical basis. 
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PRIMARY OUTCOME: 
EFFECT OF TRIAL DRUGS IN REDUCING PAIN IN CEGANAVATHAM:  
Before treatment:  
     40 subjects had pain in neck, 28 had radiating pain in upper limbs, 38 had 
radiating pain in shoulders. 
After treatment:  
      100% patients among 40 had reduction in neck pain, 89.29% among 28 had 
reduction in radiating pain in upper limbs, and 84.21% among 38 had reduction in 
radiating pain in shoulders. 
Statistical Analysis: 
       All collected data were entered into computer using MS Excel Software using 
different columns as variables and rows as patients. SPSS software was used to perform 
stasistical analysis. Basic descriptive stasistics include frequency distributions and 
crosss tabulations were performed. The Quantity variables were expressed as mean ± 
Standard deviation and qualitative data as percentage. A probability value of < 0.05  was 
considered to indicate as stasistical significance. Paired „t‟ test was performed for 
determining the significance between before and after treatment. 
MEAN AND STANDARD DEVIATION OF PAIN IN NECK 
Pain in the Neck Mean Standard deviation „t‟ value & „p‟ 
value 
Before treatment 7.03 1.310 20.970,  
P < 0.0001 After treatment 2.8 0.91 
The average of pain score before treatment and after treatment were 7.03 and 2.8 
respectively. 
Pain in the Neck „t‟ value df Sig.(2 tailed) 
Pain before 
treatment-after 
treatment 
20.970 39 P < 0.0001 
Mean ±Standard deviation of  score for pain Before and after treatment 
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Pain in neck -BT 7.03 ± 1.310 t = 20.970,  
 p < 0.0001 
 highly significant 
Pain in neck -AT 2.8 ± 0.91 
There is statistically highly significant difference between the pain score before 
and after treatment (p<0.0001). 
SECONDARY OUTCOME: 
EFFECT OF TRIAL DRUGS IN REDUCING RESTRICTION OF 
MOVEMENTS IN CEGANAVATHAM: 
Before treatment: 38 patients had restriction of movements. 
After treatment: 71.05% among 38 had reduction in restriction of movements. 
EFFECT OF VARMAM TREATMENT WITH TRIAL DRUGS IN 
CEGANAVATHAM: 
Before treatment:  
       Among 10 patients included in the trial, all the 10 has reported with pain in 
nape, radiating pain in upper limbs, radiating pain in shoulders and 7 reported 
numbness, 2 with giddiness. 
After treatment:      
          100% patients among 10 had reduction in neck pain, 100% among 10 had 
reduction in radiating pain in upper limbs, 90% among 10 had reduction in radiating 
pain in shoulders, 100% among 7 had reduction in numbness, 100% among 2 had 
reduction in giddiness. 
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RESULT: 
RESULT 
PATIENTS 
NO PERCENTAGE 
Good 24 60 
Moderate 7 17.5 
Mild 9 22.5 
Nil 0 0 
Total 40 100 
 
Inference:   
 Good result was seen in 60 % of treated patients 
Moderate Enhancement was seen in 17.5% of treated patients. 
Mild Enhancement was seen in 22.5% of treated patients. 
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OUT-PATIENTS’ PROGRESS CHART 
Sl.no OP.no 
Neck pain Pain in ULs 
BT AT BT AT 
1 C 19750 4 1 3 1 
2 C 79908 8 4 7 3 
3 C 79512 8 2 8 2 
4 C 76422 5 3 5 2 
5 C 66120 6 2 6 1 
6 AG 4328 6 2 6 1 
7 A 3509 6 4 6 4 
8 C 77525 6 2 6 2 
9 C 47245 7 3 7 2 
10 C 85082 6 3 5 3 
11 AR 6360 6 3 5 3 
12 C 84197 5 2 5 1 
13 C 71571 6 2 7 1 
14 C 85995 7 2 7 1 
15 C 76372 7 2 7 3 
16 C 88856 8 3 8 4 
17 B 88348 7 2 7 3 
18 B 52576 8 2 8 3 
19 C 84710 8 3 8 2 
20 C 23917 6 3 6 4 
NOTE: BT-Before Treatment; AT-After Treatment ; ULs-Upper limbs 
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IN-PATIENTS’ PROGRESS CHART 
Sl.no IP. no 
Neck pain Pain in ULs 
BT AT BT AT 
1 IP 3930 5 3 5 2 
2 IP 3941 6 3 6 2 
3 IP 4894 8 3 8 3 
4 IP 4947 6 2 6 2 
5 IP 4000 7 3 7 4 
6 IP 4007 7 4 7 4 
7 IP 4993 5 3 5 4 
8 IP 5011 7 4 6 4 
9 IP 5025 9 5 8 4 
10 IP 5048 8 3 6 3 
11 IP 5063 8 4 7 3 
12 IP 5072 8 4 6 3 
13 IP 4133 9 3 8 3 
14 IP 5078 7 2 7 2 
15 IP 4137 9 3 9 2 
16 IP 4139 9 4 8 5 
17 IP 5090 8 2 7 3 
18 IP 5104 8 2 7 3 
19 IP 4176 8 5 8 5 
20 IP 5139 9 3 9 2 
 
NOTE: BT-Before Treatment ; AT-After Treatment ; ULs-Upper limbs 
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Progress in patients treated with Varmam in addition to Trial drugs 
Sl.no IP .no 
Neck pain Pain in ULs 
BT AT BT AT 
1 IP 3930 5 3 5 2 
2 IP 4894 8 3 8 3 
3 IP 4947 6 2 6 2 
4 IP 4000 7 3 7 4 
5 IP 4007 7 4 7 4 
6 IP 5048 8 3 6 3 
7 IP 5072 8 4 6 3 
8 IP 4133 9 3 8 3 
9 IP 5078 7 2 7 2 
10 IP 4137 9 3 9 2 
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OUT-PATIENTS’ BL00D INVESTIGATION CHART 
 
Sl.no op .no 
Hb 
gm/dl 
T.WBC  
Cells/Cu.mm 
T.RBC 
million 
Cells/cu.m
m ESR(1/2 hr) ESR(1hr) 
BLOOD 
SUGAR(F) 
mg%  
BLOOD 
SUGAR(PP) 
mg%  
BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1 C 19750 14.7 16 9100 9800 5 5 2 2 16 4 95 101 125 111 
2 C 79908 16.6 16.8 11800 9800 5.2 5.3 2 2 4 4 83 92 118 101 
3 C 79512 17.3 16.8 6500 6700 5.6 5.3 2 2 4 4 104 92 143 105 
4 C 76422 11.1 11.9 5600 6400 4 4.4 8 2 22 4 97 107 101 121 
5 C 66120 15.8 16.3 5200 5700 5.6 5.7 2 2 4 4 92 104 106 130 
6 AG 4328 12.6 13.5 8300 7700 4.1 4.4 2 4 4 4 81 91 137 104 
7 A 3509 14.5 15.4 7000 5400 4.5 4.7 2 2 4 4 79 98 117 109 
8 C 77525 15.5 15.3 6500 7300 5.2 5.2 2 2 4 4 96 80 117 103 
9 C 47245 12.3 12.2 7300 7600 4 4 4 6 8 14 96 98 104 113 
10 C 85082 13.2 13.2 7800 7000 4.6 4.5 22 6 46 16 84 100 106 122 
11 AR 6360 14.9 14.5 9400 8600 5.3 5.2 2 4 4 16 84 93 116 106 
12 C 84197 12.8 13.1 5800 7400 4.5 4.6 2 6 4 14 83 92 88   
13 C 71571 16.3 17.1 7800 8500 5.1 5.4 2 42 8 90 84 77 128 98 
14 C 85995 14.6 15 7300 7000 5 5.2 2 2 6 4 110 84 124 115 
15 C 76372 13.5 12.2 7900 8400 4.4 4.6 22 2 44 6 94 94 111 107 
16 C 88856 13.7 13.7 10300 9000 4.6 `4.6 2 4 4 18 99 99 112 110 
17 B 88348 12.6 10.5 10900 9600 4.6 4.3 16 6 34 22 75 100 96 147 
18 B 52576 12.4 12.3 8700 6600   4.2 4 8 8 22 104 94 115 102 
19 C 84710 9.2 8.4 8300 10000 4.1 4.1 4 4 8 12 102 114 119 127 
20 C 23917 13.5 11.9 8200 9300 4.5 4.4 12 14 22 30 101 99 111 111 
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OUT-PATIENTS’ BL00D INVESTIGATION CHART 
 
Sl.no op .no 
Urea 
gm/dl 
Creatinine 
mg/dl 
SGOT                  
IU 
SGPT                  
IU 
Alk.Phos 
mg/dl 
Calcium 
mg/dl 
Phosphorus 
mg/dl 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1 C 19750 14 16 0.4 0.5 20 20 22 16 227 169 10.3 11.6 2.7 3 
2 C 79908 28 14 0.8 0.4 24 12 25 14 204 130 9.7 11.1 3 3.2 
3 C 79512 16 16 0.5 0.5 18 14 20 16 127 159 11.7 10.4 3.5 3.1 
4 C 76422 16 17 0.5 0.5 20 15 21 17 163 150 10.3 10 2.8 3 
5 C 66120 16 19 0.5 0.5 17 35 20 48 179 220 10 10.6 3.2 3 
6 AG 4328 17 16 0.6 0.5 18 16 20 20 190 194  10.1 10.2 3.1  3 
7 A 3509 30 20 1 0.8 22 26 24 30 166 143 10.6 10.4 3.1 3.2 
8 C 77525 15 14 0.5 0.4 38 26 72 28 180 172 10.9  10.2 3.2  3.1 
9 C 47245 16 35 0.7 0.9 10 11 11 13 140 166 10.1 10 3.2 3 
10 C 85082 16 16 0.7 0.5 28 15 25 16 263 171 10.1 10 3.6 2.9 
11 AR 6360 17 17 0.5 0.6 18 15 19 18 199 177 9.8 10.5 3.1 2.8 
12 C 84197 16 17 0.7 0.5 23 18 24 20 166 180 10.4 10.9 3.2 3 
13 C 71571 17 15 0.5 0.4 27 14 28 16 176 135 9.9 10 3.1 2.9 
14 C 85995 22 26 0.6 0.7 33 19 38 21 195 160 10.3 10.5 3.4 3.1 
15 C 76372 19 14 0.6 0.4 14 11 15 13 196 173 10.2 10.4 3 2.9 
16 C 88856 19 18 0.5 0.6 22 16 23 17 165 174 11.4 10.9 3.9 3.2 
17 B 88348 19 16 0.5 0.6 16 18 20 20 247 182 11.7 10.7 3.2 3.2 
18 B 52576 15 14 0.4 0.4 18 13 19 14 166 187 10.8 10.8 3.1 2.8 
19 C 84710 17 14 0.5 0.5 20 16 21 18 152 186 10 10.4 2.9 3 
20 C 23917 17 16 0.6 0.5 14 15 15 17 145 189 10.1 9.4 3.1 3 
 
NOTE :  ASO titer , CRP and RA factor were negative in all trial patients before and 
after treatment. 
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OUT-PATIENTS’ URINE INVESTIGATION CHART 
 
Sl.n
o op .no 
Albumin Sugar 
Deposits Deposits 
PUS CELLS EPI CELLS 
BT AT BT AT BT AT BT AT 
1 C 19750 NIL NIL NIL NIL 2 TO 3 1 TO 2 2 TO 3 1 TO 2 
2 C 79908 NIL NIL NIL NIL 1 TO 2 2 TO 4 1 TO 2 1 TO 2 
3 C 79512 NIL NIL NIL NIL 1 TO 2 2 TO 4 1 TO 2  2 TO 4 
4 C 76422 NIL NIL NIL NIL 2 TO 3 1 TO 2 2 TO 3 1 TO 2 
5 C 66120 NIL NIL NIL NIL 2 TO 3 2 TO 4 2 TO 3 2 TO 4 
6 AG 4328 NIL NIL NIL NIL 1 TO 2 3 TO 4 1 TO 2 3 TO 4 
7 A 3509 NIL NIL NIL NIL 2 TO 3 2 TO 4 2 TO 3 2 TO 4 
8 C 77525 NIL NIL NIL NIL 2 TO 3 2 TO 3 2 TO 3 2 TO 3 
9 C 47245 NIL NIL NIL NIL 8 TO 10 1 TO 2 4 TO 8 2 TO 4 
10 C 85082 NIL NIL NIL NIL 2 TO 4 1 TO 2 2 TO 4 2 TO 4 
11 AR 6360 NIL NIL NIL NIL 1 TO 2 2 TO 3 1 TO 2 1 TO 2 
12 C 84197 NIL NIL NIL NIL 2 TO 4 4 TO 5 3 TO 6 4 TO 5 
13 C 71571 NIL NIL NIL NIL 2 TO 4 `PLENTY 2 TO 4 10 TO 12 
14 C 85995 NIL NIL NIL NIL 2 TO 4 2 TO 4 2 TO 4 1 TO 2 
15 C 76372 NIL NIL NIL NIL 2 TO 3 2 TO 4 2 TO 3 2 TO 4 
16 C 88856 NIL NIL NIL NIL 1 TO 2 3 TO 4 1 TO 2 3 TO 4 
17 B 88348 NIL NIL NIL NIL 1 TO 2 8 TO 10 1 TO 2 PLENTY 
18 B 52576 NIL NIL NIL NIL 2 TO 4  2 TO 4 2 TO 4 1 TO 2 
19 C 84710 NIL NIL NIL NIL 1 TO 2 8 TO 10 1 TO 2 PLENTY 
20 C 23917 NIL NIL NIL NIL 1 TO 2 4 TO 8 1 TO 2 4 TO 8 
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IN-PATIENTS’   BL00D   INVESTIGATION   CHART 
 
Sl.no IP .no 
Hb 
gm/dl 
T.WBC  
Cells/Cu.mm 
T.RBC 
million 
Cells/cu.mm ESR(1/2 hr) ESR(1hr) 
BLOOD 
SUGAR(F) 
mg%  
BLOOD 
SUGAR(PP) 
mg%  
BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1 IP 3930 12.8 14.3 6,400 7500 4.4 4.8 2 16 6 42 99 85 120 131 
2 IP 3941 11.3 11.2 8,100 6600 4.2 4.1 2 6 22 18 80 86 100 105 
3 IP 4894 14.8 14.9 6,000 6200 5 5 2 2 4 4 97 70 101 88 
4 IP 4947 15.6 12.3 8,200 7100 5.1 5 6 4 12 8 94 106 105 140 
5 IP 4000 13 13.3 6,900 6500 4.5 4.4 10 2 24 4 97 85 132 104 
6 IP 4007 10.6 10 9,300 7700 4.1 3.7 4 6 10 18 92 86 106 97 
7 IP 4993 9.1 9.2 6,800 6600 4.9 4.9 14 2 28 18 95 89 107 106 
8 IP 5011 11.5 11.1 7,200 5200 3.8 3.6 2 4 8 14 103 75 136 85 
9 IP 5025 17 15.5 8,600 8900 5.3 5.5 2 2 4 4 106 85 117 114 
10 IP 5048 15.4 12.9 7,600 6400 5.1 5.1 2 2 6 4 102 101 120 121 
11 IP 5063 15.6 15.5 6,800 6900 5.4 5.3 4 4 10 10 108 106 146 138 
12 IP 5072 14.8 13.4 5100 6400 5.1 5.3 2 2 4 4 86 97 104 120 
13 IP 4133 12.9 11.5 5900 6200 4.3 4.4 10 6 28 12 75 92 98 108 
14 IP 5078 15 12.3 5200 5000 4.9 4.7 2 2 4 4 101 94 127 102 
15 IP 4137 10.9 8.6 8400 8200 4.6 4.5 2 2 4 4 115 102 128 106 
16 IP 4139 14.5 12.8 6300 7900 4.7 4.7 4 2 8 6 92 79 107 118 
17 IP 5090 15.4 13.5 7900 7900 5.1 5.1 2 4 6 10 104 113 125 175 
18 IP 5104 15.1 13 10600 7500 4.9 5 6 2 20 6 91 97 104 117 
19 IP 4176 12.4 12.4 7400 7300 4.1 4.2 24 13 60 42 100 99 119 115 
20 IP 5139 15.8 12 6400 6800 4.9 4.3 2 2 8 6 109 107 138 125 
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IN-PATIENTS’   BL00D   INVESTIGATION   CHART 
 
 
 
NOTE :  ASO titre, CRP and RA factor were negative in all trial subjects before and 
after treatment. 
Sl.no IP .no 
Urea 
gm/dl 
Creatinine 
mg/dl 
SGOT                  
IU 
SGPT                  
IU 
Alk.Phos 
mg/dl 
Calcium 
mg/dl 
Phosphorus 
mg/dl 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1 IP 3930 21 22 0.6 0.6 22  20 26 23 166 146 11.2 11.2 3.2 3.1 
2 IP 3941 15 15 0.5 0.4 24 13 26 14 182 140 10.6 10.4 3.2 3.1 
3 IP 4894 24 16 0.7 0.5 18 16 20 18 227 172 12.3 10 4 3 
4 IP 4947 20 17 0.7 0.5 19 16 20 18 193 199 10.6 10 3.4 2.8 
5 IP 4000 23 24 0.6 0.6 35 19 30 22 189 166 10 10.9 2.9 3 
6 IP 4007 22 19 0.7 0.5 64 19 58 22 186 189 10 11.2 3.2 3.4 
7 IP 4993 19 18 0.6 0.5 11 21 16 22 199 171 10.3 10 3.6 2.8 
8 IP 5011 30 40 0.8 1 11 15 10 17 146 199 10.6 10.6 3.1 3 
9 IP 5025 30 28 0.8 0.8 26 24 27 25 170 216 11 10 3 2.8 
10 IP 5048 16 14 0.5 0.4 17 38 19 41 162 163 10.6 10.9 3 3.2 
11 IP 5063 20 18 0.6 0.6 20 19 22 21 190 180 10.6 10.6 3 3 
12 IP 5072 21 14 0.6 0.4 12 18 14 21 145 192 10.5 10.9 3.2 3.3 
13 IP 4133 15 15 0.4 0.5 15 18 17 20 150 172 10.6  10.5 3.1  3.1 
14 IP 5078 25 24 0.7 0.7 14 12 15 13 147 145 10 10.1 3.2 2.9 
15 IP 4137 14 14 0.4 0.4 30 12 31 14 159 153 11 10.5 3 3.2 
16 IP 4139 14 15 0.4 0.5 18 13 19 15 160 152 10.5 10 3.5 2.7 
17 IP 5090 15 15 0.4 0.5 18 29 20 31 169 167 11 10.8 3 3.3 
18 IP 5104 21 17 0.6 0.6 22 22 23 25 186 169 11.2 10.5 3.1 3 
19 IP 4176 19 18 0.5 0.5 25 24 26 25 159 155 10.7 10.7 3.6 3.5 
20 IP 5139 14 18 0.4 0.6 20 17 22 19 147 161 9.9 10.5 2.6 3 
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IN-PATIENTS’   URINE   INVESTIGATION   CHART 
 
Sl.no IP .no 
Albumin Sugar 
Deposits Deposits 
PUS CELLS EPI CELLS 
BT AT BT AT BT AT BT AT 
1 IP 3930 NIL NIL NIL NIL 2 TO 3 3 TO 4 1 TO 2 1 TO 2 
2 IP 3941 NIL NIL NIL NIL 2 TO 3 1 TO 2 2 TO 3 2 TO 3 
3 IP 4894 NIL NIL NIL NIL 2 TO 4 1 TO 2 2 TO 4 2 TO 4 
4 IP 4947 NIL NIL NIL NIL 1 TO 2 2 TO 4 1 TO 2 2 TO 4 
5 IP 4000 NIL NIL NIL NIL 1 TO 2 2 TO 4 2 TO 3 2 TO 4 
6 IP 4007 NIL NIL NIL NIL 8 TO 10 2 TO 4 2 TO 3  1 TO 2 
7 IP 4993 NIL NIL NIL NIL 2 TO 4 1 TO 2 2 TO 4 2 TO 4 
8 IP 5011 NIL NIL NIL NIL 2 TO 3 2 TO 3 2 TO 3 1 TO 2 
9 IP 5025 NIL NIL NIL NIL 1 TO 2 1 TO 2 1 TO 2 2 TO 4 
10 IP 5048 NIL NIL NIL NIL 1 TO 2 2 TO 4 1 TO 2 3 TO 6 
11 IP 5063 NIL NIL NIL NIL 2 TO 4 2 TO 3 1 TO 2 1 TO 2 
12 IP 5072 NIL NIL NIL NIL 2 TO 3 2 TO 4 2 TO 3  2 TO 4 
13 IP 4133 NIL NIL NIL NIL 2 TO 4 2 TO 4 2 TO 4 2 TO 4 
14 IP 5078 NIL NIL NIL NIL 1 TO 2 2 TO 4  1 TO 2 2 TO 4 
15 IP 4137 NIL NIL NIL NIL 2 TO 4 2 TO 4 2 TO 4 2 TO 4 
16 IP 4139 NIL NIL NIL NIL 2 TO 4 2 TO 4 2 TO 4 2 TO 4 
17 IP 5090 NIL NIL NIL NIL 2 TO 4 2 TO 4  2 TO 4  2 TO 4 
18 IP 5104 NIL NIL NIL NIL 2 TO 4 2 TO 4 2 TO 4  2 TO 4 
19 IP 4176 NIL NIL NIL NIL 2 TO 4 2 TO 4 3 TO 5 3 TO 4 
20 IP 5139 NIL NIL NIL NIL 1 TO 2 2 TO 3 2 TO 4 2 TO 3 
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DISCUSSION 
Ceganavatham has increased nowadays due to the modern life style 
modifications and occupational reasons in the society. Severity of the disease has 
become a challenge for the practitioners to discover newer therapies. Various treatments 
and medicines have been tried previously for treating this condition. With this due 
respect, the indications of trial drugs mentioned in Siddha sastric texts were chosen for 
the study. 
The internal medicine Maha Analuruva Chooranam was analyzed methodically 
and Biochemical analysis was done. Acute toxicity study was carried out to confirm the 
safety of the drug. Repeated oral toxicity study conducted with this drug in rats did not 
exhibit significant changes in blood counts and in haemoglobin content. The 
biochemical markers of Liver and Kidney function tests did not show evidence of Liver 
and Kidney toxicity. There was no significant change in biochemical parameters like 
blood cholesterol, blood sugar. No significant changes in body weight, food, water 
intake were observed in drug treated animals when compared to controls. 
40 patients were admitted for the trial, out of which, 20 were out-patients and 20 
were in-patients. 10 of the 20 in-patients were given varmam therapy along with the 
internal and external medicines. Progress of the patients was documented and assessed 
regularly. 
 Various criteria like distribution of gender, age, kaalam (seasonal variation) and 
diet were assessed. Clinical manifestations and assessment of the enhancement in the 
prognosis of the disease with trial drugs and with varmam were taken into account for 
evaluating the efficacy of trial drugs.  
The study reveals highest range of occurrence of disease between the age of 41-
50 among study sample. The reason is obviously the degenerative changes in this age 
group. According to Siddha concept, during 40-50 years of age which the principle 
element Prithvi (earth) combines with appu(water) resulting in weakness, general 
debility and degenerative changes. 
Males are affected more than females among the study sample (52.5%). This 
may be due to increased mechanical stress and lack of essential vitamins and minerals. 
95% of subjects among the 40 were non-vegetarians.          
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On considering their role in society, 80% patients of study sample were from 
below middle class group, 17.5% were from middle class group and the remaining 2.5% 
were from above middle class group. 
Among the 40 subjects, home makers were in higher percentage (32.5%),                    
persons in labour job stood next (17.5%), followed by clerks and tailors (10%), operator, 
supervisors and drivers (7.5%), farmer, mechanic and musician (2.5%). Heavy house-
hold works act as an aggravating factor in home makers. Occupation with postures 
involving prolonged neck flexion is a causative factor in case of labourers, clerical 
persons, supervisors and tailors. Excessive strain to the vertebral column due to 
prolonged travel for long distances is a causative factor of this condition in drivers. 
Lifting heavy weights causes much strain to cervical spine in heavy weight lifting 
mechanics and farmers. Adapting a particular posture for long time aggravates the 
causative factor in musicians.  
Highest occurrence (72.5%) was reported in Mudhuvenil kaalam and 27.5% was 
reported during Kaar kaalam. According to Siddha literature, the Vatha kuttram attains 
thannilai valarchi (mild derangement) during mudhuvenil kaalam and vetrunilai valarchi 
(much derangement) during Kaar kaalam. Vatham elevates in the body between the 
months of aadi to iyppasi ie from the midst of muthuvenil kaalam.  
Viyaanan and Samaanan vayus were affected in all the 40 subjects and Abaana 
vayu was affected in 7 patients. In Pitham, Saathaka pitham was affected in 40 patients, 
Ranjagam in 3 patients and Analakam in 1 patients. In Kabam, Santhigam was affected 
in all the 40 patients and this  may be the reason for the joint involvement. Naadi nadai 
(Pulse reading) was examined in all the patients. 40% patients had pithavatha nadi, 
17.5% patients had vathapitha nadi, 15% patients had kabapitha nadi, 22.5% subjects 
had kabavatha nadi and 5% patients had pithakaba nadi. 
Malam was affected (constipation) in 6 patients. Kai was affected in all the 40 
subjects (100%). 
Among 40 subjects of the trial 100% subjects reported with pain in nape, 70% 
with radiating pain in upper limbs, 95% reported radiating pain in shoulders, 62.5% 
reported numbness in upper limbs, 27.5% with giddiness, 2.5% with burning sensation 
in upper limbs , 95% reported restriction of movements, 7.5% with swelling. 
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Laboratory investigation of blood and urine were done for all 40 subjects prior to 
and after the trial. There were no significant changes in the parameters. Pre-treatment 
and post-treatment results of Liver function tests and renal function tests were normal. 
The radiographic studies of the subjects showed narrowed joint space and 
presence of osteophytes. The trial drug showed reduction in clinical signs and symptoms 
rather than any changes in radiographic studies. 
The treatment was focused to stabilize the affected kuttram and to get relieved 
from symptoms. Before treatment the patients were advised to take Agasthiyar 
Kuzhambu-200 mgs with palm jaggery early morning for purgation followed by rest on 
that day. The next day onwards treatment with the trial drugs “Maha Analuruva 
Chooranam” (Internal medicine) and “Pungan ennai” (External medicine) was started.10 
among 20 in-patients were given varmam therapy regularly. During treatment, the 
subjects were advised to follow pathiyam (diet restrictions), to avoid lifting heavy 
weights and to avoid adopting certain postures involving prolonged neck flexion. 
After treatment, 100% patients were relieved from pain in nape, 89.29% from 
radiating pain in right  upper limb, 95.65% from radiating pain in left upper limb 
84.21% from radiating pain in shoulders, 80% from numbness in upper limbs, 72.73% 
from giddiness, 100% from burning sensation in upper limbs, 71.05% from restriction 
of movements, 66.67% from swelling. 
Primary outcome: 
Effect of trial drugs in reducing pain in Ceganavatham was statistically highly 
significant. 
100% patients among 40 had reduction in neck pain, 89.29% among 28 had 
reduction in radiating pain in right upper limb, 95.65% among 23 had reduction in 
radiating pain in left upper limb and 84.21% among 38 had reduction in radiating pain 
in shoulders post-treatment. 
Secondary outcome: 
Effect of trial drugs in reducing restriction of movements in Ceganavatham was 
good. 
71.05% among 38 had reduction in restriction of movements after treatment. 
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Effect of Varmam with Trial drugs in Ceganavatham: 
100% patients among 10 had reduction in neck pain, 100% among 10 had 
reduction in radiating pain in upper limbs, 90% among 10 had reduction in radiating 
pain in shoulders, 100% among 7 had reduction in numbness, 100% among 2 had 
reduction in giddiness post-treatment . 
Varmam therapy produced immediate relief from pain for about three to five 
hours in the patients. Numbness was reduced considerably for all the 7 patients with 
numbness, restriction of movement reduced in 8 out of 9 patients. Overall improvement 
was good. 
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SUMMARY 
      The study was started after analyzing the internal medicine methodically. 
Biochemical analysis was done. Acute toxicity study was carried out to confirm the 
safety of the drug. 
40 patients were admitted for trial among whom 20 were out-patients and 20 
were in-patients. 10 of the in-patients were given Varmam therapy in addition to internal 
and external medicines. Clinical manifestations, assessment of the improvement in the 
patients treated with trial drugs and with Varmam in addition were taken into account 
for evaluating the efficacy of trial drugs and the effect of Varmam. Progress of the 
patients was regularly documented. 
            Based on regular observation for 48 days, the outcome was assessed. Effect of 
trial drugs in reducing pain in Ceganavatham was statistically highly significant. Effect 
of trial drugs in reducing restriction of movements in Ceganavatham was good. Effect of 
Varmam with trial drugs in Ceganavatham was good. 
           Enhancement in Patient Symptoms was Good in 24 Patients, Moderate in 7 
patients and Mild in 9 patients. 
            Varmam therapy produced moderate relief from pain, numbness and restriction 
of movements. Patients treated with trial drugs and Varmam showed Good enhancement 
when compared to those who were treated only with trial drugs. Duration of relief from 
pain and numbness was about 3-5 hours in these subjects immediately after 
manipulating Varmam. 
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CONCLUSION 
Siddha literature is cherished with plenty of formulations for various disease 
conditions. This study was done with the sastric medicines “Maha Analuruva 
Chooranam” (Internal medicine) and “Pungan Ennai” (External medicine). These are 
indicated for vatha diseases in Siddha texts. 
Among study sample, 60% had Good Improvement, 17.5% had moderate 
improvement and 22.5% had mild improvement. The results of the study reveal the fact 
that these medicines are efficacious in reducing pain, numbness and restriction of 
movements in Ceganavatham. 
            Varmam therapy along with trial drugs was effective as the overall improvement 
was good and to certain extent earlier in the subjects who were given Varmam therapy. 
Many of these subjects had reduction or relief from pain, numbness for about three to 
five hours after manipulating Varmam points. 
 The acute toxicity study have shown no renal and hepato toxicity. Hence the 
trials drugs are considered as very safe. 
            Thus it is concluded that “Maha Analuruva Chooranam” (Internal medicine) and 
“Pungan Ennai” (External medicine) are effective in reducing pain, numbness, swelling 
and restriction of movements in Ceganavatham. Varmam therapy along with trial drugs 
was effective in giving quick and immediate relief from symptoms. 
 However further work with large number of patients should be carried out 
towards finding the ideal response. 
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NATIONAL INSTITUTE OF SIDDHA 
ACUTE TOXICITY STUDY OF MAHA ANALURUVA CHOORANAM 
[WHO Guidelines, 1993] 
Principle: 
   Acute toxicity was carried out in Swiss albino mice with a single exposure of 10 
times of the recommended therapeutic dose of test compound the study duration will be 
14 days. 
Animal species  : Swiss albino mice 
Age / Weight / Size  :  6 weeks.  Mice-20-25 gms. 
Gender   :   Both male and female 
Number of Animals   : Mice: 10 
Acclimatization Period : 7 Days 
Clinical dose   : 3.0 gms\day 
S.No Group No of mice 
1 Vehicle control (saline) 10  (5 male, 5 female) 
 
2 
Toxic dose 
10 X therapeutic dose 
(0.054gms) 
10  (5 male, 5 female) 
Test Animals  
      Test animals were obtained from the animal laboratory of the King institute, 
Chennai and stocked at National institute of siddha, Chennai. All the animals were kept 
under standard environmental condition (27+ or – 2 degree c).The animals had free 
access to water and standard pellet diet (Sai Durga foods pvt.ltd, Bangalore).The 
principles of laboratory animal care were followed and the  Institutional ethical 
committee approved the use of animals and the study design. (1248/ac/09/CPCSEA/4-
24/ 2011) 
Route of administration: 
Oral route was selected, because it is the normal route of clinical administration. 
Test substance and vehicle 
       Maha Analuruva Chooranam is Brown in colour.  The test substance is insoluble 
in water, in order to obtain and ensure the uniformity in drug distribution the drug is 
dissolved by aqueous Tween 80 solution (10%).  
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Administration of doses 
           Maha Analuruva Chooranam was suspended in aqueous Tween 80 solution 
(10%), with uniform mixing and it was administered to the groups in a single oral dose. 
The control groups received equal volume of the vehicle. The animals were weighed 
before giving the drug. The dose level was calculated according to body weight and 
surface area. Since the clinical dose was 3.0gms\day it was converted to animal dose 
(0.054gms) and then administered. The principle of laboratory animal care was 
followed. 
Observations 
 Observations were made and recorded systematically and continuously observed 
as per the guideline after substance administration. The animals were monitored for 
behavioural parameters like 
1. Awareness 
- Alertness 
- Visual placing 
- Stereotype 
- Passivity 
2. Mood 
-  Grooming 
-  Restlessness 
-  Irritability 
-  Fearfulness 
3. Motor activity 
- Spontaneous activity 
- Reactivity 
- Touch response 
- Pain response.  
Animals were observed for body weight and mortality for 14 days. If animals 
died during the period of study, the animals were sacrificed.  At the end of the 14
th
 day 
all animals were sacrificed and necropsy was done. 
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Body Weight 
  Individual weight of animals was determined before the test substance 
was administered and daily for 14 days. Weight changes were calculated and recorded. 
At the end of the test, surving animals were weighed and sacrificed. 
Results:   
Maha Analuruva Chooranam at the dose 0.054gms/animal did not exhibit any 
mortality in mice. 
 No behavior changes were noted for the first 4 hours and for the next 24 hours 
and throughout the study period of 14 days. No weight reduction was noted before and 
after the acute study duration. Reflexes were found to be normal before and after the 
study. All other observations were found to be normal before and after the study. In 
Necropsy, the organs of the animal such as, Liver, Heart, Lungs, Pancreas, Spleen, 
Stomach, Intestine, Kidney, Urinary bladder, Uterus all appeared normal. 
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BIO - CHEMICAL ANALYSIS OF  MAHA  ANALURUVA  CHOORANAM 
ANALYSED AT NATIONAL INSTITUTE OF SIDDHA 
S.No EXPERIMENT OBSERVATION INFERENCE 
1.  Physical Appearance of sample Brown in colour  
2. Solubility: 
a. A little (500mg) of the sample is shaken 
well with distilled water. 
b. A little (500mg) of the sample is shaken 
well with con. HCl/ Con. H2So4 
 
Sparingly soluble 
 
 
Presence of 
Silicate 
3. Action of Heat: 
   A small amount (500mg) of the sample is 
taken in a dry test tube and heated gently at 
first and then strong. 
 
White fumes   
evolved 
 
Presence of 
Carbonate 
 
4. Flame Test: 
  A small amount (500mg) of the sample is 
made into a paste with con. HCl in a watch 
glass and introduced into non-luminous part 
of the Bunsen flame. 
 No Bluish green 
flame appeared. 
Absence of Copper 
5. Ash Test:s A filter paper is soaked into a 
mixture of sample and dil. cobalt nitrate 
solution and introduced into the Bunsen 
flame and ignited 
 No Yellow 
coloured flame 
Absence  of 
sodium 
 
Preparation of Extract:  5gm of Maha Analuruva Chooranam is weighed accurately 
and placed in a 250ml clean beaker and added with 50ml of distilled water. Then it is 
boiled well for about 10 minutes. Then it is cooled and filtered in a 100ml volumetric 
flask and made up to 100ml with distilled water. 
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S.No EXPERIMENT OBSERVATION INFERENCE 
 I. Test For Acid Radicals   
1.  Test For Sulphate: 
a.2ml of the above prepared extract is taken in 
a test tube to this added 2ml of 4% dil. 
ammonium oxalate solution 
No Cloudy 
appearance 
present 
Absence  
of  Sulphate 
2. Test For Chloride: 
2ml of the above prepared extracts is added 
with 2ml of dil-HCl is added until the 
effervescence ceases off. 
No cloudy 
appearance 
present 
Absence 
of Chloride 
3. Test For Phosphate: 
2ml of the extract is treated with 2ml of 
dil.ammonium molybdate solution and 2ml of 
con.HNo3 
No cloudy yellow 
appearance 
present 
Absence 
of Phosphate 
4.  Test For Carbonate: 
2ml of the extract is treated with 2ml dil. 
magnesium sulphate solution 
No Cloudy 
appearance 
present 
Absence 
of Carbonate 
C Test For Nitrate: 
1gm of the substance is heated with copper 
turning and concentrated H2So4 and viewed 
the test tube vertically down. 
No Brown gas  
evolved 
Absence  
of Nitrate 
6. Test For Sulphide: 
1gm of the substance is treated with 2ml of 
con. HCL 
No Rotten Egg 
Smelling gas 
evolved 
Absence 
of Sulphide 
7. Test For Fluoride & Oxalate: 
2ml of extract is added with 2ml of dil. Acetic 
acid and 2ml dil.calcium chloride solution and 
heated. 
No Cloudy         
appearance 
Absence  
of fluoride and 
oxalate 
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8. 
Test For Nitrite: 
3drops of the extract is placed on a filter paper, 
on that-2 drops of dil.acetic acid and 2 drops 
of dil. Benzidine solution is placed. 
No Characteristic 
changes 
Absence  
of Nitrite 
9. Test For Borate: 
  2 Pinches (50mg) of the substance is made 
into paste by using dil.sulphuric acid and 
alcohol (95%) and introduced into the blue 
flame. 
Bluish green 
colour flame did 
not appear. 
   Absence  
of borate 
II. Test For Basic Radicals 
1. Test For Lead: 
2ml of the extract is added with 2ml of 
dil.potassium iodine solution. 
No Yellow 
Precipitate is 
obtained. 
Absence of 
Lead 
2. Test For Copper: 
a. One pinch(50mg) of substance is made into 
paste with con. HClin a watch glass and 
introduced into the non-luminuous part of the 
flame. 
 
No Blue colour 
flame 
No Blue colour 
precipitate 
formed. 
  Absence  
of copper 
3. Test For Aluminium: 
To the 2ml of extract dil.sodium hydroxide is 
added in 5 drops to excess. 
No characteristic 
changes 
  Absence 
of aluminium 
4. Test For Iron: 
a.To the 2ml of extract add 2ml of 
dil.ammonium solution 
b.To the 2ml of extract 2ml  thiocyanate 
solution and 2ml  of con HNo3 is added 
 
Red colour 
appeared 
 
Presence of Iron 
5. Test For Zinc:  
To 2ml of the extract dil.sodium hydroxide 
solution is added in 5 drops to excess and 
dil.ammonium chloride is added.  
 
White precipitate 
is   not formed 
  Absence  
of Zinc 
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6. Test For Calcium:  
2ml of the extract is added with 2ml of 4% 
dil.ammonium oxalate solution  
No Cloudy 
appearance and 
white precipitate  
was obtained. 
   Absence  
of calcium 
7. Test For Magnesium:  
To 2ml of extract dil.sodium hydroxide 
solution is added in drops to excess. 
White precipitate 
was  obtained 
   Presence  
of Magnesium 
8. Test For Ammonium: 
  To 2ml of extract 1 ml of Nessler's reagent 
and excess of dil.sodium hydroxide solution 
are added. 
  No Brown 
colour appeared 
     Absence  
 of ammonium 
9. Test For Potassium:  
   A pinch (25mg) of substance is treated of 
with 2ml of dil.sodium nitrite solution and 
then treated with 2ml of dil.cobalt nitrate in 
30% dil.glacial acetic acid. 
 
No Yellowish 
precipitate was 
obtained. 
 
   Absence  
of Potassium 
10. Test For Sodium: 
    2 pinches (50mg) of the substance is made 
into paste by using HCl and introduced into 
the blue flame of Bunsen burner. 
  
Yellow coloured 
flame appeared 
   
 Presence   
of Sodium 
11. Test For Mercury:  
   2ml of the extract is treated with 2ml of 
dil.sodium hydroxide solution.  
No yellow 
precipitate was 
obtained. 
  Absence of 
Mercury 
12. Test For Arsenic:  
   2ml of the extract is treated with 2ml of 
dil.sodium hydroxide solution. 
 
No brownish red 
precipitate was 
obtained. 
 
Absence  
of Arsenic 
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III. Miscellaneous 
1.
  
Test For Starch:  
2ml of extract is treated with weak dil.Iodine 
solution  
 
No Blue colour 
developed 
Absence  
of starch 
2.
  
Test For Reducing Sugar:  
    5ml of Benedict's qualitative solution is 
taken in a test tube and allowed to boil for 2 
minutes and added 8 to 10 drops of the extract 
and again boil it for 2 minutes. The colour 
changes are noted. 
 
 
Brick red colour  
is developed 
Presence of  
reducing sugar 
3.
  
Test For The Alkaloids: 
a) 2ml of the extract is treated with 2ml of 
dil.potassium lodide solution. 
b)  2ml of the extract is treated with 2ml of 
dil.picric acid. 
c)  2ml of the extract is treated with 2ml of 
dil.phosphotungstic acid. 
 
Red colour 
developed 
 Yellow colour 
developed 
White precipitate 
developed 
 
- 
 
  Presence  
of Alkaloid 
4.
  
Test For Tannic Acid:  
  2ml of extract is treated with 2ml of dil.ferric 
chloride solution  
No black 
precipitate was 
obtained 
Absence of 
Tannic acid 
5.
  
Test For Unsaturated Compound: 
  To the 2ml of extract 2ml of dil.Potassium 
permanganate solution is added.  
Potassium 
permanganate is 
not decolourised 
Absence of 
unsaturated 
compound 
6.
  
Test For Amino Acid: 
    2 drops of the extract is placed on a filter 
paper and dried well. 20ml of Biurette reagent 
is added. 
 
No Violet colour 
developed 
 
   Absence   
of amino acids 
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7. Test For Type Of Compound: 
    2ml of the extract is treated with 2 ml of 
dil.ferric chloride solution.  
No green colour 
developed 
No red colour 
developed 
 
 
No violet colour 
developed 
No blue colour 
developed 
Absence of oxy 
quinole 
pinephrine and 
pyro catechol. 
Anti pyrine, 
Aliphatic amino 
acids and 
meconic acid 
are absent  
Apomorphine 
salicylate and 
Resorcinol are 
absent 
Morphine, 
Phenol cresol 
and 
hydrouinoneare 
absent 
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Preliminary Qualitative Phyto chemical tests procedure and interpretation of 
results 
S.NO CONSITUENTS INFERENCE 
1.  Silicate Present 
2.  Carbonate Present 
3.  Iron Present 
4.  Alkaloids Present 
5.  Reducing sugar Present 
6.  Chloride Absent 
7.  Copper Absent 
8.  Sodium Absent 
9.  Sulphate Absent 
10.  Phospate Absent 
11.  Nitrate Absent 
12.  Oxalate Absent 
13.  Fluoride Absent 
14.  Borate Absent 
15.  Lead Absent 
16.  Aluminium Absent 
17.  Zinc Absent 
18.  Calcium Absent 
19.  Magnesium Absent 
20.  Ammonium Absent 
21.  Potassium Absent 
22.  Mercury Absent 
23.  Arsenic Absent 
24. Starch Absent 
25. Sulphide Absent 
26. Tannic Acid Absent 
27. Unsaturated compound Absent 
28. Amino Acid Absent 
29. Type of compounds Absent 
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     NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
 
PRECLINICAL AND CLINICAL STUDY ON “MAHA ANALURUVA 
CHOORANAM “(INTERNAL) AND “PUNGAN ENNAI” (EXTERNAL) IN THE 
TREATMENT OF “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
FORM l - SCREENING AND SELECTION PROFORMA 
1.OP NO:  ................................................................. 
2. NAME:  ………………………………………….   
3. AGE:      ………       4.GENDER: …………....... 
5. OCCUPATION: ………………………………..      6.INCOME:   ………………… 
7. ADDRESS:    ……………………………………     
…………………………………… 
…………………………………… 
8. CONTACT NO:    ……………………………………              
 INCLUSION CRITERIA: 
 Age : 15-60 Yrs      Yes / No 
 Sex : Both male and female     Yes / No 
 Patients having symptoms of neck pain radiating to shoulders and upper limbs 
with or without numbness, giddiness and neck stiffness Yes / No  
 Patients who are willing to undergo radiological investigation and Laboratory 
investigations.       Yes / No 
 Patients who are willing to sign the informed consent stating that he/she will 
conscientiously  stick to the treatment during 48days but can opt out of the trial 
of his/her own conscious discretion.    Yes / No 
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EXCLUSION CRITERIA: 
 Trauma 
 Congenital anomalies of spine 
 Cervical rib 
 Spina bifida 
 Ankylosing spondylosis 
 Tuberculosis of spine 
 Diabetes mellitus 
 Hypertension 
 Cardiac diseases 
 Pregnancy and lactation 
 Neoplasms 
 Patients with any other serious systemic illness 
ADMITTED TO TRIAL: 
                          YES                        NO                 
 
 
 
      If yes,             OPD                    IPD 
 
 
 
Date:        
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                           Signature of the HOD   
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
 
PRECLINICAL AND CLINICAL STUDY ON “MAHA ANALURUVA 
CHOORANAM “(INTERNAL) AND “PUNGAN ENNAI” (EXTERNAL) IN THE 
TREATMENT OF “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
FORM lI -HISTORY TAKING PROFORMA 
1. SERIAL NO OF THE CASE: …….   2.OP/IP NO: ...................................................  
3. NAME: ……………………………………… 4. AGE: …….. 5. GENDER: …….. 
5. OCCUPATION: ……………………………      6. INCOME:   ………………….. 
7.COMPLAINTS & DURATION:   
 
 
 
 
                                                                                                                                                                              
8. PERSONAL HISTORY: 
PERSONAL HABITS YES NO 
IF YES, SPECIFY 
DURATION/QUANTITY 
Smoking    
Tobacco Chewing    
Alcoholism    
Narcotic drugs    
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9. HISTORY OF PREVIOUS ILLNESS: 
 
 
 
 
10. FAMILY HISTORY: 
 Whether this problem runs in family? 
                                         1. Yes                               2.No         
                                     If yes, mention the relationship of affected person(s) 
                                               1._________________ 
                                               2._________________ 
                                               3._________________ 
11.DIETARY HABIT:     
                                1.Vegetarian              
                                2.Non-vegetarian 
12. MENSTRUAL AND OBSTETRIC HISTORY: 
 
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD 
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 NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
 
PRECLINICAL AND CLINICAL STUDY ON “MAHA ANALURUVA 
CHOORANAM “(INTERNAL) AND “PUNGAN ENNAI” (EXTERNAL) IN THE 
TREATMENT OF “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
FORM III - CLINICAL ASSESSMENT PROFORMA 
 
1. SERIAL NO: …………………   
2.OP / IP NO: ......................................    
3. NAME: ……………………………   4.AGE: ……     5.GENDER: .................            
                
GENERAL EXAMINATION: 
Height (cms)                : ………………………….                   
Weight (kg)    : ………………………….                   
Temperature(°F)     : ………………………….                   
Pulse rate(/min)   : ………………………….                   
Heart rate(/min)   : ………………………….                   
Respiratory rate(/min)  : ………………………….                   
Blood pressure(mm/Hg)       : ………………………….        
 
    
137 
 
     Present           Absent 
Pallor  
Jaundice 
Cyanosis 
Lymphadenopathy  
Pedal edema 
Clubbing 
Jugular vein pulsation 
SYSTEMIC EXAMINATION 
CardioVascular System  : ………………………….                   
Respiratory system   : ………………………….                   
Gastro-intestinal system  : ………………………….                   
CentralNervous System  : ………………………….                   
Urogenital system   : ………………………….                   
Endocrine System   : ………………………….         
EXAMINATION OF LOCOMOTOR SYSTEM 
EXAMINATION OF CERVICAL REGION:   
COMPLAINTS 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 
Pain in neck     
Pain in shoulder     
Nature of pain     
Onset of pain     
Radiating pain in right upper limb     
Radiating pain in left upper limb     
Numbness     
Tenderness     
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Restriction of movements     
Burning sensation     
OTHER SYMPTOMS 
             Giddiness     
             Other joints     
 
COMPLAINTS 29
th
 day 36
th
 day 43
rd
 day 49
th
 day 
Pain in neck     
Pain in shoulder     
Nature of pain     
Onset of pain     
Radiating pain in right 
upper limb 
    
Radiating pain in left upper 
limb 
    
Numbness     
Tenderness     
Restriction of movements     
Burning sensation     
 
OTHER SYMPTOMS 
             Giddiness     
             Other joints     
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CLINICAL EXAMINATION  
 I.INSPECTION:               
 0
th
 day 
8
th
 
day 
15
th
 
day 
22
nd
 
day 
29
th
 
day 
36
th
 
day 
43
rd
 
day 
49
th
 
day 
Attitude:         
Muscle 
wasting 
        
Swelling         
 
II PALPATION:   
 0
th
 day 8
th
 day 
15
th
 
day 
22
nd
 
day 
29
th
 day 
36
th
 
day 
43
rd
 
day 
49
th
 day 
Tenderness         
Local heat         
Joint 
stiffness 
        
 
III. RESTRICTION OF MOVEMENTS: 
 
0
th
 day 
8
th
 
day 
15
th
 
day 
22
nd
 
day 
29
th
 day 
36
th
 
day 
43
rd
 
day 
49
th
 
day 
Rotation         
Flexion         
Extension         
Lateral 
bending 
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SIDDHA SYSTEM OF EXAMINATIONS:  
1. THEGI:  [BODY CONSTITUTION]  
1. Vatha udal 
2. Pitha udal 
3. Kaba udal 
4. Thontha udal             ………………………………… 
2. NILAM:  [LAND WHERE PATIENT LIVED MOST] 
   1. Kurinji    (Hilly terrain)                                   
   2. Mullai    (Forest range)                       
    3. Marutham    (Plains)                            
4. Neithal     (Coastal belt)                    
     5. Paalai  (Arid regions)  
3. KAALAM: 
1. Kaar kaalam                               4.Pinpani kaalam      
2. Koothir kaalam                           5. Ilavenil kaalam 
3. Munpani kaalam                           6.Muthuvenil kaalam 
4. GUNAM: 
           1.Sathuvam                2.Raasatham             3.Thaamatham 
 
5. IMPORIGAL (SENSORY ORGANS): 
 Before treatment After treatment 
Mei   
Vaai   
Kann   
Mooku   
Sevi   
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6. KANMENDHIRIYAM (MOTOR ORGANS): 
 0
th 
day 8
th 
day 15
th 
day 22
nd 
day 29
th 
day 36
th 
day 43
rd 
day 49
th 
day 
Kai         
Kaal         
Vaai         
Eruvai         
Karuvai         
 
7. KOSANGAL (SHEATH): 
       Before treatment After treatment 
Annamaya kosam   
Pranamaya kosam   
Manomaya kosam   
Vignanamaya kosam   
Ananthamaya kosam   
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8. UYIR THAATHUKKAL: [THREE HUMORS] (VALI, AZHAL,IYAM) 
A) VALI 
 0
th
 day 
8
th
 
day 
15
th
 
day 
22
nd
 
day 
29
th
 
day 
36
th
 
day 
43
rd
 
day 
49
th
 
day 
Praanan         
Abaanan         
Samaanan         
Udhaanan         
Viyaanan         
Naagan         
Koorman         
Kirukaran         
Devathathan         
Dhananjeyan         
B) AZHAL 
 
0
th
  
day 
8
th
  
day 
15
th
 
day 
22
nd
  
day 
29
th
 
day 
36
th
 
day 
43
rd
 
day 
49
th
 
day 
Analakam         
Ranjakam          
Saathakam          
Prasakam          
Aalosakam         
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C) IYAM 
 0
th
 day 
8
th 
 day 
15
th
 
day 
22
nd
  
day 
29
th
 
day 
36
th
 
day 
43
rd
 
day 
49
th
 
day 
Avalambagam         
Kilethagam         
Pothagam         
Tharpagam         
Santhigam         
 
9. SEVEN UDAL THATHUKKAL: (SEVEN SOMATIC COMPONENTS)  
         Before treatment After treatment 
Saaram   
Senneer   
Oon   
Kozhuppu   
Enbu   
Moolai   
Sukkilam/ Suronitham  
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10. ENVAGAI THERVU:  
I. NAADI: [PULSE PERCEPTION]         
Day Naadi 
0
th
  day  
8
th 
day
 
 
15
th
  day  
22
nd
  day  
29
th
  day  
36
th
  day  
43
rd
  day  
49
th
  day  
 
II. SPARISAM: [PALPATION] 
Day Sparisam 
0
th
  day  
8
th 
day
 
 
15
th
  day  
22
nd
  day  
29
th
  day  
36
th
  day  
43
rd
  day  
49
th
  day  
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III. NAA: [TONGUE] 
Day NAA 
0
th
  day  
8
th 
day
 
 
15
th
  day  
22
nd
  day  
29
th
  day  
36
th
  day  
43
rd
 day  
                             49
th 
day 
 
 IV.NIRAM: [COMPLEXION]   
    1. Vadham         
     2. Pitham 
      3. Kabam  
 V.MOZHI: [VOICE] 
      1. High Pitched 
      2. Low Pitched 
      3. Medium Pitched 
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VI.VIZHI: [EYES] 
Day Vizhi 
0
th
  day  
8
th 
day
 
 
15
th
  day  
22
nd
  day  
29
th
  day  
36
th
  day  
43
rd
 day  
49
th
  day  
VII. MALAM: [BOWEL HABITS / STOOLS] 
     Before treatment After treatment 
Niram   
                          Irugal   
Ilagal   
Others   
 VIII. MOOTHIRAM [URINE EXAMINATION]   
NEERKKURI: 
Neerkkuri Before treatment After treatment 
Niram 
 
  
Manam   
Edai   
Nurai   
Enjal   
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NEIKKURI 
Neikkuri Before treatment After treatment 
Snake like pattern   
Annular/Ringed pattern   
Pearl beaded pattern   
Other patterns   
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PAIN ASSESMENT: 
UNIVERSAL PAIN ASSESMENT SCALE 
 
 Grade   0    :  No Pain 
                Grade 1 -3 :   Mild pain 
                 Grade 4-6 :   Moderate pain 
                         Grade 7-10 :   Severe pain     
                         - Reference: Clinical Manual for Nursing Practise.( National Institute of 
Health Warren Grant Magnuson Clinical Center )  
GRADATION: 
Grade 1- Fit for all activities do their work without support (Normal) 
Grade 2 – Mild Pain and Mild restriction of Movements. 
Grade 3- Moderate Pain with or without radiation to upper limbs and Moderate 
restriction of Movements 
Grade 4-Severe Pain with or without radiation to upper limbs and Severe 
restriction of Movements 
Date:      
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                        Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
 
PRECLINICAL AND CLINICAL STUDY ON “MAHA ANALURUVA 
CHOORANAM “(INTERNAL) AND “PUNGAN ENNAI” (EXTERNAL) IN THE 
TREATMENT OF “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
VARMAM THERAPY – OBSERVATION CHART. 
ASSESSMENT FORM 
SERIAL NO:  
OP/IP NO: 
NAME:        
AGE/ GENDER:                                  
COMPLAINTS AND DURATION: 
VARMAM POINTS (IP PATIENTS):     
          Muduchi Varmam  
Kakkattai Kaalam  
Manibanthaga Varmam 
Kai viral madakku varmam  
Kavuli Kaalam  
Date Pain Tenderness 
Radiating 
pain 
Stiffness Numbness 
Duration 
of relief 
Other 
clinical 
features. 
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OTHER REMARKS: 
 
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
 
PRECLINICAL AND CLINICAL STUDY ON “MAHA ANALURUVA 
CHOORANAM “(INTERNAL) AND “PUNGAN ENNAI” (EXTERNAL) IN THE 
TREATMENT OF “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
FORM IV : LABORATORY INVESTIGATIONS PROFORMA 
1. SERIAL NO OF THE CASE: …………………   
2.OP / IP NO: ......................................    
3. NAME: ……………………………   4.AGE: ……     5.GENDER: .................   
A) BLOOD INVESTIGATIONS:                        
BLOOD INVESTIGATIONS 
NORMAL 
VALUES 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Hb ( gm/dL) 
M: 13-18 
W: 11-16 
  
T.RBC (millions cells / Cu.mm) 
M: 4.5-6.5 
W: 3.5-5.5 
  
ESR (mm) 
½ hr. -   
1 hr. 
M: 0-10 
W: 0-20 
  
T.WBC (Cells / Cu.mm) 4000-11000   
Differential 
Count (%) 
Polymorphs 40-75   
Lymphocytes 20-35   
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Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
 
BLOOD INVESTIGATIONS NORMAL 
VALUES 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Blood 
glucose 
(mg/dl) 
Fasting 70-110   
PP 80-140   
Lipid 
profile 
(mg/dl) 
Serum cholesterol 150-200   
HDL 30-60   
LDL Up to 130   
VLDL 40   
TGL Up to 160   
 
 
RFT 
(mg/dl) 
Blood urea 16-50   
Serum creatinine 0.6-1.2   
Serum Uric acid 
M: 3-9 
W: 2.5-7.5 
  
LFT 
(mg/dl) 
Total bilirubin 0.2-1.2   
Direct bilirubin 0.1-0.2   
Indirect bilirubin 0.2-0.7   
Total protein 6-8   
Serum Albumin 3.5-5.5   
Serum globulin 2-3.5   
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Serum calcium 9-11   
Serum phosphorus 2-5   
SGOT (IU/L) 0-40   
SGPT (IU/L) 0-35   
Alkaline phosphatase 
(IU/L) 
80-290   
 CRP   
 ASO titre   
 RA factor   
B) URINE INVESTIGATIONS: 
URINE 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
Albumin   
Fasting sugar   
PP sugar   
Deposits   
Bile salts   
Bile pigments   
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C) RADIOLOGICAL EXAMINATIONS 
X-Ray cervical spine- AP view, Lateral view 
 BEFORE TMT AFTER TMT 
XRAY 
CHANGES 
  
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD 
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PRECLINICAL AND CLINICAL STUDY ON “MAHA ANALURUVA 
CHOORANAM “(INTERNAL) AND “PUNGAN ENNAI” (EXTERNAL) IN THE 
TREATMENT OF “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
FORM V: INFORMED CONSENT FORM 
“I have read the foregoing information, or it has been read to me. I have had 
the opportunity to ask questions about it and any questions I have asked have been 
answered to my satisfaction.  
            I   consent voluntarily to participate in this study and understand that I have 
the   right to withdraw from the study at any time without in any way it affecting my 
further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date: 
Signature of the participant: 
In case of illiterate participant 
  “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm 
that the individual has given consent freely.”                                                   
 
Date: 
 
 Signature of a witness                                            Left thumb Impression of the 
Participant     
(Selected by the participant bearing no connection with the survey team)       
Date:    
Station:                                                                                  
Signature of participant:                                                 
Signature of the Investigator:      Signature of the Lecturer:                                                          
   
Signature of the HOD 
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                                   §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, ¦ºý¨É 47 
«§Â¡ò¾¢¾¡Š ÀñÊ¾÷ ÁÕòÐÅÁ¨É 
¦ºý¨É 
º¸É Å¡¾õ §¿¡öì¸¡É º¢ò¾ ÁÕóÐ¸Ç¢ý (Á¸¡ «ÉÖÕÅ ÝÃ½õ ÁüÚõ  Òí¸ý 
±ñ¦½ö) ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø  ÀÊÅõ. 
´ôÒ¾ø ÀÊÅõ 
                           
¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀð¼Ð 
    ¿¡ý þó¾ ¬ö¨Å ÌÈ¢ò¾ «¨ÉòÐ Å¢ÀÃí¸¨ÇÔõ §¿¡Â¡Ç¢ìÌ ÒÃ¢Ôõ 
Å¨¸Â¢ø ±ÎòÐ¨Ãò§¾ý ±É ¯Ú¾¢ÂÇ¢ì¸¢§Èý. 
 §¾¾¢ :                                                     ¨¸¦Â¡ôÀõ: 
 þ¼õ:                                                      ¦ÀÂ÷     : 
§¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø 
±ýÉ¢¼õ  þó¾ ÁÕòÐÅ ¬öÅ¢ý ¸¡Ã½ò¨¾Ôõ, ÁÕó¾¢ý ¾ý¨Á ÁüÚõ 
ÁÕòÐÅ ÅÆ¢Ó¨È ÀüÈ¢Ôõ, ¦¾¡¼÷óÐ ±ÉÐ ¯¼ø þÂì¸ò¨¾ ¸ñ¸¡½¢ì¸×õ, 
«¾¨É À¡Ð¸¡ì¸×õ ÀÂýÀÎõ ÁÕòÐÅ ¬ö×ìÜ¼ ÀÃ¢§º¡¾¨É¸û ÀüÈ¢   
¾¢Õô¾¢ «Ç¢ìÌõ Å¨¸Â¢ø ¬ö× ÁÕòÐÅÃ¡ø Å¢Çì¸¢ì ÜÈôÀð¼Ð. 
¿¡ý þó¾ ÁÕòÐÅ ¬öÅ¢ý §À¡Ð, ¸¡Ã½õ ±Ð×õ ÜÈ¡Áø, ±ô¦À¡ØÐ 
§ÅñÎÁ¡É¡Öõ þó¾ ¬öÅ¢Ä¢ÕóÐ   ±ý¨É Å¢ÎÅ¢òÐ ¦¸¡ûÙõ ¯Ã¢¨Á¨Â 
¦¾Ã¢ó¾¢Õì¸¢ý§Èý. ¿¡ý ±ýÛ¨¼Â Í¾ó¾¢ÃÁ¡¸ §¾÷× ¦ºöÔõ ¯Ã¢¨Á¨Âì 
¦¸¡ñÎ º¸É Å¡¾ §¿¡öì¸¡É Á¸¡ «ÉÖÕÅ ÝÃ½õ (¯û ÁÕóÐ) ÁüÚõ Òí¸ 
±ñ¦½ö ¨¾Äõ (¦ÅÇ¢ ÁÕóÐ) ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ 
ÁÕòÐÅ ¬öÅ¢üÌ ±ý¨É ¯ðÀÎò¾ ´ôÒ¾ø «Ç¢ì¸¢§Èý. 
 §¾¾¢:                                                        ¨¸¦Â¡ôÀõ: 
þ¼õ:                                                        ¦ÀÂ÷     : 
 
 §¾¾¢:                                                            º¡ðº¢ì¸¡Ã÷ ¨¸¦Â¡ôÀõ: 
þ¼õ:                                                            ¦ÀÂ÷                :                                                                  
¯È×Ó¨È         : 
Å¢Ã¢×¨ÃÂ¡Ç÷ ¨¸¦Â¡ôÀõ:                              Ð¨Èò¾¨ÄÅ÷ ¨¸¦Â¡ôÀõ: 
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PRECLINICAL AND CLINICAL STUDY ON “MAHA ANALURUVA 
CHOORANAM “(INTERNAL) AND “PUNGAN ENNAI” (EXTERNAL) IN THE 
TREATMENT OF “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
FORM VI - WITHDRAWAL FORM 
SI NO:                 
OP / IP NO:                                               
NAME: 
AGE / GENDER :                
DATE OF TRIAL COMMENCEMENT:  
DATE OF WITHDRAWAL FROM TRIAL:  
REASONS FOR WITHDRAWAL: 
 Long absence at reporting :                                    Yes/ No 
 Irregular treatment:                                                Yes/ No 
 Shift of locality :                                                    Yes/No 
 Increase in severity of symptoms:                         Yes/No 
 Development of severe adverse drug reactions:    Yes/No 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD  
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PRECLINICAL AND CLINICAL STUDY ON “MAHA ANALURUVA 
CHOORANAM “(INTERNAL) AND “PUNGAN ENNAI” (EXTERNAL) IN THE 
TREATMENT OF “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
FORM VII – PATIENT INFORMATION SHEET 
Name of Principal Investigator: Dr.V. Vikram kumar 
Name of the institute: National Institute of Siddha, 
                                       Tambaram Sanatorium, 
                                        Chennai-47. 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL. 
       I, Dr. V. Vikram kumar studying M.D (Siddha) at National Institute of  Siddha, 
Tambaram Sanatorium is doing a trial on  Cegana vatham (Cervical spondylosis) . It is a 
most common degenerative disease, occurring throughout the world. In this regard, I am 
in a need to ask you few questions. I will maintain confidentiality of your comments and 
data  obtained. There will be no risk of disclosing your identity and no physical, 
psychological or professional risk is involved by taking part in this study. Taking part in 
this study is voluntary. No compensation will be paid to you for  taking  part in this 
study. 
           You can choose not to take part. You can choose not to answer a specific 
question. There is no specific benefit for you if you take part in the study. However, 
taking part in the study may be of benefit to the community, as it may help us to 
understand the problem of defaulters and potential solutions. 
             If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal medicine 
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„„Maha Analuruva Chooranam (Internal medicine) 1.5gm b.d with honey for 48 days) 
and „„Pungan Ennai‟‟ (External medicine), if you wish to stay in the In Patient ward 
Varmam Treatment will be provided to you assuring that you will not be definitely hurt 
in any course of treatment. 
  The information I am collecting in this study will remain between you and the 
principal investigator (myself). I will ask you few questions through a questionnaire. I 
will not write your name on this form. I will use a code instead.  
The questionnaire will take approximately 20 minutes of your time. 
If you wish to find out more about this study before taking part, you can ask me 
all the questions you want or contact Dr.V.Vikram kumar, PG Scholar cum principal 
investigator of this study, attached to National Institute of Siddha Ph : 9944457603, 
Chennai-47. You can also contact the Member-secretary of Ethics committee, National 
Institute Siddha, Chennai 600047, for rights and participation in the study.  
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 §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, ¦ºý¨É 47 
«§Â¡ò¾¢¾¡Š ÀñÊ¾÷ ÁÕòÐÅÁ¨É 
¦ºý¨É                                                                        
º¸É Å¡¾õ §¿¡öì¸¡É º¢ò¾ ÁÕóÐ¸Ç¢ý (Á¸¡ «ÉÖÕÅ ÝÃ½õ ÁüÚõ  
Òí¸ý ±ñ¦½ö) ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø  
ÀÊÅõ. 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ¦ÀÂ÷:   ÁÕòÐÅ÷ Å¢.Å¢ìÃõ ÌÁ¡÷ 
¿¢ÚÅÉò¾¢ý ¦ÀÂ÷            §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
                              ¾¡õÀÃõ º¡Éð§¼¡Ã¢Âõ 
                               ¦ºý¨É 600047 
§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¢ø Àð¼ §ÁüÀÊôÒ ÀÂ¢ýÚ ÅÕõ ¿¡ý 
ÁÕòÐÅ÷. Å¢.Å¢ìÃõ ÌÁ¡÷ º¸É Å¡¾õ ±ýÛõ §¿¡Â¢ø ÁÕòÐÅ ¬Ã¡öîº¢Â¢ø 
®ÎÀðÎû§Çý.               
º¸É Å¡¾õ ±ýÛõ §¿¡Â¡ÉÐ ¸ØòÐô ÀÌ¾¢Â¢ø «Ê ÀÎÅ¾¡Öõ ±ÖõÒ 
§¾öÁ¡Éò¾¡Öõ «¾¢¸ ÀÙ àìÌÅ¾¡Öõ Ó¨ÈÂ¡É þÕì¨¸ Ó¨È¸¨Çì 
¸¨¼ôÀ¢Êì¸¡¾¾¡Öõ ¯ñ¼¡¸¢ÈÐ. 
-Ð ÀÃÅì ÜÊÂ §¿¡ö «øÄ. 
-ó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Çì §¸ð¸×õ, §¾¨ÅÂ¡É 
¬öÅ¸ô ÀÃ¢§º¡¾¨ÉìÌ ¾í¸¨Ç ¯ðÀÎò¾×õ ¯û§Çý. 
-ó¾ ¬Ã¡öîº¢ìÌ ¾¡í¸û Å¢ÕôÀò¾¢ý §ÀÃ¢ø ¯ðÀÎõ Àðºò¾¢ø 
¯ûÁÕó¾¡¸ Á¸¡ «ÉÖÕÅ ÝÃ½õ 1.5¸¢ §¾É¢ø Ì¨ÆòÐ 2 §Å¨Ç(¸¡¨Ä 
Á¡¨Ä) ¯½×ìÌô À¢ý ´Õ Áñ¼Äõ (48¿¡ð¸û) ¯ð¦¸¡ûÇ §ÅñÎõ. ¦ÅÇ¢ 
ÁÕó¾¡¸ Òí¸ý ±ñ¦½ö ¦ÅÇ¢§Â ¾¼Å §ÅñÎõ. ¦ÅÇ¢ §¿¡Â¡Ç÷¸û 7 
¿¡ð¸ÙìÌ ´ÕÓ¨È ÁÕòÐÅÁ¨ÉìÌ ÅÃ§ÅñÎõ. ¯û §¿¡Â¡Ç¢Â¡¸ ¾í¸ 
Å¢ÕôÀõ ¦¾Ã¢Å¢ìÌõ Àðºò¾¢ø §¿¡öìÌò ¾Ìó¾ Å÷Áî º¢¸¢î¨º «Ç¢ì¸ôÀÎõ 
-ó¾ ÁÕóÐ º¢ÈôÀ¡¸ º¸É Å¡¾õ  §¿¡öì¸¡¸ «í¸£¸Ã¢ì¸ôÀð¼ º¢ò¾ 
ÁÕòÐÅ áÄ¢ø ÜÈôÀðÎûÇÐ. 
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-ó¾ ¬Ã¡öîº¢Â¢ø ¾í¸¨Ç «ÛÁ¾¢ò¾ À¢ÈÌ ¯í¸ÙìÌ Å¢ÕôÀõ 
-ø¨Ä¦ÂÉ¢ø ±ô§À¡Ð §ÅñÎÁ¡É¡Öõ ¬Ã¡öîº¢Â¢ø þÕóÐ Å¢Ç¸¢ì 
¦¸¡ûÇ ¯Ã¢¨Á ¯ûÇÐ. 
-ó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ §¿¡Â¢ý ¾ý¨Á ÀüÈ¢Ôõ ÁüÈ 
Å¢ÀÃí¸ÙìÌõ Ó¾ý¨Á ¬Ã¡öîº¢Â¡ÇÃ¡É ÁÕòÐÅ÷: Å¢.Å¢ìÃõ ÌÁ¡÷ (Àð¼ 
§Áü ÀÊôÀ¡Ç÷ º¢ÈôÒ ÁÕòÐÅ Ð¨È) «Å÷¸¨Ç ±ó¾ §¿Ãò¾¢Öõ ¦¾¡¼÷Ò 
¦¸¡ûÇÄ¡õ ¨¸ô§Àº¢ ±ñ 9944457603 
 
§ÁÖõ  -ó¾ ¬Ã¡öîº¢ìÌ ¾ì¸ «ÛÁ¾¢î º¡ýÚ (IEC) ¦ÀÈôÀðÎûÇÐ. 
þó¾ ÁÕóÐ ÓüÈ¢Öõ À¡Ð¸¡ôÀ¡É ãÄ¢¨¸¸¨Çì ¦¸¡ñÎ 
¾Â¡Ã¢ì¸ôÀðÎûÇÐ. Àì¸ Å¢¨Ç×¸¨Ç ²üÀÎò¾¡Ð. 
§ÁÖõ ¯½× Ó¨ÈÂ¢ø ÁÕòÐÅÃ¡ø ÜÈôÀÎõ Àò¾¢Âõ  ¸¡ìÌÁ¡Ú 
«È¢×Úò¾ ÀÎ¸¢ÈÐ. 
-Ð ºõÀó¾Á¡É ¾í¸ÇÐ «¨ÉòÐ Å¢ÅÃí¸Ùõ Ã¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ 
±É ¯Ú¾¢«Ç¢ì¸¢§Èý. 
-¾¢ø ÀÂ½ôÀÊ Ó¾Ä¢Â ±ó¾ ¯¾Å¢ò ¦¾¡¨¸Ôõ ÅÆí¸ô À¼ Á¡ð¼¡Ð. 
-ó¾ ¬Ã¡öîº¢Â¢ý §À¡Ð ¯¼ÖìÌ §ÅÚ À¡¾¢ôÒ ²üÀÎõ Àðºò¾¢ø 
§¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø ¾ì¸ º¢¸¢î¨º «Ç¢ì¸ôÀÎõ. 
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PRECLINICAL AND CLINICAL STUDY ON “MAHA ANALURUVA 
CHOORANAM “(INTERNAL) AND “PUNGAN ENNAI” (EXTERNAL) IN THE 
TREATMENT OF “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
FORM VIII - DRUG COMPLIANCE FORM 
SERIAL NO:  
OP/IP NO: 
NAME:        
AGE/ GENDER:                                  
DRUG NAME:  Maha Analuruva Chooranam 
OPD: 
On 1
st    
 day-Date:   Drugs issued: 21(Gms) Drugs returned: (Gms) 
On 8
th
   day-Date:     Drugs issued: 21(Gms) Drugs returned:  (Gms) 
On 15
th
 day-Date:         Drugs issued: 21(Gms) Drugs returned:  (Gms) 
On 22
nd
 day-Date:         Drugs issued: 21(Gms) Drugs returned:  (Gms) 
On 29
th
 day-Date:          Drugs issued: 21(Gms) Drugs returned:  (Gms) 
On 36
th
 day-Date:          Drugs issued: 21(Gms) Drugs returned:  (Gms) 
On 43
rd
 day-Date:          Drugs issued: 21(Gms) Drugs returned:  (Gms)  
 
 
 
 
 
164 
 
IPD: 
Day        Date Morning Evening Day       Date Morning Evening 
Day 1    Day 2    
Day 3    Day 4    
Day 5    Day 6    
Day 7    Day 8    
Day 9    Day 10    
Day 11    Day 12    
Day 13    Day 14    
Day 15    Day 16    
Day 17    Day 18    
Day 19    Day 20    
Day 21    Day 22    
Day 23    Day 24    
Day 25    Day 26    
Day 27    Day 28    
Day 29    Day 30    
Day 31    Day 32    
Day 33    Day 34    
Day 35    Day 36    
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Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD  
 
 
 
 
 
 
 
 
 
 
 
 
Day 37    Day 38    
Day 39    Day 40    
Day 41    Day 42    
Day 43    Day 44    
Day 45    Day 46    
Day 47    Day 48    
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PRECLINICAL AND CLINICAL STUDY ON “MAHA ANALURUVA 
CHOORANAM “(INTERNAL) AND “PUNGAN ENNAI” (EXTERNAL) IN THE 
TREATMENT OF “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
FORM IX - DIETARY ADVICE FORM 
§º÷ì¸ì ÜÊÂ ¯½×¸û (Diet to be included): 
¸¡ö¸û (Vegetables): 
 ¸ò¾Ã¢ôÀ¢ïÍ (Unripe brinjal) 
 ÓÕí¨¸ôÀ¢ïÍ (Unripe drumstick) 
 «Å¨ÃôÀ¢ïÍ (Unripe Dolichos bean) 
¸£¨Ã¸û (Greens): 
 ¦À¡ýÉ¡í¸ñ½¢ (Sessile plant [Alternanthera sessilis] ) 
 ãì¸¢Ãð¨¼ (Hog weed [Boerhaavia diffusa] ) 
 àÐ§Å¨Ç (Climbing brinjal [Solanum trilobatum] ) 
 ÓÕí¨¸ì¸£¨Ã (Leaves of Drumstick [Moringa oleifera] ) 
 ¸È¢§ÅôÀ¢¨Ä (Curry leaf [Murraya koenigii] ) 
 Ó¼ì¸Úò¾¡ý (Winter cherry [Cardiospermum halicacabum] ) 
 «Ú¸£¨Ã (Amaranthus tristis) 
 ¸Ã¢º¡¨Ä (trailing eclipta [Eclipta prostrate] ) 
ÀÆí¸û (Fruits):  
     Á¡Ð¨Ç (Pomegranate) 
     ¬ôÀ¢û (Apple) 
     ÀôÀ¡Ç¢ (Papaya) 
     ¬ÃïÍ (Orange) 
     §ÀÃ£î¨º (Dates) 
              «ò¾¢ (Fig) 
              ¿¡Åø (Jambul [Syzygium cumini] ) 
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«¨ºÅõ (Non-vegetarian diet): 
  ¦ÅûÇ¡ðÎì¸È¢ (Meat)  
  ¸¡¨¼ (Quail) 
  º¢Ú þÈ¡ø Á£ý (Prawn) 
¾Å¢÷ì¸ §ÅñÊÂ¨Å¸û (Diet to be avoided):                                            
              Í¨Ã (Bottle gourd)                              
              âº½¢ (Pumpkin)                             
              ¦ÅûÇÃ¢ì¸¡ö (Cucumber)             
Ò¼¨Ä (Snake gourd) 
À£÷ìÌ (Ridged gourd)    
  ¯ÙóÐ (Black gram)                                                
¦Á¡î¨º (Indian butter Bean) 
¸¡Ã¡Á½¢ (Cow gram) 
¦¸¡ûÙ (Horse gram)                       
¸ÎÌ (Mustard)                          
±ñ¦½ö (Gingelly oil)         
ÒÇ¢ôÒ (Sour)   
¯ôÒ (Salt)           
Å¡Ôô ¦À¡Õð¸û (Vatha diet)  
¯Õ¨Çì ¸¢ÆíÌ (Potato) 
Å¡¨Æì ¸¡ö (Plantain) 
Ò¨¸Â¢¨Ä (Tobacco)      
ÁÐ «ÕóÐ¾ø (Alcohol) 
¦Àñ§À¡¸õ (þîº¡ Àò¾¢Âõ) [Sexual intercourse] 
 
ÁÕòÐÅ «È¢×¨Ã (Medical advice): 
 ®ÃÁ¢øÄ¡ò ¾¨ÃÂ¢Öõ, ÀÎì¨¸Â¢Öõ ÀÎò¾ø §ÅñÎõ (Should avoid 
sleeping in wet floor or mattress 
 ÌÇ¢÷ ¸¡üÚ ÀÎõÀÊÂ¡É þ¼ò¾¢ø  þÕôÀ¨¾ ¾Å¢÷ì¸×õ (Try to avoid 
cool breeze)  
 ¾¨ÄÂ¨É ÀÂýÀÎòÐÅ¨¾ ¾Å¢÷ì¸ §ÅñÎõ (Should avoid sleeping 
in Pillow) 
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PRECLINICAL AND CLINICAL STUDY ON “MAHA ANALURUVA 
CHOORANAM “(INTERNAL) AND “PUNGAN ENNAI” (EXTERNAL) IN THE 
TREATMENT OF “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
FORM X - ADVERSE REACTION REPORTING FORM 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                    AGE:                                          GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF OCCURRENCE OF THE ADVERSE REACTION:  TIME: 
DESCRIPTION OF ADVERSE REACTION: 
 
 
 
MANAGEMENT: 
 
 
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Lecturer:                                                            Signature of the HOD
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INGREDIENTS 
                   
            Zingiber officinale    Holoptelia integrifolia stem bark 
 
 
 
 
            
Brassica juncea     Holoptelia integrifolia root bark 
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Plumbago zeylanica     Terminalia chebula 
 
 
 
 
                      
                 Nigella sativa          Pongamia glabra 
 
 
 
 
 
171 
 
 
 
 
                 
                     Piper longum     Emblia ribes  
   
 
 
 
        
    
              Allium sativum               Picorrhiza kurroa 
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          Syzygium aromaticum               Piper nigrum 
 
 
 
 
                      
               Carum capticum             Anethum graveolens 
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                 Acorus calamus     Ferula asafoetida 
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                   MAHA ANALURUVA  CHOORANAM 
   
 
                
                              PUNGAN ENNAI 
 
